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Abstract	
	Schwann	cells	of	peripheral	nerves	undergo	significant	changes	in	morphology	and	gene	expression	during	development	and	regeneration	of	 the	peripheral	nervous	system	 (PNS)	 after	 nerve	 injury.	 This	 plasticity	 is	 associated	 with	 the	 greater	regenerative	capability	of	the	PNS	compared	with	the	CNS.	The	transcription	factor	c-Jun	 is	highly	expressed	 in	Schwann	cells	 following	nerve	 injury	and	 is	required	for	 the	 reprogramming	of	mature	Schwann	cells	 to	become	repair	Schwann	cells	that	promote	regeneration.	Mice	with	a	Schwann	cell-specific	c-Jun	deletion	fail	to	generate	 these	 repair	 cells	 after	 nerve	 injury	 and	 consequently	 have	 a	 severe	failure	of	axonal	regeneration.	One	striking	phenotype	of	Schwann	cells	lacking	c-Jun	 is	 that	 in	 culture	 they	 lack	 normal	 bi-	 and	 tri-polar	 morphology	 and	 in	 the	distal	stump	of	injured	nerve	they	form	irregular	and	flattened	profiles.	I	assessed	whether	the	loss	of	c-Jun	affected	their	ability	to	migrate,	an	important	property	of	repair	Schwann	cells	 in	vivo	after	nerve	injury.	Using	two	complementary	 in	vitro	assays,	 I	 revealed	 a	 significant	 reduction	 in	 cell	 migration	 and	 found	 that	 c-Jun	deletion	 caused	 changes	 to	 the	 actin	 cytoskeleton	 and	 reduced	 the	 formation	 of	focal	adhesions.	Nevertheless,	performing	quantitative	polymerase	chain	reaction	on	a	number	of	genes	already	known	to	regulate	the	cytoskeleton	failed	to	reveal	differences	 between	RNA	 from	 c-Jun	knockout	 Schwann	 cells	 and	 control	RNA.	 I	next	 investigated	whether	 Schwann	 cell	 deletion	 of	 c-Jun	 leads	 to	 a	 reduction	 of	Schwann	 cell	 migration	 and	 axonal	 outgrowth	 across	 the	 nerve	 bridge	 of	 the	transected	 nerve.	 I	 developed	 an	 assay	 to	 create	 a	 nerve	 bridge	 that	 can	 be	replicated	easily	in	size	and	proximal-distal	location.	I	achieved	this	by	transecting	the	peroneal	 branch	of	 the	 sciatic	 nerve	while	 leaving	 the	 tibial	 branch	 intact	 to	support	 the	 two	 nerve	 stumps.	 This	 method	 provides	 a	 useful	 model	 of	 nerve	transection.	The	results	reveal	 that	 in	 the	c-Jun	cKO	mouse	at	7	days	after	 injury	Schwann	 cells	 succeeded	 in	 migrating	 across	 the	 nerve	 bridge,	 but	 axons	 show	poor	re-entry	into	the	distal	nerve	stump.	This	requires	further	investigation.	
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Chapter	1:	General	introduction	
1.1	Schwann	cells,	the	major	glial	cells	of	the	peripheral	nervous	system	Schwann	cells	are	the	major	glial	cell	type	found	in	the	peripheral	nervous	system	(PNS).	 The	 term	 ‘Schwann	 cell’	 encompasses	 several	 functionally	 distinct	vertebrate	 glial	 cell	 types	 of	 common	 origin.	 Mature	 Schwann	 cells	 classically	function	to	support	motor	and	sensory	neurons	by	facilitating	the	transmission	of	action	potentials	 from	sensory	receptors	 to	 the	central	nervous	system	(CNS),	or	from	 the	 CNS	 to	 muscle	 fibers.	 The	 importance	 of	 this	 supporting	 role	 is	 most	apparent	 when	 it	 is	 perturbed	 in	 neuropathies	 such	 as	 Charcot-Marie-Tooth	disease,	where	mutations	in	Schwann	cells	can	severely	impair	motor	and	sensory	function.	Although	restricted	to	vertebrates	in	the	literal	sense,	many	invertebrates	such	 as	Drosophila	 possess	 peripheral	 glia	 that	 share	many	 of	 the	 functions	 and	characteristics	 of	 Schwann	 cells.	 This	 long	 evolutionary	 history	 hints	 at	 the	essential	 functions	 these	 glial	 cells	 provide	 in	 the	 PNS,	 which	 are	 necessary	 for	complex	multicellular	life.	
1.1.1	Schwann	cell	subtypes.	Mature	 Schwann	 cells	 exist	 as	 myelinating	 and	 non-myelin-forming	 cell	 types.	Myelin,	a	complex	substance	composed	of	a	 layered	arrangement	of	proteins	and	lipids,	provides	electrical	 insulation	along	axons	and	accelerates	action	potentials	by	enabling	saltatory	conduction.	Myelin	 is	also	synthesised	by	oligodendrocytes,	the	Schwann	cell	counterpart	 in	 the	CNS.	Myelinating	Schwann	cells	are	 found	 in	spinal	 nerves	 and	nerve	 roots,	where	 they	 each	 ensheath	 one	 large	 calibre	 axon	(greater	 than	 1	 µm	 in	 diameter).	 Non-myelin-forming	 Schwann	 cells	 can	 be	classified	 into	 several	 subtypes	 based	 on	 their	 location	 and	 function:	 Remak	
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Schwann	 cells,	 terminal	 Schwann	 cells	 and	 satellite	 Schwann	 cells.	However,	 the	term	‘non-myelinating	Schwann	cell’	 is	often	applied	to	only	the	Remak	Schwann	cells.	These	are	found	in	spinal	nerves	and	nerve	roots,	and	small-diameter	axons	are	 enveloped	within	 invaginations	 of	 the	 Remak	 Schwann	 cell	membrane,	with	the	number	of	axons	per	cell	ranging	from	one	to	over	ten.	Terminal	Schwann	cells	are	 located	 at	 skeletal	 neuromuscular	 junctions	 (NMJ)	 and	 surround	 both	 the	nerve	 terminal	 and	 synaptic	 cleft.	 Each	 NMJ	 typically	 contains	 one	 to	 three	terminal	 Schwann	 cells,	 a	 number	 that	 varies	 with	 species	 and	 synapse	 size.	Satellite	 Schwann	 cells	 of	 the	 sensory,	 sympathetic	 and	 parasympathetic	 ganglia	are	 large,	 flattened	 cells	 covering	 the	 soma	 of	 sensory	 neurons	 (Armati	 2007;	Jessen	&	Mirsky	2005).	The	 PNS	 is	 also	 home	 to	 a	 number	 of	 other	 glial	 cell	 types	 (Fig.	 1.1),	 which	include	 olfactory	 ensheathing	 cells	 of	 the	 olfactory	 nerve,	 the	 enteric	 glia	 of	 the	enteric	nervous	system	and	glia	that	reside	at	specialised	sensory	receptor	nerve	endings,	such	as	the	Pacinian	corpuscle	(Jessen	&	Mirsky	2005).		 	
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Figure	1.1:	Schwann	cell	subtypes	The	 adult	 PNS	 is	 home	 to	 four	 specialised	 Schwann	 cell	 subtypes.	 Myelinating	Schwann	cells	and	Remak	Schwann	cells	reside	within	spinal	nerves	and	roots	and	associate	intimately	with	axons.	Terminal	Schwann	cells	surround	the	synapses	of	skeletal	 muscle	 fibers	 and	 nerve	 terminals	 -	 the	 neuromuscular	 junction	 (NMJ),	and	satellite	Schwann	cells	cover	the	soma	of	neurons	in	the	PNS	ganglia.	
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1.2	Schwann	cell	embryonic	and	postnatal	development	All	 Schwann	 cells	 of	 the	 adult	 PNS	 are	 generated	 during	 development	 from	 the	neural	crest.	Neural	crest	cells	delaminate	from	the	neuroepithelium	and	migrate	along	set	pathways	(Le	Douarin	&	Kalcheim	1999).	The	Schwann	cells	of	the	nerve	trunk	originate	 from	the	neural	crest	cells	 that	embark	upon	a	ventral	migration	pathway,	 whereas	 Schwann	 cells	 of	 the	 dorsal	 and	 ventral	 roots	 and	 satellite	Schwann	cells	of	the	dorsal	root	ganglia	(DRGs)	derive	from	both	migrating	neural	crest	cells	and	boundary	cap	cells.	Boundary	cap	cells	are	the	origin	of	the	majority	of	 glial	 cells	 in	 the	 nerve	 roots,	 and	 DRGs	 and	 are	 themselves	 derived	 from	 the	neural	crest	(Jessen	&	Mirsky	2005;	Maro	et	al.	2004).		 Mature	 myelinating	 and	 Remak	 Schwann	 cells	 are	 generated	 from	 the	neural	crest	via	two	intermediate	cell	types,	the	Schwann	cell	precursor	(SCP)	and	the	immature	Schwann	cell.	The	neural	crest	cell	to	SCP	transition	begins	at	E12-13	 in	 the	 mouse	 (E14-15	 in	 rat).	 Immature	 Schwann	 cells	 appear	 from	 E13-15	(E15-17	in	rat)	and	persist	until	birth	(Jessen	et	al.	1994;	Dong	et	al.	1995;	Dong	et	al.	1999).	The	cells	of	each	stage	differ	widely	in	respect	of	their	antigenic	markers,	cell	 morphology,	 motility,	 association	 with	 axons,	 interactions	 with	 the	extracellular	 matrix	 (ECM)	 and	 their	 requirement	 for	 survival	 factors	 (Jessen	 &	Mirsky	2005).	The	embryonic	and	postnatal	development	of	boundary	cap-derived	Schwann	 cells,	 satellite	 Schwann	 cells	 and	 terminal	 Schwann	 cells	 has	 yet	 to	 be	fully	elucidated.				
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1.3	Schwann	cell	morphology	and	migration	
1.3.1	Schwann	cell	precursor	
1.3.1.1	Schwann	cell	precursor	migration	‘Primitive	 sheath	 cells’,	 or	 Schwann	 cell	 precursors	 as	 they	 later	became	known,	were	first	described	in	the	tadpole	fin	owing	to	the	easy	visualisation	of	developing	nerves	 within	 the	 embryo	 by	 light	 microscopy.	 These	 observations	 revealed	 an	important	 characteristic	 of	 Schwann	 cell	 precursors	 in	 vivo	 is	 their	 ability	 to	migrate	-	almost	always	in	a	proximal	to	distal	manner,	moving	at	an	average	rate	of	 60	 µm/day	 and	 thus	 populating	 the	 entire	 nerve	 length	 with	 Schwann	 cells	(Speidel	 1932).	 In	 agreement	 with	 this,	 rat	 Schwann	 cell	 precursors	 exhibit	 a	migration	rate	of	105	µm/hour	in	vitro	(Jessen	et	al.	1994).	As	with	the	tadpole	fin,	the	 lateral	 line	 of	 the	 zebrafish	 has	 proven	 conducive	 for	 studying	 Schwann	 cell	precursors	in	vivo.	Live	imaging	using	transgenic	zebrafish	expressing	zFoxD3-GFP	to	label	neural	crest-derived	cells,	and	the	lipophilic	dye	DiD	to	label	axons,	reveals	that	as	the	axons	extend	along	the	lateral	line,	Schwann	cell	precursors	migrate	at	the	same	rate,	and	at	a	distance	of	no	more	than	20	µm	behind	the	axonal	growth	cone.	 In	 this	 study,	 Schwann	 cell	 precursors	 co-migrating	with	 the	 growth	 cone	were	 always	 observed	 to	 follow,	 not	 lead	 (Gilmour	 et	 al.	 2002).	 Furthermore,	additional	studies	have	shown	that	and	embryonic	nerves	are	capable	of	reaching	their	 final	 targets	 in	 the	 absence	 of	 Schwann	 cell	 precursors	 (Grim	 et	 al.	 1992;	Riethmacher	et	al.	1997;	Woldeyesus	et	al.	1999).		Schwann	 cell	 precursors	 are	 also	 intimately	 associated	 with	 the	 growing	peripheral	nerve	fronts	 in	the	mouse.	Here,	 they	are	seen	in	contact	with	growth	cones	 in	 the	 extreme	 periphery,	 close	 to	 the	 axonal	 targets.	 Schwann	 cell	
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precursors	 are	 even	 found	 to	 extend	 in	 front	 of	 the	 growth	 cone,	 providing	 a	potential	substrate	for	the	growth	cone	to	follow	(Wanner,	Mahoney,	et	al.	2006b).	Genetic	labelling	of	actin	of	the	peripheral	glia	in	Drosophila	shows	these	cells	also	migrate	with	 axons,	 as	 a	 continuous	 chain	 in	 the	 developing	 nerve.	 The	 leading	cells	of	the	chain	extend	filopodia,	similar	to	those	seen	in	the	zebrafish,	composed	of	actin	and	microtubules	(Sepp	et	al.	2000;	Sepp	&	Auld	2003).		 The	 studies	 described	 above	 show	 that	 while	 the	 role	 of	 Schwann	 cell	precursors	 in	 growth	 cone	 guidance	 remains	 unclear,	 they	 are	 integral	 to	 the	growing	 nerve	 and	 co-exist	 with	 axons	 along	 their	 entire	 length	 during	development.	 Although	 axons	 are	 capable	 of	 growing	 into	 the	 periphery	 in	 the	absence	of	Schwann	cell	precursors,	 they	are	defasciculated	and	 fail	 to	 innervate	distal	targets	correctly	(J.	K.	Morris	et	al.	1999).	For	Schwann	cell	precursors	to	populate	the	entire	nerve	length,	they	must	be	 either	 increasing	 in	 number	 by	 mitosis,	 continually	 differentiating	 from	 the	neural	 crest,	or	a	 combination	of	 the	 two,	whilst	 concurrently	keeping	pace	with	the	 axons	 growing	 into	 the	 periphery.	 The	 progression	 from	 neural	 crest	 to	Schwann	cell	precursors	is	poorly	understood,	but	it	is	known	that	motor	neurons	arrest	 the	 migration	 of	 the	 Schwann	 cell	 precursor,	 as	 ablation	 of	 the	 ventral	neural	tube	(and	thus	motor	neurons)	causes	Schwann	cell	precursors	to	disperse	from	 the	 ventral	 root	 area.	 Neural	 crest	 cell	 migration	 is	 not	 affected	 by	 the	absence	 of	 motor	 neurons.	 The	 precise	 timing	 and	 location	 of	 Schwann	 cell	precursor	generation	is	not	well	characterised,	but	the	observation	that	a	subset	of	neural	 crest	 cells	 express	myelin	protein	 zero	 (MPZ)	 indicates	 that	 Schwann	cell	precursor	differentiation	begins	before	their	association	with	axons	at	the	ventral	roots	 (Bhattacharyya	et	 al.	 1994;	Bhattacharyya	et	 al.	 1991).	 It	 is	 suggested	 that	the	 subset	 of	 neural	 crest	 cells	 destined	 to	 become	 Schwann	 cell	 precursors	 are	
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attracted	 to	 axons	by	 contact	or	 a	diffusible	 cue	 (Bhattacharyya	et	 al.	 1994)	 and	once	 they	 are	 at	 the	 nerve	 roots,	 these	 neural	 crest	 cells	 feed	 into	 chains	 of	Schwann	 cell	 precursors	 that	 co-migrate	 with	 growth	 cones	 into	 the	 periphery	(Klämbt	2010).	Schwann	cell	precursors	actively	proliferate	by	mitosis	whilst	they	are	 migrating	 along	 the	 growing	 axons	 (Speidel	 1932).	 Thus,	 Schwann	 cell	precursors	 achieve	 complete	 coverage	 of	 the	 nascent	 peripheral	 nerves	 by	 a	combination	 of	 differentiation	 from	 the	 neural	 crest	 and	 cell	 division,	 while	moving	 along	 the	 axons	 to	 settle	 in	 the	 periphery.	 The	 relative	 contributions	 of	migration	and	proliferation	to	achieve	complete	coverage	of	the	nerve	are	unclear.	If	proliferation	is	blocked,	co-migration	of	peripheral	glia	and	growth	cones	along	the	 zebrafish	 lateral	 line	 is	 unaffected	 (Lyons	 et	 al.	 2005),	 indicating	 that	proliferation	is	not	critical	in	this	animal	model.	
1.3.1.2	Molecular	control	of	Schwann	cell	precursor	migration	Neuregulin	 1	 (NRG1)	 is	 critical	 for	 Schwann	 cell	 precursor	 generation	 and	 their	migration,	proliferation	and	survival	(Jessen	&	Mirsky	2005).	 In	mice	deficient	 in	NRG1	signalling	(by	knocking	out	NRG1,	ErbB2	or	ErbB3),	neural	crest	cells	fail	to	migrate	 past	 the	 level	 of	 the	 dorsal	 aorta	 along	 the	 ventromedial	 migration	pathway,	 to	 the	 location	 of	 sympathetic	 ganglia	 formation	 (Britsch	 et	 al.	 1998).	These	NRG1	mutants	die	from	cardiac	defects	at	embryonic	day	11,	however	if	this	cardiac	 defect	 is	 rescued	 the	mice	 can	 live	 until	 birth	 and	 the	 effect	 of	NRG1	on	Schwann	cells	may	be	determined.	This	reveals	a	severe	depletion	of	Schwann	cells	in	the	peripheral	nerve	trunk	(Riethmacher	et	al.	1997;	Woldeyesus	et	al.	1999;	J.	K.	 Morris	 et	 al.	 1999).	 As	 NRG1	 signalling	 is	 critical	 to	 Schwann	 cell	 precursor	survival	and	proliferation,	it	is	difficult	to	tease	out	its	role	in	cell	migration	using	genetic	mutants.	In	the	zebrafish,	it	is	possible	to	use	pharmacological	inhibitors	of	
 
 
	 18	
ErbB3	 to	disrupt	NRG1	 signalling	 for	 a	 short	period	without	 inducing	 significant	cell	 death.	 The	 effect	 of	 this	 is	 a	 dramatic	 decrease	 in	 Schwann	 cell	 precursor	migration	and	an	uncoupling	of	their	co-migration	with	axonal	growth	cones.	Cell	migration	 along	 the	 lateral	 line	 resumes	 once	 the	 inhibitor	 is	 removed.	 NRG1	signalling	 inhibition	 also	 misdirects	 Schwann	 cell	 precursor	 movement	 in	 some	cells,	and	Lyons	et	al.	propose	that	NRG1	affects	Schwann	cell	precursor	directed	migration	 and	 is	 continuously	 required	 for	 their	 motility,	 rather	 than	 simply	allowing	 the	 cells	 to	 become	 competent	 at	 migrating	 (Lyons	 et	 al.	 2005).	 In	agreement	with	this,	Schwann	cell	precursors	deficient	in	ErbB3	have	significantly	reduced	 migration	 from	 DRG	 explants,	 but	 exogenous	 NRG1	 does	 not	 enhance	wildtype	Schwann	cell	precursor	migration	(J.	K.	Morris	et	al.	1999).	Recent	work	in	zebrafish	has	shown	that	knocking	down	NRG1	type	III	directly	leads	to	reduced	migration	along	 the	pLL	and	overexpression	of	human	NRG1	 type	 III	 in	neurons	causes	ectopic	Schwann	cell	precursor	migration	(Perlin	et	al.	2011).	Dynamic	remodelling	of	the	actin	cytoskeleton	by	the	Rho	family	GTPases	is	crucial	for	cell	motility	(Raftopoulou	&	A.	Hall	2004)	and	unsurprisingly,	this	holds	true	for	the	peripheral	glia	of	Drosophila.	Expression	of	constitutively	active	RhoA	and	 Rac1	 in	 these	 cells	 results	 in	 abrogated	 cell	 migration,	 however	 the	 over-expression	 or	 deletion	 of	 Cdc42	 causes	 no	 migration	 phenotype	 (Sepp	 &	 Auld	2003).	Rac1	and	Cdc42	appear	not	to	control	Schwann	cell	precursor	migration	in	the	mammalian	PNS,	 since	genetic	deletion	of	 these	proteins	 in	Schwann	cells	 at	E12	 does	 not	 lead	 to	 a	 deficit	 of	 Schwann	 cell	 numbers	 at	 E17.5	 or	 affect	 their	movement	along	axons	(Benninger	et	al.	2007;	Nodari	et	al.	2007).	
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1.3.1.3	Schwann	cell	precursor	morphology	and	cytoskeletome	
	 In	 vivo,	 Schwann	 cell	 precursors	 have	 extensive	 sheet-like	 processes	 that	are	 in	 contact	 with	 compact	 axon	 bundles	 and	 other	 precursor	 cells.	 Electron	microscopy	observations	have	revealed	the	developing	peripheral	nerve	contains	very	little	extracellular	matrix	(ECM)	at	this	point,	although	it	is	possible	that	some	ECM	 is	present.	Schwann	cell	precursors	 lack	a	basal	 lamina	and	 therefore	make	contact	with	axons	and	other	precursors	via	their	plasma	membrane.	Schwann	cell	precursors	 extend	 their	 sheet-like	 processes	 around	 the	 compact	 axon	 bundles	and	also	within	 them,	 separating	 the	bundles	 into	 smaller	domains	 (Jessen	et	 al.	1994).	 These	 flattened	 sheets	 are	 very	 elongated,	 longitudinally	 along	 the	 axon	bundle	(Wanner,	Guerra,	et	al.	2006a).	The	pioneer	Schwann	cell	precursors	that	follow	 closely	 behind	 axonal	 growth	 cones	 of	 the	 zebrafish	 lateral	 line	 have	 a	dynamic	and	polarised	shape,	with	filopodia	at	the	front	of	the	cell,	characteristic	of	 migrating	 cells	 (Gilmour	 et	 al.	 2002).	 Similarly,	 at	 the	 nerve	 front	 of	 the	developing	mouse	PNS,	Schwann	cell	precursors	extend	lamellipodia	and	filopodia.	These	 are	 observed	 both	 in	 contact	 with,	 and	 ahead	 of	 growth	 cones	 (Wanner,	Mahoney,	et	al.	2006b).	In	culture,	Schwann	cell	precursors	are	highly	motile	and	form	 groups	 of	 highly	 flattened	 cells	 with	 many	 cell-cell	 contacts	 (Jessen	 et	 al.	1994).	Schwann	 cell	 precursors	 express	 vimentin,	 an	 intermediate	 filament	 (IF)	that	 is	often	used	as	a	marker	of	mesenchymal	cells	and	is	expressed	throughout	the	 Schwann	 cell	 lineage	 (Mirsky	 et	 al.	 2001).	 Vimentin	 is	 known	 to	 induce	 cell	migration	 in	 numerous	 cell	 types	 (Vuoriluoto	 et	 al.	 2010;	 Gilles	 et	 al.	 1999).	Another	IF	protein,	nestin,	is	expressed	by	Schwann	cell	precursors	and	this	is	also	strongly	associated	with	cell	migration.	GAP-43,	which	is	expressed	at	high	levels	in	 growth	 cones	 and	 axons	 where	 it	 is	 involved	 in	 axon	 elongation	 and	 neurite	
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outgrowth,	is	also	expressed	by	Schwann	cell	precursors	(Curtis	et	al.	1992;	Jessen	et	 al.	 1994;	Dong	 et	 al.	 1999).	 To	 date,	 the	 only	 Schwann	 cell	 precursor-specific	marker	 is	 the	 cell	 adhesion	 molecule	 (CAM)	 N-cadherin.	 The	 absence	 of	endoneurial	 space	 between	 the	 Schwann	 cell	 precursors	 is	 correlated	 with	 N-cadherin	 expression	 and	 the	 presence	 of	 extensive	 cell-cell	 contacts.	 N-cadherin	expression	is	especially	high	in	the	Schwann	cell	precursors	at	the	growing	nerve	front,	in	close	proximity	to	the	axonal	growth	cones	(Wanner,	Guerra,	et	al.	2006a).	
1.3.2	Immature	Schwann	cell	
	 The	transition	from	Schwann	cell	precursor	to	immature	Schwann	cell	takes	place	between	E13-E15	in	the	mouse	(and	E15-E17	in	rat).	At	this	time,	significant	events	 in	 nerve	 organogenesis	 are	 taking	 place,	 such	 as	 increased	 production	 of	ECM,	vascularisation	and	establishment	of	the	perineurium	surrounding	the	nerve	(Jessen	&	Mirsky	2005).	The	nature	of	the	Schwann	cell-axon	relationship	changes	dramatically	 when	 Schwann	 cell	 precursors	 differentiate.	 Innervation	 of	 axonal	targets	 is	 complete	 by	 this	 stage,	 and	 thus	 the	 requirement	 for	 Schwann	 cell	colonisation	of	additional	axonal	territory	and	therefore	longitudinal	Schwann	cell	migration,	 is	 unnecessary.	 The	most	 striking	 changes	 in	 immature	 Schwann	 cell	spatial	behaviour	initially	occur	in	the	transverse	plane	of	the	nerve,	in	contrast	to	the	 longitudinal	 (proximal-distal)	 movement	 of	 Schwann	 cell	 precursors.	Immature	 Schwann	 cells	 become	 arranged	 into	 groups	 or	 ‘families’	 that	 share	 a	common	 basal	 lamina	 and	 ensheath	 large	 bundles	 of	 axons.	 Surrounding	 these	axon-Schwann	 cell	 families	 are	 endoneurial	 fibroblasts,	 blood	 vessels	 and	 ECM	(Jessen	&	Mirsky	2005).	Following	this,	another	change	in	Schwann	cell	behaviour	occurs,	 when	 Schwann	 cells	 start	 to	 elongate	 longitudinally	 to	 establish	 the	presumptive	myelin	 internode.	 Schwann	 cell	 elongation	 is	necessary	 to	maintain	
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coverage	of	the	axon	since	the	embryonic/neonatal	nerve	is	continuously	growing	in	length	but	the	number	of	Schwann	cells	does	not	increase.	
1.3.2.1	Radial	sorting	Shortly	 after	 Schwann	 cell	 families	 are	 established,	 a	 process	 occurs	 whereby	individual	large	diameter	axons	are	isolated	and	ensheathed	by	a	single	Schwann	cell.	This	has	been	termed	‘radial	sorting’	and	requires	immature	Schwann	cells	to	extend	 radial	 lamellipodia	 into	 the	 axon	 bundle	 and	 segregate	 large	 diameter	axons	(Webster	&	Favilla	1984).	The	rearrangement	of	axon	bundles	by	immature	Schwann	cells	to	form	a	1:1	ratio	of	large	diameter	axons	and	Schwann	cells,	and	also	 the	 generation	 of	 Remak	 Schwann	 cells	 containing	multiple	 small	 diameter	axons,	 requires	 remarkable	 precision	 and	 control	 over	 the	 Schwann	 cell	cytoskeleton.	The	signals	that	control	this	process	have	slowly	been	revealed,	and	initial	 insights	 were	 gained	 from	 studying	 mouse	 models	 with	 axonal	 sorting	phenotypes.	Correct	radial	sorting	is	highly	dependent	on	there	being	a	sufficient	number	of	 Schwann	cells	 in	 the	nerve	 to	 segregate	 the	axons,	 therefore	proteins	that	 have	 an	 effect	 on	 cellular	 proliferation,	 but	 not	 process	 extension	 can	 also	perturb	the	sorting	of	axons.		 The	 first	 axonal	 sorting	 phenotype	 identified	was	 in	 dystrophic	mice	 that	have	 mutations	 in	 the	 basal	 lamina	 protein	 laminin	 211,	 causing	 muscular	dystrophy.	Congenital	muscular	dystrophy	1A	patients	also	lack	the	gene	encoding	the	 laminin	α2	chain.	Dystrophic	mice	have	a	sorting	defect,	 in	which	bundles	of	naked	axons	remain,	with	no	ensheathment	by	Schwann	cells	(Bradley	&	Jenkison	1973).	 Immature	Schwann	cells	express	 the	 laminin	receptor	β1-integrin,	and	 its	inactivation	 provides	 an	 almost	 complete	 block	 on	 myelination.	 Using	 mice	 in	
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which	 β1-integrin	 is	 conditionally	 deleted	 in	 Schwann	 cells,	 the	 block	 on	myelination	was	 shown	 to	 be	 due	 to	 a	 failure	 in	 radial	 sorting	 to	 generate	 pro-myelinating	Schwann	cells.	These	mice	display	a	similar	phenotype	to	dystrophic	mice	 (Fernandez-Valle	 et	 al.	 1994;	 Feltri	 et	 al.	 2002).	 Additional	 radial	 sorting	phenotypes	have	been	found	in	mice	with	conditional	deletions	of	genes	encoding	proteins	downstream	of	laminin-integrin	signalling,	such	as	focal	adhesion	kinase	(FAK)	 (Grove	 et	 al.	 2007),	 Rac1	 (Nodari	 et	 al.	 2007)	 and	 integrin-linked	 kinase	(ILK)	 (Pereira	 et	 al.	 2009).	 Rac1	 specifically	 has	 been	 linked	 to	 the	 extension	 of	radial	 lamellipodia	 by	 Schwann	 cells	 that	 are	necessary	 for	 the	 sorting	 of	 axons.	Immature	 Schwann	 cells	 of	 the	 Rac1	 cKO	 mouse	 have	 shorter	 processes	 and	almost	no	radial	lamellipodia.	The	presence	of	large-diameter	axons	within	Remak	bundles	 indicates	 a	 reduced	 ability	 for	 Rac1	 KO	 Schwann	 cells	 to	 sort	 axons.	Expression	 of	 a	 mutated	 form	 of	 the	 protein	 NF2	 (also	 called	 merlin	 or	schwannomin)	from	a	gene	in	which	exons	2	and	3	are	deleted,	to	mimic	the	muted	gene	 in	NF2	patients,	 can	partially	 rescue	 the	defects	 in	axial	process	 length	and	myelination	in	Rac1	KO	Schwann	cells,	but	does	not	restore	the	normal	abundance	of	radial	lamellipodia	(Guo	et	al.,	2012).	This	finding	suggests	that	Rac1	mediated	axial	process	extension	 is	somewhat	dependent	on	NF2.	 It	seems	that	NF2	 is	not	involved	 in	 Rac1-dependent	 radial	 sorting,	 since	 the	 sorting	 defects	 observed	 in	the	Rac1	cKO	mice	are	unchanged	in	the	Rac1	cKO&NF2-del	mice.	There	are	now	several	interconnected	pathways	that	have	been	identified	in	regulating	Schwann	cell-mediated	radial	sorting	of	axons	(Figure	1.2).					
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Figure	1.2:	Radial	sorting	involves	a	number	of	molecular	pathways.	
An illustration of the molecular pathways involved in radial sorting of axons, 
adapted from Feltri et al, 2015. Depicted are two immature Schwann cells, 
inserting processes into an axon bundle. Cyclic AMP (cAMP), Dystroglycan 
(DG), Focal adhesion kinase (FAK), Grb2-Associated Binder (Gab), Gpr (G 
protein-coupled receptor), Histone deacetylase (Hdac), Integrin (α6β1, α7β1), 
Integrin-linked kinase (ILK), Jun activation domain–binding (Jab), lymphoid cell 
kinase (Lck), Leucine-rich-glioma inactivated (Lgi), Liver Kinase B (Lkb), 
Neurofibromin (Nf), Neural Wiskott–Aldrich syndrome protein (N-Wasp) and 
Protein Kinase A (PKA) 				
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1.3.2	Myelinating	Schwann	cell	An	 immature	 Schwann	 cell	 that	 has	 become	 associated	 with	 a	 solitary	 large-diameter	axon	is	termed	a	pro-myelinating	Schwann	cell.	This	is	a	transient	stage,	occurring	 before	 the	 onset	 of	 axonal	 ensheathment	 in	 the	 days	 following	 birth.	Myelination	 begins	 when	 the	 leading	 edge	 of	 the	 Schwann	 cell	 inner-mesaxon	starts	 to	 extend	 and	 wrap	 spirally	 around	 the	 axon.	 This	 extensive	 membrane	synthesis	and	spiral	wrapping	of	the	axon	generates	the	multi-lamella	structure	of	myelin	(Bunge	et	al.	1989).	Parallels	between	the	two	morphological	processes	of	myelination	 and	 cell	 migration	 can	 be	 seen,	 such	 as	 the	 requirement	 for	 actin	polymerisation	 for	membrane	extension	and	 the	 involvement	of	 the	RhoGTPases	and	other	modulators	of	the	actin	cytoskeleton.	
1.3.2.1	Cytoskeletal	control	of	myelination	Actin	polymerisation	is	required	for	myelination,	as	its	inhibition	in	Schwann	cell-neuron	 cocultures	 by	 cytochalasin	 D	 provides	 a	 complete	 block	 on	 myelination	(Fernandez-Valle	et	al.	1997).	Myosin	II,	an	actin	cross-linking	protein	that	enables	contraction	 of	 actomyosin	 bundles	 is	 also	 crucial	 for	 myelination,	 since	 its	inhibition	 similarly	 blocks	myelin	 formation	 in	 vitro	 (Wang	 et	 al.	 2008).	 Thus	 it	appears	that	in	order	for	a	Schwann	cell	to	elaborate	its	myelin	sheath	around	an	axon,	 both	 actin	 polymerisation	 and	 actomyosin	 contraction	 are	 required.	 In	support	 of	 this,	 several	 regulators	 of	 actin	 microfilament	 assembly/disassembly	and	 myosin	 II	 activity	 described	 below	 are	 also	 regulators	 of	 myelination.	 An	important	caveat	in	studying	the	involvement	of	the	cytoskeleton	in	myelination	is	the	 complication	 of	 the	 signals	 that	 drive	 membrane	 protrusion	 involved	 in	ensheathment	are	similar	to	those	required	for	the	extension	of	radial	lamellipodia	
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during	radial	sorting,	as	described	earlier.	To	correctly	implicate	the	involvement	of	 specific	 cytoskeletal	 regulators	 in	 controlling	myelination,	 radial	 sorting	must	first	proceed	normally	and	this	makes	in	vivo	evidence	hard	to	obtain.		 	The	 actin-regulating	 RhoGTPases	 Cdc42	 and	 Rac1	 are	 both	 required	 for	correct	 radial	 sorting	 (Benninger	 et	 al.	 2007;	Nodari	 et	 al.	 2007),	 however	 some	Schwann	 cells	 in	 these	 conditional	 knockout	 mice	 do	 progress	 to	 the	 pro-myelinating	 stage.	 These	 cells	 are	 arrested	 and	 do	 not	 go	 on	 to	 myelinate,	indicating	an	 involvement	 in	both	ensheathment	and	radial	sorting	 for	these	two	proteins	(Feltri	et	al.	2008;	Guo	et	al.	2012).		
1.3.3	Bungner/denervated	Schwann	cell	The	 Bungner	 Schwann	 cell	 (also	 referred	 to	 as	 a	 denervated	 or	 dedifferentiated	Schwann	cell)	 is	generated	 from	both	myelinating	and	non-myelinating	Schwann	cells	of	the	mature	nerve	when	they	lose	contact	with	axons.	A	nerve	injury	such	as	crush	or	transection	will	cause	an	axon	to	become	separated	from	the	perikaryon	and	then	degenerate.	The	accompanying	Schwann	cells	will	 lose	contact	with	the	axonal	membrane.	An	unknown	 signal	 causes	 the	 Schwann	 cell	 to	 switch	 from	a	phenotype	that	can	support	the	intact	axon,	for	example	by	maintaining	the	myelin	sheath	 and	 nodes	 of	 Ranvier,	 to	 a	 phenotype	 that	 is	 supportive	 of	 nerve	 repair.	This	 repair	 program	 enables	 Bungner	 cells	 to	 provide	 an	 environment	 that	 is	permissive	for	axon	regrowth	through	the	regenerating	nerve;	by	secreting	trophic	factors,	 expressing	 surface	 molecules	 that	 interact	 with	 axons,	 recruiting	macrophages	to	clear	debris	from	the	nerve,	remodelling	the	extracellular	matrix	and	 forming	 guidance	 conduits	 called	 Bands	 of	 Büngner.	 (Arthur-Farraj	 et	 al.	2012).	 These	 functions	 are	 distinct	 from	 those	 of	 the	 immature	 Schwann	 cell,	which	 share	 similar	 antigenic	 markers	 and	 the	 process	 of	 generating	 Bungner	
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Schwann	 cells	 has	 been	 referred	 to	 as	 ‘transdifferentiation’	 rather	 than	‘dedifferentiation’.	Another	important	difference	is	that	Bungner	Schwann	cells	are	for	 the	most	part	without	 any	axonal	 contact.	All	 other	 cells	 of	 the	 Schwann	 cell	lineage	 are	 in	 constant	 association	 with	 axons.	 The	 Bungner	 Schwann	 cell	 will	quickly	re-differentiate	into	a	myelinating	or	non-myelinating	Schwann	cell	when	contact	is	re-established.		
1.3.3.1	Bungner/denervated	Schwann	cell	migration		Bungner	 Schwann	 cells	 are	 highly	 motile,	 a	 characteristic	 that	 is	 important	 for	effective	 nerve	 regeneration,	 for	 example	 in	 bridging	 the	 gap	 between	 two	transected	nerve	stumps.	The	 first	observations	of	Schwann	cell	motility	were	of	Bungner/denervated	Schwann	cells	 spreading	out	 from	explants	of	degenerating	peripheral	 nerves	 –	 the	 observations	 of	 migrating	 Schwann	 cell	 precursors	 by	Speidel	were	made	some	time	later.	Ingebrigtsen	recorded	cells	migrating	from	the	nerve	explant	approximately	five	days	after	being	in	culture	and	hypothesised	the	same	behaviour	might	take	place	in	vivo	following	nerve	transection	(Ingebrigtsen	1913).		To	date,	the	vast	majority	of	studies	that	consider	the	molecular	control	of	Schwann	cell	migration	have	utilised	cultured	Bunger/denervated	Schwann	cells,	and	many	 of	 these	 have	wrongly	 been	 used	 as	 an	 in	 vitro	 model	 to	 understand	Schwann	 cell	 precursor	 migration	 during	 development.	 For	 this	 reason,	 in	 vitro	studies	for	Bungner	Schwann	cell	migration	are	plentiful,	but	there	are	few	in	vivo	studies	 of	 the	 molecular	 control	 of	 their	 migratory	 behaviour	 during	 nerve	regeneration.	
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1.3.3.2	Molecular	control	of	Bungner/denervated	Schwann	cell	migration	
1.3.3.2.1	Neuregulin	NRG1	stimulation	of	ErbB2/3	is	required	for	the	persistent	and	directed	migration	of	Schwann	cell	precursors,	as	discussed	previously	(Section	1.3.1.2).	Some	studies	have	used	denervated	Schwann	cell	cultures	to	provide	 indirect	 in	vitro	evidence	for	 the	 role	 of	 NRG1	 in	 Schwann	 cell	 precursor	 migration,	 since	 the	 precursor	requires	NRG1	 for	 its	 survival.	Expression	of	NRG1	 isoforms	and	ErbB2/3	 in	 the	distal	nerve	stump	increases	following	injury,	first	detectable	at	3	days	(Fricker	et	al.	 2013).	 Mahanthappa	 et	 al.	 found	 that	 secreted	 NRG1	 (also	 known	 as	 Glial	Growth	 Factor	 2)	 increases	 the	 motility	 of	 denervated	 Schwann	 cells	 at	concentrations	 insufficient	 to	 induce	 proliferation	 (Mahanthappa	 et	 al.	 1996).	Later	 studies	 have	 implicated	 several	 signalling	 pathways	 in	 NRG-ErbB2/3	induced	Schwann	cell	migration;	these	include	MAPK,	Rac1/Cdc42-JNK	and	Shp2-Src-FAK	 (Meintanis	 et	 al.	 2001;	 Yamauchi	 et	 al.	 2008;	 Grossmann	 et	 al.	 2009).	Expression	of	 the	 fibronectin	receptor	 integrin	α5β1	 is	 increased	 in	 the	Bungner	Schwann	cell	after	nerve	crush.	Integrin	α5β1	forms	a	protein	complex	with	ErbB2	and	 FAK	 after	 both	 crush	 (in	 vivo)	 and	 stimulation	 with	 NRG	 (in	 vitro).	 siRNA	knockdown	of	the	integrin	α5	subunit	is	sufficient	to	significantly	reduce	the	pro-migratory	 effect	 of	NRG	on	denervated	 Schwann	 cell	 cultures	 grown	on	 laminin,	collagen	and	fibronectin	substrates	(Wakatsuki	et	al.	2013).		Terminal	 Schwann	 cells,	 which	 are	 of	 the	 same	 origin	 as	 the	myelinating	and	non-myelinating	Schwann	cells	also	respond	to	activation	of	NRG1-ErbB2	by	becoming	 motile.	 Hayworth	 et	 al.	 show	 that	 inducible	 expression	 of	 a	constitutively	 active	 ErbB2	 receptor	 in	 terminal	 Schwann	 cells	 results	 in	 them	
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developing	extensive	 sprouts	and	migrating	away	 from	motor	endplates,	 as	 seen	following	nerve	injury	(Hayworth	et	al.	2006).	
1.3.3.2.2	Neurotrophins	Neurotrophins	 are	 a	 class	 of	 secreted	 growth	 factors	 that	 support	 the	 growth,	development	and	 function	of	neurons,	expression	of	many	members	 is	 increased	as	part	of	the	regenerative	process	that	occurs	following	nerve	injury.	Specifically,	expression	 of	 nerve	 growth	 factor	 (NGF),	 brain	 derived	 neurotrophic	 factor	(BDNF),	 neurotrophin-4	 (NT-4)	 and	 the	 receptors	 p75NTR	 and	 TrkC	 are	upregulated	in	the	distal	nerve	stump	after	injury	(Heumann	et	al.	1987;	Meyer	et	al.	1992;	Funakoshi	et	al.	1993).		 Schwann	 cells	 show	 enhanced	 migration	 from	 nerve	 explants	 in	 the	presence	of	NGF	 (Anton,	Weskamp,	 et	 al.	 1994b).	Another	 study	has	 shown	 that	deletion	of	Schwann	cell	p75NTR,	the	binding	partner	of	NGF,	has	negligible	effect	on	the	migration	of	Schwann	cell	precursors	(Bentley	&	Lee	2000).	Yamauchi	et	al.	have	 shown	 that	 BDNF	 inhibits	 Bungner	 Schwann	 cell	 migration	 by	 binding	 to	p75NTR	 and	 initiating	 a	 signalling	 cascade	 involving	 Src,	 Vav2	 and	 Rho	 A	(Yamauchi	 et	 al.	 2004).	 They	 have	 also	 found	 that	 neurotrophin-3	 (NT-3)	stimulates	migration	of	cultured	Schwann	cells	via	TrkC,	although	the	relevance	of	this	to	nerve	regeneration	is	unclear,	since	NT-3	expression	decreases	within	the	weeks	following	nerve	injury	(Yamauchi	et	al.	2003;	Funakoshi	et	al.	1993).	
1.3.3.2.3	Extracellular	matrix	Mature	Schwann	cells	of	the	nerve	reside	within	endoneurial	tubes	(also	called	the	endoneurium),	which	is	the	innermost	layer	of	connective	tissue	surrounding	the	
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nerve	 fiber.	 The	 Schwann	 cell	 basal	 lamina	 is	 composed	 of	 proteins	 such	 as	laminin,	 fibronectin	 and	 collagen.	 These	 proteins	 are	 currently	 used	 in	 nerve	guidance	repair	conduits,	partly	due	to	their	ability	 to	enhance	Schwann	cell	and	neuronal	growth	cone	migration.	Upon	nerve	transection,	Schwann	cells	have	been	observed	to	crawl	along	the	tubes	in	the	distal	stump	and	migrate	out	of	the	proximal	end	(Holmes	&	Young	1942;	Holmes	et	al.	1940).	At	the	inter-stump	gap,	Schwann	cells	migrate	across	a	cellular	 bridge	 formed	 by	 inflammatory	 cells	 and	 fibroblasts	 of	 the	 perineurium	(Rexed	1942).	Fibronectin	is	strongly	expressed	in	the	nerve	bridge	and	enhances	denervated	Schwann	cell	migration	via	α5-integrin	(Lefcort	et	al.	1992;	Baron-Van	Evercooren	 et	 al.	 1982).	 Collagens	 V	 and	 IV	 are	 major	 constituents	 of	 the	endoneurial	 and	 perineurial	 basal	 laminae	 and	 promotes	 migration	 of	 cultured	Bungner	Schwann	cells.	Binding	of	syndecan	3	on	the	Schwann	cell	membrane	to	collagen	V	 induces	Erk1/2	 activation	 and	 Schwann	 cell	migration	 (Erdman	et	 al.	2002).	The	predominant	laminin	isoforms	present	in	the	Schwann	cell	basal	lamina	are	 laminins	 2	 and	 8	 (Feltri	 &	 Wrabetz	 2005).	 Blocking	 of	 laminin	 2	 inhibits	Schwann	cell	migration,	and	both	laminin	1	and	2	enhance	Schwann	cell	migration	in	 vitro	 through	 interactions	 with	 β1-integrin	 (Anton,	 Sandrock,	 et	 al.	 1994a;	Milner	et	al.	1997).							
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1.4	The	cytoskeleton	In	 common	 with	 many	 other	 fundamental	 components	 of	 cell	 biology,	 the	cytoskeleton	was	 first	described	 from	observations	made	 in	 the	nervous	 system.	The	 first	 illustration	 of	 the	 cytoskeleton	 was	 made	 by	 Robert	 Remak	 in	 1844,	where	 he	 noted	 delicate	 fibrils	 within	 the	 ganglion	 cell	 of	 the	 crayfish	 (Remak,	1844).	 The	 significance	 of	 this	 observation	 went	 largely	 unrealised	 in	 the	proceeding	decades,	and	was	even	contradicted	by	Thomas	Huxley,	who	described	the	 content	 of	 the	 crayfish	 ganglion	 as	 “perfectly	 pellucid,	 and	without	 the	 least	indication	 of	 structure”	 (Huxley,	 1880).	 This	 ambiguity	 was	 removed	 when	Sigmund	Freud	reported	 identical	observations	to	Remak,	“The	nerve	cells	 in	the	brain	and	in	the	ventral	ganglionic	chain	consist	of	two	substances,	one	of	which	is	arranged	 as	 a	 network	 in	 the	 fibrils	 of	 the	 nerve	 fibers,	 and	 the	 other	 is	homogeneously	continuous	in	between”	(Freud,	1882).	The	structures	observed	by	Remak	and	Freud	were	 later	 termed	neurofibrils	by	Apáthy	and	Bethe	(Frixione,	2000).	The	first	questions	this	finding	posed	to	these	early	cell	biologists	was	that	of	the	function	of	the	filaments	within	the	neuron,	and	whether	they	are	present	in	other	 cells.	 Ramón	 y	 Cajal	 correctly	 predicted	 that	 neurofibrils	 did	 not	 have	 a	specific	 role	 in	 the	 conduction	 of	 nerve	 impulses,	 a	 conclusion	 he	 came	 to	 as	similar	filaments	had	been	discovered	in	many	other	cell	types,	such	as	epithelial	and	egg	cells	(R.	Cajal,	1903).	Around	the	same	time,	Walther	Flemming	provided	another	 example	 of	 intracellular	 filaments	 and	 significantly,	 observed	 their	 first	known	function	within	the	cell,	describing	the	involvement	of	“pale	threads”	in	the	transport	 of	 chromosomes	during	 cell	 division	 (Flemming,	 1880).	 By	 the	 turn	 of	the	 20th	 Century,	 biologists	 had	 observed	 what	 we	 now	 know	 as	 intermediate	filaments	and	microtubules,	and	found	at	least	one	role	for	these	structures.	
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The	evolving	view	of	the	cytoplasm	as	an	environment	of	great	biochemical	complexity,	playing	host	to	the	multitude	of	metabolic	processes	being	discovered	at	 that	 time,	 led	 Rudolph	 Peters	 to	 postulate	 that	 an	 intracellular	 three-dimensional	 protein	 network	 might	 provide	 the	 necessary	 structure	 to	 allow	complex	 metabolism	 in	 the	 cell	 (Peters	 1930).	 The	 French	 embryologist	 Paul	Wintrebert	 coined	 the	 term	 cytoskeleton,	 or	 “cytosquelette”	 to	 describe	 an	 idea	shared	with	Edwin	Conklin,	that	‘there	must	be	in	existence	a	network	within	the	cell	 that	 will	 properly	 redistribute	 intracellular	 contents	 following	 mechanical	disorganisation’	(Conklin	1917,	Frixione,	2000).	The	 advent	 of	 electron	 microscopy	 enabled	 further	 examination	 of	 the	neurofibrils	 described	 by	 Remak.	 Studies	 of	 disrupted	 nerves	 allowed	 the	visualisation	 of	 long,	 tubular	 structures	 within	 the	 axon,	 termed	 “neurotubules”	and	 today	 known	 as	microtubules	 (De	Robertis	&	 Schmitt	 1948)	 and	 thin	 intra-axonal	filaments	(Schmitt	&	Geren	1950)	which	were	later	termed	neurofilaments	(Gray	&	Guillery	1961).	The	cytoskeleton	as	we	know	it	today	is	composed	of	three	types	 of	 filaments;	 microtubules,	 intermediate	 filaments	 and	 microfilaments	 (F-actin).	 The	 latter	 had	 not	 been	 visualised	 during	 this	 early	 era	 of	 cell	 biology,	however	 the	 discovery	 of	 myosin	 in	 contractile	 muscle	 led	 scientists	 to	 find	 its	binding	 partner,	 actin	 (Straub	 1943).The	 finding	 that	 myosin	 decorated	 actin	filaments	with	 a	 characteristic	 ‘arrowhead’	 configuration	 allowed	 researchers	 to	detect	the	presence	of	F-actin	in	many	other	cell	types	(Moore	et	al.	1970;	Ishikawa	et	al.	1969)	The	 three	 filament	 types	 that	 form	 the	 cytoskeleton	 often	 span	 tens	 or	hundreds	of	micrometres	and	are	formed	by	the	repetitive	assembly	of	many	tiny	subunits.	 Rapid	 assembly	 and	 disassembly	 of	 these	 subunits	 allows	 the	 cell	 to	quickly	form	or	break	the	cytoskeletal	structures	necessary	for	organelle	transport	
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and	 cell	motility.	An	 array	of	 accessory	proteins	 regulate	 the	 spatial	 distribution	and	 behaviour	 of	 the	 cytoskeleton	 subunits	 or	 polymers,	 allowing	 the	 cell	 to	integrate	extracellular	or	 intracellular	signals	 to	 trigger	dynamic	 transformations	of	 the	 cytoskeleton	 for	 events	 such	 as	 phagocytosis,	 organelle	 transport	 and	 cell	movement.	In	the	following	sections,	I	will	describe	the	molecular	biology	of	these	cytoskeletal	proteins,	with	an	emphasis	on	their	role	in	cell	migration.	
1.4.1	The	actin	cytoskeleton	Proteins	 belonging	 to	 the	 actin	 family	 are	 capable	 forming	 filaments	 (F-actin),	which	can	assemble	and	disassemble	as	required	by	the	cell.	There	are	six	highly	conserved	actin	isoforms,	however	only	two	(β-actin	and	γ-actin)	are	expressed	in	the	majority	of	cells.	Actin	monomers	are	also	referred	to	as	G-actin	due	 to	 their	globular	form,	and	to	distinguish	them	from	their	polymerised	form,	F-actin.	Actin	has	 a	 molecular	 weight	 ~42	 kDa.	 Actin	 polymerisation	 at	 the	 leading	 edge	 of	 a	migrating	cell	provides	the	force	that	allows	the	cell	membrane	to	extend	forward.	This	protrusion	at	the	front	of	the	cell	is	called	the	lamellipodium	and	its	extension	is	driven	by	 the	assembly	of	actin	monomers	 into	 filamentous	actin,	 in	a	process	known	as	treadmilling	(Pollard	&	Borisy,	2003).	
β-actin	 is	 the	 isoform	 of	 actin	 most	 implicated	 in	 cell	 migration	 and	morphology.	 It	 is	 extremely	 well	 conserved	 across	 most	 species,	 with	approximately	80%	similarity	between	the	yeast	and	human	forms	of	the	protein.	The	 reason	 for	 this	 is	 probably	 due	 to	 the	 very	 large	 numbers	 of	 proteins	 that	interact	with	actin,	thus	limiting	the	variability	of	actin	binding	sites.	It	is	the	most	abundant	protein	in	the	cell	cortex,	and	the	most	abundant	protein	overall	in	many	cell	 types	 (Pollard	&	Borisy	 2003).	 An	 important	 feature	 of	 actin	 is	 its	 ability	 to	
 
 
	 33	
hydrolyse	ATP,	which	acts	 as	 a	 timer	 for	 the	 stability	of	F-actin	 (Bugyi	&	Carlier	2010).	
1.4.1.1	Actin	nucleation	Most	ATP-bound	actin	monomers	in	the	cell	exist	in	a	complex	with	the	accessory	protein	 profilin,	 which	 catalyses	 the	 exchange	 of	 ADP	 to	 ATP.	 This	 act	 of	sequestering	 the	 ATP-actin	 available	 for	 polymerisation	 into	 F-actin	 is	 an	important	 step	 in	 the	 temporal	 and	 spatial	 control	 of	 actin	 filament	 growth.	Thymosin	 β4	 is	 another	 protein	 that	 helps	 to	 sequester	 actin	 monomers	 in	 the	cytoplasm,	 and	 both	 these	 actin-binding	 proteins	 suppress	 the	 spontaneous	nucleation	of	actin	monomers	that	generates	F-actin	(Chesarone	&	Goode	2009).			 In	order	to	overcome	the	barriers	that	prevent	the	dynamic	formation	of	F-actin,	cells	express	an	array	of	factors	that	act	as	a	seed	for	the	polymerisation	of	an	actin	filament,	these	are	called	‘nucleation	factors’	and	exist	as	3	classes,	based	on	 the	 mechanism	 by	 which	 they	 enable	 filamentous	 actin	 assembly.	 Class	 1	nucleation	factors	include	the	Arp2/3	complex	and	N-WASP/SCAR.	These	proteins	mimic	 G-actin	monomers,	 providing	 part	 of	 the	 nucleus	 from	which	 F-actin	 can	elongate	 (Fig.	 1.3).	 Importantly,	 Arp2/3	 can	 only	 initiate	 F-actin	 polymerisation	when	bound	to	an	already	present	actin	filament,	and	results	in	the	nascent	actin	filament	growing	out	at	an	angle	of	70°	to	generate	a	branch	(Chesarone	&	Goode	2009).	Formins	 are	 the	 protein	 family	 that	 form	 class	 2	 of	 the	 actin	 nucleation	factors.	They	catalyse	the	formation	of	F-actin	by	capturing	spontaneously	formed	actin	 dimers	 and	 trimers	 via	 their	 FH2	 domains.	 Unlike	 Arp2/3,	 which	 remains	associated	with	the	pointed	end	of	the	growing	actin	filament,	formins	move	with	
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the	 growing	 barbed	 end,	 ready	 to	 insert	 additional	 actin	 subunits	 (Pring	 et	 al.	2003).	Unlike	Arp2/3,	formins	do	not	require	an	existing	actin	filament	to	induce	actin	polymerisation.	The	third	class	of	actin	nucleation	factors	 includes	Spire,	 first	 identified	 in	Drosophila.	 Spire	 has	 four	 WASP	 homology	 2	 (WH2)	 domains,	 each	 of	 which	recruit	an	actin	monomer	and	align	them	to	form	the	F-actin	nucleus	(Quinlan	et	al.	2005).			
			
Figure	1.3.	Arp2/3	interacts	with	F-actin		Arp2/3	 nucleates	 a	 new	 actin	 filament	 after	 activation	 by	 members	 of	 the	WASP/SCAR/WAVE	 family.	 The	 new	 actin	 filament	 is	 capped	 at	 its	 pointed	 end,	and	grows	from	its	barbed	end	at	an	angle	of	70°	from	the	existing	actin	filament.	Adapted	from	(Machesky	et	al.	1999).	
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1.4.1.2	Actin	elongation,	treadmilling	and	disassembly	Once	actin	 filament	polymerisation	 is	 initiated,	 F-actin	 continues	 to	 extend	at	 its	barbed	 end	 until	 it	 is	 either	 abrogated	 by	 a	 capping	 protein,	 or	 the	 pool	 of	 free	ATP-actin	is	exhausted.	The	cell	expresses	a	class	of	proteins,	referred	to	as	actin	elongation	proteins,	which	shield	the	barbed	end	from	these	capping	proteins	and	allowing	the	barbed	end	to	continue	extending.	Formins	constitute	one	member	of	this	class,	since	they	remain	attached	to	the	barbed	end	of	the	F-actin	via	their	FH2	domains.	Another	member	 is	Ena/VASP,	which	seems	 to	have	a	 less	potent	anti-capping	ability	than	formin.	There	are	conflicting	reports	on	the	protection	it	offers	to	the	barbed	end,	although	it	seems	to	depend	on	Ena/VASP	concentration	(Bear	&	Gertler	2009).	 It	 is	clear,	however,	 that	both	 formins	and	Ena/VASP	accelerate	the	 rate	 of	 F-actin	 elongation,	 up	 to	 5-fold	 and	 7-fold	 respectively	 (Chesarone	&	Goode	2009).	
	 Treadmilling	 refers	 to	 the	 scenario	 where	 each	 end	 of	 the	 actin	 (and	microtubule)	 filament	 possesses	 a	 different	 affinity	 for	 addition	 of	 subunits	(Critical	 concentration,	 Cc).	 The	 barbed	 end	 of	 F-actin	 has	 a	 lower	 Cc	 than	 the	pointed	 end,	 meaning	 that	 ATP-actin-monomers	 bind	 more	 easily.	 If	 the	concentration	of	 cytosolic	 free	ATP-actin	 is	higher	 than	 the	Cc	of	 the	barbed	end	and	pointed	end,	polymerisation	will	occur	at	both.	 If	 it	 is	 less,	 then	disassembly	will	take	place	at	both	ends.	In	reality,	the	presence	of	actin-binding	proteins	such	as	 Arp2/3,	 formins	 and	 capping	 proteins	will	 prevent	 the	 free	 association	 of	 G-actin	at	either	the	pointed	or	barbed	end.	Actin	treadmilling	takes	place	when	actin	monomers	are	being	added	to	the	barbed	end,	whilst	being	removed	at	the	pointed	end.	If	the	rate	of	these	is	the	same,	it	is	called	‘steady	state	treadmilling’.	As	actin	will	 slowly	 hydrolyse	 ATP	 into	 ADP,	 there	 exists	 a	 gradient	 along	 the	 actin	
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filament,	 with	 the	 barbed	 end	 containing	 ATP-bound	 actin	 monomers	 and	 the	pointed	end	composed	of	mostly	ADP-bound	actin	(Bugyi	&	Carlier	2010).	In	order	for	actin	treadmilling	to	proceed,	a	constant	supply	of	ATP-actin	is	required.	 As	mentioned	 previously,	 the	 G-actin	 binding	 protein	 profilin	 captures	ADP-actin	monomers,	 catalyses	 the	 transfer	of	ADP	 to	ATP	and	delivers	 them	 to	the	barbed	end	of	the	growing	actin	filament.	This	process	requires	the	supply	of	ADP	actin,	which	is	removed	from	the	pointed	end	of	F-actin	by	ADF/Cofilin,	which	speeds	 up	 F-actin	 disassembly	 and	 therefore	 the	 liberation	 of	 ADP-actin.	 Cofilin	does	this	by	increasing	actin	disassembly	at	the	pointed	end,	and	also	by	severing	F-actin	 and	 exposing	more	pointed	 ends	 from	which	ADP-actin	 can	disassemble.	Gelsolin	 is	 another	F-actin	 severing	protein	 that	 promotes	disassembly	 (Bugyi	&	Carlier	2010).	
1.4.1.3	Capping	protein	F-actin	 Capping	 Protein	 (CP)	 is	 a	 heterodimeric	 protein	 that	 binds	 tightly	 to	 the	barbed	 end	 of	 F-actin,	 preventing	 the	 addition	 or	 subtraction	 of	 any	 actin	monomers.	CP	is	associated	with	lamellipodia	protrusion	and	cell	migration,	since	it	 prevents	 excessive	 elongation	 of	 F-actin	 and	 promotes	 Arp2/3	 induced	 actin	nucleation	and	branching.	Lack	of	CP	leads	to	the	formation	of	filopodia	(Takeda	et	al.	2010).	
1.4.1.4	Actin	cross-linking/bundling	proteins	There	are	several	classes	of	actin-binding	proteins	that	can	bind	and	cross-link	two	or	 more	 actin	 filaments.	 These	 can	 be	 classified	 depending	 on	 the	 type	 of	macrostructure	 they	 form	 and	 are	 often	 associated	 with	 certain	 cellular	
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specialisations	(Fig.	1.4).	Filopodia	and	microvilli	require	actin	bundling	proteins,	such	as	villin	and	fimbrin	to	extend	parallel,	unbranched	bundles	of	F-actin	away	from	 the	 plasma	 membrane.	 	 These	 are	 found	 in	 many	 cell	 types,	 including	intestinal	 epithelial	 cells	 and	 Schwann	 cells.	 In	 contrast,	 lamellipodia	 require	 a	branched	actin	network,	where	cross-linking	proteins	such	as	Arp2/3,	filamins	and	spectrins	 hold	 two	 F-actins	 at	 angles	 of	 up	 to	 90	 degrees.	 This	 creates	 the	 3-dimensional	mesh	of	actin	filaments	found	in	the	cell	cortex	and	is	required	for	the	extension	 of	 lamellipodia	 for	 cell	 migration,	 or	 other	 cell	 morphogenetic	 events	such	as	radial	sorting	by	Schwann	cells.		Actin	bundles	can	be	further	divided	between	those	that	allow/disallow	the	binding	of	another	actin-binding	protein,	myosin	II.	Myosins	are	a	superfamily	of	motor	 proteins	 that	 hydrolyse	 ATP,	 bind	 actin	 and	 can	 exert	 mechanical	 force.	They	are	classically	known	to	be	involved	in	muscle	fiber	contraction,	but	are	also	important	 in	 cell	 motility	 (Cramer	 2013).	 The	 presence	 of	 myosin	 II	 in	 actin	bundles	 allows	 them	 to	 become	 contractile	 by	 sliding	 actin	 filament	 across	 one	another.	Contractile	bundles	are	 formed	by	F-actin	cross-linking	proteins	such	as	
α-actinin	and	are	found	in	actin	stress	fibers.	The	role	of	myosin	II	and	actin	stress	fibers	in	cell	migration	will	be	discussed	later.		 	
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Figure	1.4.	Actin	macrostructures.	Actin	 filaments	 can	 be	 arranged	 into	 macrostructures	 that	 consist	 of	 either	bundled,	 parallel	 filaments,	 e.g.	 microvilli,	 or	 as	 branched	 networks	 such	 as	lamellipodia.	Each	structure	is	generated	by	a	specific	actin	cross-linking	protein.	Adapted	from	(Revenu	et	al.	2004),	
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1.4.1.5	Rho	GTPases	The	Rho	 family	of	GTPases	 are	 small	G	proteins	 that	 cycle	between	active	 (GTP-bound)	 and	 inactive	 (GDP-bound)	 states,	 acting	 as	molecular	 switches	 (Fig.	 1.5).	The	active	 ‘on’	 and	 inactive	 ‘off’	 states	 are	 controlled	by	 two	 classes	of	proteins:	Guanine	 Exchange	 Factors	 (GEFs)	 and	GTPase	Activating	 Proteins	 (GAPs).	 There	are	20	members	of	 the	Rho	 family	 in	mammals,	 the	most	 studied	of	 these	being	RhoA,	Rac1	and	Cdc42	(A.	Hall	1998).	The	Rho	GTPases	are	primarily	known	 for	 their	 role	 in	actin	cytoskeleton	remodelling,	 but	have	numerous	other	 functions	 in	 the	 cell,	 including	promoting	gene	transcription,	cell	polarity	and	microtubule	dynamics	(Etienne-Manneville	&	A.	Hall	2002).	They	play	a	critical	role	in	integrating	intracellular	and	extracellular	signals	to	control	the	cytoskeleton,	and	thus	cell	morphology	and	migration.	It	 has	 been	 uncovered	 through	 the	 use	 of	 dominant	 negative	 and	constitutively	 active	 forms	 of	 RhoA,	 Rac	 and	 Cdc42	 these	 three	 GTPases	 control	different	 aspects	 of	 actin	 dynamics.	 RhoA	 regulates	 the	 formation	 of	 contractile	actin-myosin	 stress	 fibers,	 Rac	 promotes	 the	 polymerisation	 of	 actin	 to	 form	lamellipodia,	 and	 Cdc42	 promotes	 actin	 polymerisation	 to	 form	 filopodia.	 The	signals	 that	 regulate	 these	 proteins,	 and	 their	 downstream	 effectors	 are	 too	numerous	to	go	into	detail	here,	but	these	will	be	further	discussed	in	the	context	of	cell	migration.		 	
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Figure	1.5.	Rho	GTPases	act	as	molecular	switches	The	 RhoGTPases	 cycle	 between	 an	 active	 (GTP-bound)	 state	 and	 inactive	 (GDP-bound)	state.	This	cycle	is	controlled	by	Guanine	Exchange	Factors	(GEFs),	GTPase	Activating	 Proteins	 (GAPs)	 and	 Guanine	 Dissociation	 Inhibitors	 (GDIs).	 Adapted	from	(Raftopoulou	&	A.	Hall	2004)	
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1.5	Regulation	of	cell	migration	Motility	 is	 a	 fundamental	 cellular	 process,	 necessary	 for	 development,	 tissue	regeneration	and	wound	healing,	formation	of	neuronal	connections	and	immune	responses.	The	mechanism	by	which	most	cells	migrate	remains	the	same	amongst	organisms	as	diverse	as	protozoa	and	mammals,	and	involves	(i)	the	protrusion	of	the	cell	front	and	forward	displacement	of	cytoplasm	through	rapid	branched	actin	polymerisation,	(ii)	attachment	of	the	advancing	plasma	membrane	to	a	substrate,	(iii)	 contraction	 of	 actin-myosin	 stress	 fibers	 to	 translocate	 the	 cell	 body,	 (iv)	release	 of	 focal	 adhesions	 at	 the	 cell	 rear,	 and	 finally	 (v)	 the	 recycling	 of	 cell	membrane	and	proteins	from	the	cell	rear.		 Cells	 migrate	 in	 response	 to	 a	 number	 of	 external	 signals,	 including	chemical	 and	mechanical	 factors.	Mechanotaxis	 refers	 to	 the	 directed	motility	 of	cells	in	response	to	cues	such	as	fluidic	shear	stress	and	substrate	rigidity	(Lo	et	al,	2000).	 Chemotactic	 signals	 are	 diffusible	 chemicals	 that	 form	 a	 gradient	 in	 the	medium,	 and	 include	 an	 array	 of	 proteins	 and	 lipids	 that	 affect	 cell	 motility.	Perhaps	 the	 best	 known	 are	 chemokines,	 a	 subset	 of	 cytokines	 that	 induce	chemotaxis.	 Examples	 of	 these	 include	 Interleukin-1	 and	 CCL5.	 These	 diffusible	signals	 bind	 to	 an	 array	 of	 complementary	 receptors	 on	 cells	 and	 activate	intracellular	cell	 signalling	pathways	 that	 lead	 to	rearrangement	of	 the	actin	and	microtubule	cytoskeletons.	ECM	is	a	further	cue	for	directed	cell	migration,	and	the	induction	 of	 cell	 motility	 by	 adherence	 to	 a	 gradient	 of	 chemoattractants	 is	referred	 to	as	haptotaxis,	 and	plays	a	major	 role	 in	 successful	wound	healing.	 In	addition	 to	 the	 aforementioned	 types	 of	 cell	 migration,	 contact	 inhibition	 of	locomotion	 provides	 another	 means	 for	 directed	 cell	 movement.	 In	 this	 case,	 a	group	 of	 cells	 collide	 and	 cease	 movement	 in	 the	 direction	 of	 collision.	 Contact	
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inhibition	of	locomotion	is	regulated	by	a	number	of	cell	surface	proteins,	such	as	cadherins,	delta-notch,	integrins,	ephrins	and	nectins,	and	these	signal	to	a	number	of	 cytoskeletal	 regulatory	 proteins,	 including	 RhoA	 and	 ROCK	 (Mayor	 and	Carmona-Fontaine,	2010).		 The	 initial	 polymerisation	 of	 actin	 and	 extension	 of	 lamellipodia	 and	filopodia	results	from	signal	transduction,	normally	from	an	extracellular	cue	such	as	a	chemoattractant	or	the	extracellular	matrix.	These	signals	are	integrated	into	the	RhoGTPases	Rac1	and	Cdc42,	probably	through	their	activation	by	GEFs,	which	in	 turn	 activate	 effector	proteins	 (Fig.	 1.6).	Activated	Rac1	and	Cdc42	 localise	 to	the	 leading	 edge	 of	 the	 cell	 and	 activates	 the	 Ser/Thr	 kinase	 p65PAK	 and	 LIM	kinase,	which	then	phosphorylates	and	inactivates	Cofilin,	an	actin-depolymerising	protein	 and	 therefore	 allows	 increased	accumulation	of	polymerised	actin	 at	 the	leading	 edge.	 Both	 Rac1	 and	 Cdc42	 also	 activate	 the	 Arp2/3	 complex	 through	members	 of	 the	 WASP/SCAR/WAVE	 family,	 enhancing	 actin	 nucleation,	 F-actin	extension	and	branching	(Raftopoulou	&	A.	Hall	2004).		 Another	 important	 function	of	Rac1	 in	promoting	extension	of	 the	 leading	edge	of	 the	cell	 is	 to	 inhibit	RhoA.	RhoA	activation	at	 the	 leading	edge	of	 the	cell	would	be	detrimental	 to	 cell	migration,	 since	 it	promotes	 the	 formation	of	actin-myosin	stress	fibers	and	focal	adhesions.	It	does	this	by	activating	Rho	kinase		
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Figure	1.6.	Rho	GTPase	effector	molecules	The	RhoGTPases	activate	distinct	effectors	that	mediate	actin	polymerisation	and	stress	fiber	formation.	Adapted	from	(Raftopoulou	&	A.	Hall	2004).									 	
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(ROCK),	 which	 activates	 LIMK	 and	 stabilises	 F-actin	 in	 the	 same	 manner	 as	Rac1/Cdc42,	via	Cofilin.	ROCK	additionally	inhibits	the	phosphorylation	of	myosin	light	chain	(MLC),	which	allows	actin-myosin	cross-linking	and	formation	of	stress	fibers.	 In	 addition	 to	 this,	 RhoA	 activates	mDia,	 a	member	 of	 the	 formin	 family,	which	 nucleates	 and	 promotes	 actin	 polymerisation	 at	 focal	 adhesion	 sites	(Raftopoulou	&	A.	Hall	2004).	The	protrusive	 force	of	actin	polymerising	against	 the	 leading	edge	of	 the	cell	is	important	for	initial	stages	of	cell	migration,	but	another	force	is	needed	in	order	 to	move	 the	remainder	of	 the	cell	along.	This	 force	 is	generated	mostly	by	contraction	 of	 actin-myosin	 stress	 fibers,	 which	 as	 mentioned	 are	 induced	 by	activation	 of	 RhoA.	 Stress	 fibers,	whilst	 required	 for	 cell	migration,	 are	 typically	thinner	and	more	dynamic	in	motile	cells	than	stationary	cells	(Pellegrin	&	Mellor	2007).	Stress	fiber	role	in	cell	migration	is	rather	confused,	since	they	are	absent	in	many	motile	cells	such	as	leukocytes	and	Ameoba	(Valerius	et	al.	1982;	Rubino	et	al.	1984)	but	they	are	strongly	associated	with	the	regulation	of	focal	adhesion	size	and	turnover,	which	does	affect	the	rate	of	cell	migration	(Tojkander	et	al.	2012).		
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1.6	c-Jun	regulation	of	cell	morphogenesis	The	transcription	factor	c-Jun	is	known	to	control	cell	shape	and	motility	through	a	number	 of	 different	mechanisms,	 it	 is	 required	 for	 tissue	morphogenesis	 during	both	mouse	 and	Drosophila	 development	 and	 also	 promotes	 the	 invasiveness	 of	cancer	cells.	
1.6.1	Dorsal	closure	Dorsal	closure	of	the	Drosophila	embryo	occurs	during	mid-embryogenesis	and	involves	the	concerted	movement	and	elongation	of	the	cells	of	the	ventral	and	lateral	epidermis,	in	the	absence	of	cell	division,	so	the	two	epithelia	meet	and	fuse	at	the	dorsal	midline.	Drosophila	mutants	that	show	a	failure	in	epidermal	closing	at	 the	 dorsal	 midline	 are	 said	 to	 possess	 the	 “dorsal	 open”	 (DO)	 phenotype.	Molecular	analysis	of	these	mutants	reveals	two	main	classes	of	genes	involved	in	dorsal	closure;	those	encoding	structural	proteins	such	as	myosin	and	components	of	 focal	adhesions,	and	those	encoding	proteins	 likely	 to	regulate	and	trigger	cell	morphogenesis	(Hou	et	al.	1997).	Basket	and	hemipterous	are	Drosophila	mutants	that	 represent	 such	 regulatory	 proteins,	 and	 encode	Drosophila	 JNK	 (DJNK)	 and	
DJNK	kinase	(DJNKK).	The	Drac	mutant,	which	is	the	homologue	of	the	mammalian	small	GTPase	Rac1	also	displays	a	DO	phenotype	(Riesgo-Escovar	&	Hafen	1997b).	In	cells	of	the	leading	edge	of	the	ventral	and	lateral	epidermis,	an	unknown	signal	activates	 the	 Rac1-JNK	 pathway	 and	 in	 turn,	 the	 downstream	 targets	 DJun	 and	
DFos	(homologs	of	c-Jun	and	c-Fos,	which	together	form	the	AP-1	complex).	DJun	regulates	 the	 expression	 of	 the	 TGF-β	 homologue,	 decapentaplegic	 (dpp),	 which	binds	 to	 its	 receptors	 punt	 and	 tkv	 and	 leads	 to	 SMAD	 translocation	 to	 the	 cell	
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nucleus	 (Fig.	 1.7),	 and	 subsequent	 gene	 expression	 that	 initiates	 the	 cell	morphological	changes	necessary	to	drive	leading	cell	elongation,	and	thus	closure	of	 the	 dorsal	 midline	 of	 the	 embryo	 (Hou	 et	 al.	 1997;	 Riesgo-Escovar	 &	 Hafen	1997a;	Riesgo-Escovar	&	Hafen	1997b)..																
Figure	 1.7.	 Activation	 of	 the	DJNK	 pathway	 in	 cells	 of	 the	 leading	 edges	 of	 the	ventral	and	lateral	epidermis	of	the	Drosophila	embryo	leads	to	expression	of	DJun	and	dpp,	which	mediates	the	cytoskeletal	changes	necessary	for	cell	elongation	and	dorsal	closure.	Adapted	from	(Martín-Blanco	et	al.	1998).	
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1.6.2	Mouse	eyelid	closure	Eyelid	 closure	 in	 the	 mouse	 takes	 place	 between	 E15-E16	 and	 is	 analogous	 to	dorsal	closure	in	Drosophila	as	both	processes	involve	the	extension	and	fusion	of	two	 epithelia,	 which	 requires	 cell	 morphogenesis.	 Failure	 of	 eyelid	 closure	 is	referred	 to	 as	 the	 eye-open-at-birth	 (EOB)	 phenotype.	 The	molecular	 control	 of	this	morphogenetic	event	is	also	comparable	to	that	of	dorsal	closure	as	c-Jun	lies	downstream	of	JNK	signalling,	and	induces	the	expression	of	genes	that	affect	cell	shape	and	migration.	Activin	B	 initiates	MEKK1-MKK4	signalling,	which	activates	the	JNK1/2	pathway	and	culminates	in	the	phosphorylation	of	c-Jun	(Takatori	et	al.	2008).	Conditional	deletion	of	c-Jun	and	other	proteins	in	this	pathway	causes	the	EOB	phenotype.	Keratinocytes	are	the	cells	that	compose	the	eyelid	epidermis,	and	deletion	 of	 c-Jun	 in	 these	 cells	 reduces	 their	 expression	 of	 another	 EOB	protein,	EGF	receptor	(Zenz	et	al.	2003).		
1.6.3	Cellular	invasiveness	c-Jun	 was	 the	 first	 oncogenic	 transcription	 factor	 to	 be	 discovered	 and	 is	 over-expressed	 in	 many	 cancers.	 In	 contrast	 to	 the	 deficient	 migration	 of	 c-Jun-/-	keratinocytes	 that	causes	 the	EOB	phenotype	 in	mice,	high	expression	of	c-Jun	 is	seen	 in	malignant	keratinocytes	derived	 from	squamous	cell	 carcinoma	(Lohman	et	al.	1997).	Cellular	invasion	occurs	during	normal	development	as	well	as	cancer	metastasis,	 for	example	during	angiogenesis	and	organogenesis	(Egeblad	&	Werb	2002).	 	 Deletion	 of	 c-Jun	 in	 mouse	 embryonic	 fibroblasts	 (MEFs)	 causes	 a	significant	 reduction	 in	 cell	 motility	 and	 causes	 cell	 flattening	 and	 induction	 of	actin	 stress	 fibers	 and	 focal	 adhesions.	 Lack	 of	 c-Jun	 is	 found	 to	 increase	 the	
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activity	 of	 RhoA-activated	 kinase	 (ROCK	 II)	 through	 the	 reduction	 of	 c-Src	expression	(Jiao	et	al.	2008),	this	pathway	is	shown	in	Fig.	1.8.	Another	 pathway	 implicated	 in	 c-Jun	 dependent	 cell	 invasiveness	 and	cytoskeleton	 remodelling	 is	 that	 of	 TGF-β,	 which	 as	 mentioned	 previously	(Fig.	1.6),	 is	 also	 active	 in	 the	 dorsal	 closure	 of	 the	 Drosophila	 embryo	 and	 is	dependent	on	JNK/c-Jun.	The	response	by	3T3	cells	to	TGF-β	causes	an	increase	in	nuclear	and	cytosolic	Ca2+	and	 increased	cell	migration.	The	 increase	 in	Ca2+	 and	migration	in	response	to	TGF-β	requires	c-Jun,	as	both	are	abolished	when	c-Jun	is	deleted	 from	the	cells	 (Janowski	et	al.	2011).	Since	TGF-β	 induced	cell	migration	requires	RhoA,	a	GTPase	known	to	be	regulated	by	c-Jun,	 this	may	be	a	common	mechanism	linking	the	c-Jun-Src-ROCKII	pathway	(Jiao	et	al.	2008).	Stem	 cell	 factor	 (SCF)	 and	 its	 receptor	 kit	 are	 involved	 in	 cell	 migration,	differentiation	and	proliferation	in	a	diverse	set	of	cell	types,	including	neural	stem	cells	 and	 endothelial	 cells.	 SCF	 can	 be	 secreted	 from	 the	 cell,	 and	 Katiyar	 and	colleagues	have	shown	 that	 conditioned	medium	 from	cultured	MEFs	can	 rescue	the	migration	phenotype	of	c-Jun	-/-	MEFs.	Indeed,	it	turns	out	to	be	the	case	that	c-Jun	 regulates	 the	 expression	 of	 SCF,	 and	 SCF	 can	 rescue	 the	morphological	 and	migratory	phenotype	of	c-Jun	deleted	MEFs	(Katiyar	et	al.	2007).	This	suggests	that	SCF	can	signal	through	its	receptor	Kit	normally	in	the	absence	of	c-Jun.	Since	SCF	expressing	tumour	cells	are	mostly	found	at	the	tumour	border,	where	infiltration	occurs	 and	 also	 where	 c-Jun	 expression	 is	 highest,	 this	 pathway	 may	 also	contribute	to	c-Jun	dependent	cell	 invasiveness	and	tumour	progression	(Vleugel	et	al.	2006).		
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ErbB2,	 a	member	 of	 the	 epidermal	 growth	 factor	 receptor	 family	 plays	 a	significant	 role	 in	 both	 Schwann	 cell	 development	 and	 migration,	 and	 in	 the	induction	of	mammary	tumour	cell	invasion.	Both	c-Jun	and	ErbB2	are	over-																													
Figure	1.8.	The	transcription	factor	c-Jun	regulates	cell	shape	and	motility	through	the	 expression	 of	 c-Src	 and	 the	 inhibition	 of	 ROCK	 II	 activity.	 Deletion	 of	 c-Jun	causes	decreased	c-Src	activity,	increased	ROCK	II	activity	and	therefore	increased	focal	adhesions,	actin	stress	fibers	and	reduced	cell	migration.		
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expressed	 in	breast	 cancers,	 and	both	play	 a	 role	 in	 Schwann	 cell	 biology	during	 nerve	 regeneration,	 so	 it	 seems	 likely	 they	 are	 part	 of	 an	 overlapping	regulatory	network	of	activating	and	effector	proteins.	ErbB2	is	known	to	 induce	the	 expression	 the	 secreted	 proteins	 SCF,	 which	 is	 also	 regulated	 by	 c-Jun,	 as	discussed	 above	 (Katiyar	 et	 al.	 2007;	 Jiao	 et	 al.	 2010).	 ErbB2	 induces	 the	expression	 of	 another	 soluble	 protein,	 CCL5,	 also	 known	 as	 RANTES.	 CCL5	 is	upregulated	in	the	distal	nerve	stump	following	transection,	at	the	same	time	as	c-Jun	upregulation	in	Schwann	cells	(Taskinen	et	al,	2000).	CCL5	is	regulated	at	the	transcriptional	level	by	c-Jun.	In	contrast	to	the	MEF	cells	of	the	previous	studies,	c-Jun	dependent	migration	of	the	mammary	epithelial	tumour	cells	(METs)	is	not	induced	by	SCF,	but	instead	by	CCL5	(Jiao	et	al.	2010).		
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1.7	Peripheral	nerve	injury	and	regeneration	
The mammalian PNS has the capacity to regenerate following nerve injury, an ability 
that provides a contrast with the limited regenerative capability of the CNS. This 
difference was first observed by Ramon y Cajal, who showed that peripheral nerves 
could not regenerate through central nerve graft tissue (R. Y. Cajal 1928). It was later 
shown that nerve fibers from the CNS, which are not capable of regenerating in their 
native environment, are able to grow through transplanted peripheral nerve (David & 
Aguayo 1981; Richardson et al. 1980). The results of these studies indicate that both 
PNS and CNS neurons possess the ability to regenerate, but only the PNS provides the 
necessary conditions to enable axonal regrowth. DRG sensory neurons exist in a unique 
configuration, containing a single, branched axon (referred to as pseudobipolar) that 
extends into and connects both sensory receptors in the periphery and neurons in the 
brain (via the spinal column). The two axon branches exhibit different responses to 
injury. Injury to the peripheral branch results in spontaneous regeneration with some 
recovery of sensory function, whereas injury to the central branch does not lead to 
regeneration. Significantly, if the peripheral branch lesion is followed by similar injury 
to the central branch, the central nerve does show signs of regeneration into the 
normally inhibitory environment of the spinal cord. Richardson & Issa performed an in 
vivo experiment, in which the dorsal column of the rat spinal cord was incised 
bilaterally and a sciatic nerve graft (from the right leg) was transplanted into the midline 
of the spinal cord. DRG neurons growing into the nerve graft were labeled and counted, 
and the results demonstrated that DRGs ipsilateral to the sciatic nerve transection were 
labeled positive, demonstrating that spinal axons from the DRG neurons had 
regenerated, however, no axonal regeneration into the CNS was observed from DRGs 
of the left side that did not experience peripheral injury (Richardson & Issa, 1984).  
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Pre-degeneration of the peripheral nerve graft promotes an even greater regenerative 
response from injured central axons, however, this effect is only seen in response to 
sciatic nerve crush (Oudega et al, 1994). Chong et al. demonstrated increased 
expression of GAP-43 mRNA in L4 DRG sensory neurons in the weeks following 
sciatic nerve crush, highest at 3 weeks following the conditioning injury, and persisting 
for at least 19 weeks (Chong et al, 1996). GAP-43 is a major protein kinase C (PKC) 
substrate and plays a role in neurite formation and regeneration (Benowitz et al, 1997) 
and therefore its expression is a measure of the intrinsic growth capacity of sensory 
neurons. Chong et al also reported an increase in the number of myelinated axons that 
had grown into the nerve graft from the axons of the dorsal root compared to grafts 
without crush injury, at all following time points. (Chong et al, 1996). 
Neumann and Woolf conducted an experiment in which a peripheral lesion (sciatic 
nerve transection) was made at the same time as the central lesion, and observed 
sprouting of neurites proximal to the transected dorsal column, as well as neurites 
growing into and through the lesion. This contrasted with an absence of regenerating 
nerve fibers when no peripheral lesion was made. Peripheral lesions were also made 1 
week and 2 weeks prior to the central lesion, and these led to greater neurite outgrowth, 
including beyond the lesion site (Neumann & Woolf, 1999).  Chong et al performed a 
similar experiment, in which the left dorsal roots  L4, L5 and L6 were transected, with 
or without a simultaneous crush injury to the ipsilateral sciatic nerve. The results of this 
study demonstrated little regeneration of neurites into the spinal cord in animals that did 
not have the conditioning sciatic nerve crush injury. In rats that did experience the 
conditioning lesion, most regenerating axons were found stalled at or near the dorsal 
root entry zone, however, in all cases a subpopulation of axons were observed to enter 
the spinal cord and penetrate into the grey matter of the dorsal horn. 
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The existence of this ‘conditioning lesion’ effect implies that whilst the local 
environments of injured central and peripheral DRG axons have a large affect on their 
regenerative potential, there exists an intrinsic capacity for growth in these neurons, and 
this is sufficient to overcome the less favourable regenerative environment of the CNS.  
1.7.1	Initial	events	of	nerve	regeneration	
Immediately following nerve injury, the cells of the peripheral nerve respond to this 
trauma by activating their regeneration programme. The precise trigger for this is 
unknown, although it is likely to be a combination of cellular mechanical stress such as 
disruption to cell membranes, and the loss of signals such as action potentials that are 
normally present in the uninjured nerve.  
1.7.1.1	The	axonal	response	to	nerve	injury	in	distal	stump	
The axonal response to nerve injury occurs rapidly following crush or transection. The 
transected axons in the proximal stump quickly seal their ends to prevent further escape 
of axoplasm. The axons in the distal stump start to disintegrate within hours of injury, 
as part of the process of Wallerian degeneration. This process culminates in the removal 
or myelin and axonal debris from the distal stump (Chen et al. 2007; Waller 1850). The 
axons do not breakdown straight away, there is a lag of 24-48 hours in rodents 
(Lubinska 1977) and several days in humans (Chaudhry & Cornblath 1992) and remain 
electrically excitable during this time. There is evidence that degeneration in crush 
injuries is delayed by 2-3 hours compared to complete transection, and this occurs in a 
retrograde direction, compared to the anterograde degeneration seen in nerve transection 
injuries (Beirowski et al. 2005). Axonal beading and swelling, accompanied with the 
disintegration of the axonal cytoskeleton is seen at the start of axonal degeneration, and 
is known to be dependent on calcium and the activation of calpain and ubiquitin, which 
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suggests this is an active, rather than passive process of axonal breakdown (Gaudet et 
al. 2011). This point is further supported by the Wallerian degeneration slow, or WldS 
mouse, which has much slower axonal degeneration (Lunn et al. 1989; Perry et al. 
1991). Axons in the distal stumps of WldS mice degenerate with a delay of 2-3 weeks. 
The exact nature of the WldS mutation, identified by positional cloning, consists of an 
85 Kb tandem triplication on chromosome 4 (Lyon et al. 1993; Coleman et al., 1998). 
As a result, a chimeric protein is overexpressed in neurons that consists of the first 70 
amino acids of multi-ubiquitination factor, Ufd2 fused to the coding sequence of 
D4Cole1e/Nmnat1 (nicotinamide mononucleotide adenyltransferase1) (Conforti et al., 
2000; Mack et al., 2001). Nmnat1 enzymatic activity is known to be necessary for WldS 
mediated axonal protection (Araki et al. 2004). 
1.7.1.2	The	axonal	response	to	nerve	injury	in	the	proximal	stump	
As mentioned above, the severed ends of the axons in the proximal stump of the 
transected nerve are quickly sealed to prevent excessive egress of axoplasm. Similar to 
the distal stump, there is some axonal degeneration but this is restricted to the first node 
of Ranvier proximal to the site of transection (Zochodne, 2003). Within several hours 
the axonal cytoskeleton is rearranged, with microtubules in the most distal end of the 
axon reorganized to form traps for anterogradely transported vesicles that help to form 
the growth cone organising complex (Erez et al. 2007).  
Another early event in the axonal response to injury is the activation of signals that are 
transported retrogradely to the neuronal cell body. One of the first signals is the influx 
of Calcium ions into the axon, as mentioned previously in the context of calcium-
dependent axonal degeneration. This wave of calcium can travel up to 1mm per minute 
and occurs immediately proceeding nerve injury (Mandolesi et al. 2004).  The transient 
increase in axonal Ca2+ ions returns to resting levels within hours in mammalian 
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neurons in vivo (Howard et al. 1999). Recent data has shown that retrograde Calcium 
signaling can induce the export of histone deacetylase 5 (HDAC5) via protein kinase 
Cµ from the neuronal nucleus, which accumulates at the site of axonal injury, and is 
able to deacetylate tubulin and promote axonal regeneration  (Cho et al. 2013).  
Another retrograde signaling phase occurs later and these are trafficked from the 
injury site to the soma via dynein motors.  JNK3 and JIP3 are involved in the formation 
of retrograde signaling complexes and knockout of the JNK homologue DNK in 
Drosophila shows that it is required for the upregulation of p-Jun and p-STAT3 in 
sensory neuron soma (Shin et al. 2012).  
 Dynein motors are also used to convey a separate retrograde signaling complex 
that consists of importin-α and importin β1 bound to cargo that recognise their nuclear 
localization signal binding sites.  This cargo includes p-ERK-vimentin and p-STAT3 
(Rishal & Fainzilber 2014).  
 Whilst the exact molecular pathways that switch on the motor and sensory 
neurons of the peripheral nerve to respond to injury by acquiring a regeneration-
permissive phenotype are not fully understood, changes to the cellular architecture of 
both the proximal and distal stumps, and to the injury site are well characterized, 
particularly by electron microscopy studies in the 1960s. This early work has since been 
refined using transgenic mice expressing fluorescent markers in axons and Schwann 
cells. 
 Within 1-2 days of nerve transection, the axons of the proximal stump develop 
swellings called axon endbulbs (also referred to as boutons), which may influence nerve 
regeneration by releasing molecules such as CGRP and nitric oxide (Zochodne 2008). 
At the same time as endbulbs are forming at the axon terminals, axonal sprouts appear 
as membrane outgrowths from the parent axon. Myelinated axons normally develop 
sprouts from either the first or second node of Ranvier (Friede & Bischhausen 1980). 
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Extensive sprouting takes place, with each axon developing multiple daughter sprouts. 
Nerve crush injuries also produce axonal sprouts, and these can grow relatively easily 
into the distal stump, as the endoneurial tubes are intact and the Schwann cells that line 
these structures form the Bands of Büngner, which are permissive substrates for axons 
to regenerate on. In contrast, sprouts from the proximal stump of the transected nerve 
must advance across newly formed tissue, referred to as the ‘nerve bridge’, composed 
primarily of fibroblasts from the epineurium, and Schwann cells from the nerve stumps. 
This structure is not very favourable for axonal regrowth, and very few of the sprouts 
successfully cross the bridge (Zochodne 2008). 
1.7.1.3	Initial	changes	to	Schwann	cells	during	nerve	regeneration	
In the distal stump and at the very end of the proximal stump of the injured nerve, 
Schwann cells undergo the process of demyelination. Myelin fragmentation begins at 
the Schmidt-Lanterman Incisures (SLIs) just minutes after injury (Williams & S. M. 
Hall 1971) and by 1-2 days the myelin sheath has started to break up into ovoid 
structures. Myelin ovoids form more slowly in thicker fibers (Lubinska 1977).  It is not 
clear how myelin is broken down in the nerve, but it is known that both Schwann cells 
and macrophages make a contribution. Elimination of infiltrating macrophages by 
whole body irradiation prior to nerve injury shows that myelin breakdown occurs 
normally for the first 5 days and then slows down. This shows that the initial breakdown 
of myelin is probably carried out by Schwann cells and resident macrophages (Perry et 
al. 1995). This is supported by Arthur-Farraj et al. who show that deleting Schwann cell 
c-Jun, and thus preventing these cells from becoming activated repair cells also slows 
the rate of myelin breakdown (Arthur-Farraj et al. 2012). Recent data suggests these 
Schwann cells are not able to process myelin through the autophagy pathway, in 
contrast to wildtype Schwann cells (Carty et al, unpublished data). 
 
 
	 57	
A further response of Schwann cells to nerve injury is their re-entry into the cell 
cycle. Schwann cell proliferation is negligible in the adult nerve, but is strongly 
increased following injury (Abercrombie, 1946). The significance of the increased 
cellular proliferation is unclear, since inhibiting Schwann call proliferation by 
disrupting the cyclin D1 gene does not lead to a deficiency in regeneration of 
remyelination (Yang et al. 2008). The authors of this study only considered nerve crush 
injury, so it is unknown whether Schwann cell proliferation is necessary for the 
successful bridging of the inter-stump gap created by nerve transection injury. 
Following demyelination, Schwann cells in the distal stump are found aligned 
within their basal lamina tubes, where they proliferate and secrete neurotrophic factors. 
The attraction of regenerating axons to the distal nerve stump has been well documented 
(Politis et al. 1982). 
1.7.2	Schwann	cell	migration	during	nerve	injury	and	regeneration	
 I have discussed the migratory behaviour of Schwann cells in detail in the first 
section of this introduction, but only briefly touched on their migration during 
peripheral nerve regeneration. Abercrombie conducted a series of experiments that 
revealed the motile behaviour of Schwann cells in the degenerating nerve. He observed 
Schwann cells in pre-degenerated nerves ‘outwander’ from a nerve explant at rate 
proportional to the length of time they were degenerated in vivo, peaking at 19 days. In 
this study, Schwann cells only emigrated from the cross-section of the nerve explant 
(i.e. not through the epineurium) and there was a latency period of 4-5 days before 
emigration occurred, Abercrombie suggested this is the time taken for Schwann cells to 
fully demyelinate and become mobile. Very little emigration was observed from nerves 
that had not been predegenerated (Abercrombie, 1942). In later studies, Abercrombie 
allowed the distal portions of transected nerves to become reinnervated and then 
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measured Schwann cell outwandering, finding that reinnervation largely diminished 
emigration from the nerve of Schwann cells, but not fibroblasts, showing that Schwann 
cells lose their ability to migrate once they become re-associated with regenerating 
axons (Abercrombie et al, 1949).  
 In vivo evidence of Schwann cell migration during regeneration was first 
reported by Nageotte, who described the outgrowth from a transected nerve as a 
‘peripheral glioma’ (Frixione, 2000) and this was also described by Masson (Masson 
1932). Holmes and Young described the in vivo migratory properties of Schwann cells 
in the distal stump of the transected nerve. They observed Schwann cells migrating 
within the intact endoneurial tubes and forming an outgrowth at the end of the distal 
nerve stump. Both proximal and distal stumps formed outgrowths, however the distal 
outgrowth was much larger and more rapid. The outgrowth is progressive for several 
weeks after transection but does not continue indefinitely. Schwann cell mitoses were 
observed in cells leaving the stump so it is possible that proliferation in addition to 
migration contribute to the size of the Schwann cell outgrowth. The authors also noted 
the outgrowth of fibroblasts from the epineurium and perineurium was significant, and 
sometimes greater than the outgrowth of Schwann cells (Holmes & Young 1942; 
Holmes et al. 1940). Rexed found the Schwann cell outgrowth proceeded at a rate of up 
to 0.3mm/day, starting from the third day following transection. In the first day, the 
inter-stump gap filled with an exudate containing macrophages, fibroblasts and 
capillaries, followed by Schwann cell outgrowth at 3 days. Transection of an already 
degenerated distal stump formed two nerve stumps from which the outgrowths were 
equally intense (Rexed 1942). The asymmetry of outgrowth from the proximal and 
distal stumps following a single transection correlates with the extent of Wallerian 
degeneration that takes place. In the proximal stump, axonal degradation and Schwann 
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cell denervation is limited to 1-2 mm from the cut site in rat, limiting the pool of cells 
that can proliferate and emigrate into the gap. 
Thomas later confirmed the findings of Young and Rexed using electron 
microscopy of sections of the ‘nerve bridge’. He found that Schwann cells emigrated 
from the distal stump in columns, continuous with the Bands of Büngner. Cells of 
perineural origin, resembling fibroblasts, come to surround these Schwann cell 
columns. This leads to the formation of multiple small fascicles in the nerve bridge, 
each surrounded by a perineurium (Thomas 1966). This had been noted previously by 
Cajal and later by Morris, who applied the term ‘compartmentation’ to the formation of 
mini-fascicles in the nerve bridge and the proximal/distal stumps. Morris found that 
compartmentation only takes place in the presence of regrowing axons (J. H. Morris et 
al. 1972). 
1.7.3	The	role	of	c-Jun	in	peripheral	nerve	regeneration	
c-Jun is a key regulator of the Schwann cell response to nerve injury. c-Jun is 
upregulated rapidly, within an hour following nerve injury (Shy et al. 1996) and its 
deletion in mouse Schwann cells prevents recovery of motor and sensory function 
(Arthur-Farraj et al. 2012). c-Jun is expressed in immature Schwann cells before birth 
(Stewart et al. 1995; Parkinson et al., 2008), however, its expression is downregulated 
when Schwann cells begin myelination. Thus, c-Jun is only expressed in non-
myelinating Schwann cells in the adult, at low levels (Shy et al, 1996; Parkinson et al, 
2008). Furthermore, c-Jun is also upregulated in peripheral neurons following nerve 
injury and is required in these cells for in vivo regeneration (Behrens et al, 2002; 
Raivich et al, 2004). c-Jun regulates the transdifferentiation of mature myelinating and 
non-myelinating Schwann cells to repair cells, or ‘Bungner Schwann cells’ that promote 
nerve regeneration by controlling the expression of a number of genes. Following nerve 
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transection, there are 172 differentially regulated genes in the c-Jun cKO mouse 
compared to the control. These include genes such as GDNF, BDNF, Shh, Artemin and 
GAP-43, which fail to upregulate following injury and have been implicated in nerve 
regeneration and the trophic support of neurons. Furthermore, c-Jun protects sensory 
neurons from cell death following nerve injury, since its deletion leads to increased 
death of both large and small DRG neurons (Arthur-Farraj et al. 2012). The WldS 
mouse has limited nerve regenerative capability, in addition to the slow degradation of 
axons, as the Schwann cells remain in a differentiated state. Increased expression of c-
Jun from the low level found in WldS nerves after injury significantly enhances nerve 
regeneration  (Arthur-Farraj et al. 2012). These findings show that c-Jun controls many 
of the functions that Schwann cells carry out in their role as a repair cell in the 
regenerating nerve.  
In agreement with the above work, Fontana et al show that conditional deletion 
of c-Jun in Schwann cells perturbs motor function of the mouse whisker following 
injury to the facial nerve and dramatically increases neuronal cell death. The 
neurotrophic factors GDNF and Artemin had reduced expression in the c-Jun knockout, 
and the authors identified these proteins, along with their receptor Ret as being 
important signals that mediate the regeneration-promoting ability of c-Jun in Schwann 
cells (Fontana et al. 2012). 
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Aims	
 
 
The aim of this thesis was to characterise the effect of deleting c-Jun from Schwann 
cells to understand how this has such a large affect on their ability to promote 
regeneration of the peripheral nerve. I did this by analyzing the changes to Schwann cell 
morphology and migratory behaviour in the absence of c-Jun. I also wanted to uncover 
the molecular mechanism by which c-Jun controls Schwann cell morphology and cell 
migration. Finally, I wanted to see if the in vitro observations were also replicated in the 
regenerating mammalian peripheral nerve. 
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Chapter	2:	Materials	and	methods	
	
2.1	List	of	Reagents	
2.1.1	Reagents	for	tissue	culture	Cytosine	arabinoside	(AraC),	dimethyl	sulphoxide	(DMSO),	bovine	serum	albumin	(BSA),	 transferrin,	 selenium,	 putrescine,	 triiodothyronine	 (T3),	 thyroxine	 (T4)	progesterone,	 dexamethasone,	 insulin,	 poly-D-lysine	 (PDL),	 poly-L-lysine	 (PLL),	laminin	 and	 2’-0-dibutyryladenosine	 3’,5’-cyclicAMP	 (dbcAMP)	 were	 obtained	from	 Sigma	 (Poole,	 UK).	 Collagenase	 was	 obtained	 from	 Worthington	 (Lorne	Laboratories,	Reading,	UK).	Dulbecco’s	modified	Eagles	medium	(DMEM),	Ham’s	F-12	medium	 and	 L-15	medium,	 horse	 serum	 and	 glutamine	 were	 obtained	 from	Invitrogen	 Ltd	 (Paisley,	 UK).	 Trypsin,	 trypsin	 EDTA	 and	 penicillin/streptomycin	were	obtained	from	PAA	(UK).	Fetal	bovine	serum	(FBS)	was	obtained	from	Perbio	(UK).	 Forskolin	was	 obtained	 from	Calbiochem	 (CA,	USA).	NRGβ-1	was	 obtained	from	R&D	Systems	 (Minneapolis,	MN,	USA).	Tissue	culture	dishes,	24	well	plates	and	 centrifuge	 tubes	 were	 obtained	 from	 VWR.	 Round	 13-mm	 coverslips	 were	obtained	from	BDH	(Lutterworth,	UK).	Transwell	6.5-mm	inserts	with	8	μm	pores	were	obtained	from	Corning	(New	York,	USA).		
2.1.2	Reagents	for	molecular	biology	EDTA	 disodium	 salt,	 ethidium	 bromide,	 sodium	 citrate,	phenylmethylsulphonylfluoride	(PMSF),	sodium	hydroxide,	bromophenol	blue	and	urea	were	purchased	from	Sigma	(Poole,	UK).	10B	lysing	matrix	beads	were	from	MP	Biomedicals	 (USA).	Hybond-N	nitrocellulose	membrane	was	 from	Amersham	
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Pharmacia	Biotech	(UK).	Reblot	plus	strong	stripping	solution	was	from	Millipore	(MA	 USA).	 Super	 Signal	West	 Dura	 kit	 was	 from	 Perbio	 (UK).	 Absolute	 ethanol,	isopropanol,	 methanol,	 sodium	 dodecyl	 sulphate	 (SDS),	 sodium	 chloride	 (NaCl),	Triton	X-100	and	glycerol	were	from	BDH	Lab.	Supplies	(Poole,	UK).	Kaleidoscope	pre-stained	standards	were	 from	Biorad	(CA,	USA).	Tris	Base,	Tris-HCl,	hydrogen	peroxide,	 luminol	and	coumaric	acid	were	from	Sigma	(Poole,	UK).	SeeBlue	Plus2	pre-stained	 standards	 were	 purchased	 from	 Invitrogen	 Ltd	 (Paisley,	 UK).	 CL-XPosure	film	was	from	Thermo	Scientific	(UK).	Taq	DNA-polymerase,	dNTPs,	1KB	plus	DNA	ladder,	100mM	dNTP	set	and	Agarose	were	from	Invitrogen	Ltd	(Paisley,	UK).	
2.1.3	Reagents	for	immunolabelling	Paraformaldehyde	was	obtained	 from	Fluka	Chemicals	Ltd.	 (Buchs,	 Switzerland).	Triton	X-100,	 lysine	and	Hoechst	dye	H33258	were	obtained	 from	Sigma	 (Poole,	UK).	Citifluor	was	from	Citifluor	Ltd.	(London,	UK)	HCl	and	glycerol	were	obtained	from	BDH	(Lutterworth,	UK).		
2.1.4	Surgery	Surgical	 tools	 were	 purchased	 from	 Fine	 Science	 Tools	 (Germany).	 Vetinary	autoclips	 were	 purchased	 from	 VET-TECH	 (UK).	 Sterile	 drapes,	 swabs	 and	isofluorane	were	provided	by	the	Biological	Services	Unit	at	UCL.	
2.2	Mice	Wild-type	C57BL/6	mice	and	wild-type	Sprague-Dawley	rats	were	obtained	from	the	Biological	Services	unit	at	University	College	London.	
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P0-Cre	mice	Transgenic	mice	expressing	mP0TOT(Cre)	transgene	(P0-Cre)	were	driven	by	the	mpz	 promoter.	 P0-Cre	 transgene	 activates	 Cre-mediated	 recombination	specifically	 in	Schwann	cells	between	the	ages	of	E13.5	and	E14.5.	Strong	P0-Cre	activity	is	only	detected	in	the	peripheral	nerve,	with	slight	activity	in	the	occipital	lobe	of	the	cerebral	cortex,	Purkinje	cell	 layer	of	the	cerebellum	and	in	the	heart.	The	P0-Cre	mice	were	provided	by	Dr	L.	Wrabetz	and	Dr	M.L.	Feltri	(Hunter	James	Kelly	Research	Institute,	Buffalo,	NY,	USA).	P0-Cre	mice	have	been	used	extensively	in	Schwann	cell	reports	for	the	ablation	of	‘floxed’	genes.	P0-Cre	mice	were	used	in	this	study	to	generate	Schwann	cell	specific	ablation	of	c-Jun	as	described	below.		
c-Jun	null	mice	c-Jun	null	mice	have	been	characterised	extensively	by	members	of	the	Jessen	and	Mirsky	laboratory.	c-Jun	null	mice	were	generated	using	transgenic	mice	in	which	loxP	 sites	 are	 present	 in	 the	 5’	 untranslated	 region	 (UTR)	 of	 c-jun	 and	 in	 the	 3’	flanking	sequence	2.5	kb	downstream	of	 the	 translation	stop	codon,	known	as	c-Jun	floxed	mice	(c-Junflox/flox).	These	mice	were	kindly	provided	by	Dr	Axel	Behrens	(Cancer	 Research	 UK).	 The	 c-Junflox/flox	 mice	 were	 crossed	 with	 P0-Cre	 mice	 to	produce	 P0-Cre;c-Junflox/wt	mice.	 These	were	 subsequently	 crossed	 again	with	 c-Junflox/flox	mice,	generating	P0-Cre;	c-Junflox/flox	mice	(c-Jun	null	mice).	
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2.3	Tissue	Culture	
2.3.1	Preparation	of	coverslips	and	tissue	culture	dishes		
Substratum	coating	of	Poly-D-lysine	and	Poly-L-lysine	Round	13-mm	glass	 coverslips	were	 baked	 in	 an	 oven	 for	 4	 hours	 at	 140°C	 and	were	coated	with	20	μg/ml	Poly-D-Lysine	(PDL)	in	distilled	H2O	for	rat	Schwann	cells,	or	20	μg/ml	Poly-L-Lysine	(PLL)	in	distilled	H2O	for	mouse	Schwann	cells,	for	3	hours	at	RT.	Coverslips	and	dishes	were	then	washed	3	times,	for	15	min	each	in	sterilised	water	and	dried	overnight	 in	a	class	 I	 tissue	culture	hood	before	being	stored	 in	 sterile	 and	 desiccated	 (in	 the	 presence	 of	 silica	 gel)	 conditions	 at	 RT.	35	mm	and	60	mm	tissue	culture	dishes	were	coated	with	PDL	(20	μg/ml)	or	PLL	(20	μg/ml)	for	4	hours	at	RT.	The	solution	was	removed	and	the	dishes	rinsed	once	with	distilled	H2O	and	allowed	to	air-dry	overnight	in	a	class	I	tissue	culture	hood.			
Laminin	A	15-μl	drop	of	laminin	solution	(diluted	in	DMEM,	20	μg/ml)	was	placed	into	the	centre	 of	 each	 glass	 coverslip,	 or	 completely	 covering	 the	 culture	 dish	 and	incubated	for	30	min	at	RT.	The	laminin	solution	was	removed	immediately	prior	to	plating	cells	onto	the	coverslip.		
2.3.2	Tissue	Culture	Media	
Defined	supplemented	Medium	(DM)	This	is	a	modification	of	the	medium	of	Bottenstein	and	Sato	(1979).	A	1:1	mixture	of	DMEM	and	Ham’s	F12	medium	was	enhanced	with	the	following:	bovine	 serum	 albumin	 (0.3	mg/ml),	 putrescine	 (16	μg/ml),	 transferrin	
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(100	μg/ml),	 thyroxine	(400	ng/ml),	progesterone	(60	ng/ml),	glutamine	(1	mM),	penicillin-streptomycin	 (100	U/ml),	 triiodothyronine	 (10.1	ng/ml)	 and	 selenium	(160	ng/ml)	and	insulin	(10-6	M).	
2.2.3	Pharmacological	Agents	The	Rho	Kinase	II	(ROCKII)	inhibitor	Y-27632	was	purchased	from	Sigma	Aldrich,	dissolved	in	DMSO	and	used	at	a	final	concentration	of	10	µM	for	all	experiments.	The	c-Src	inhibitor	SU6656	was	also	purchased	from	Sigma,	dissolved	in	DMSO	and	used	at	a	final	concentration	of	2	µM	for	all	experiments.	Mitomycin-C	was	used	to	inhibit	cellular	proliferation	in	the	migration	assays.	I	purchased	this	from	Sigma,	and	the	compound	was	dissolved	in	H20	and	used	at	a	concentration	of	10	µg/ml.	
2.3.4	Serum	purified	mouse	Schwann	cell	cultures	Mouse	 Schwann	 cells	 were	 isolated	 using	 a	 protocol	 ,	 as	 follows,	 adapted	 from	previous	studies	that	isolated	rat	and	mouse	Schwann	cells	(Brockes,	1979;	Dong	et	 al.	 1995).	 The	 sciatic	 nerves	 and	 brachial	 plexuses	 were	 dissected	 from	 two	postnatal	day	6	(P6)	mice	and	transferred	to	L15	medium	(Life	Technologies)	on	ice.	 Using	 a	 dissecting	 microscope,	 the	 epineurial	 sheath	 of	 each	 nerve	 was	removed	using	 no.	 5	 forceps.	 The	 desheathed	nerves	were	 then	 transferred	 to	 a	35-mm	tissue	culture	dish	containing	5%	horse	serum	in	DMEM	+	Pen/Strep	and	left	overnight	at	37˚C	in	5%	CO2.	The	following	day,	the	nerves	were	removed	from	the	medium	and	transferred	to	a	culture	dish	containing	trypsin/collagenase,	and	left	in	the	incubator	for	30	min	at	37˚C	in	5%	CO2.	The	nerves	were	then	triturated	ten	 times	 with	 a	 blue	 pipette	 tip,	 and	 ten	 times	 with	 a	 yellow	 tip	 and	 then	 re-incubated	 for	 10	min.	 Trituration	 was	 repeated	 to	 fully	 dissociate	 the	 cells	 and	
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then	 the	 5%	 horse	 serum/DMEM	 was	 added	 to	 prevent	 further	 enzymatic	digestion.	 The	 digested	 cells	 were	 then	 transferred	 to	 a	 15-ml	 Falcon	 tube	 and	centrifuged	at	1,000	rpm	for	10	min.	The	cell	pellet	was	then	resuspended	in	2	ml	of	5%	horse	serum	+	Pen/Strep	and	 transferred	 to	a	 laminin-PLL-coated	35-mm	tissue	culture	dish.	Ara-C	was	added	to	the	dish	at	a	final	concentration	of	10-5	M	and	the	cells	were	incubated	at	37˚C	in	5%	CO2	for	3	days	to	eliminate	proliferating	fibroblasts.	 After	 3	 days,	 the	 cells	 were	 trypsinised	 and	 re-plated	 into	 a	 35-mm	dish	 containing	 Schwann	 cell	 expansion	 medium	 (Defined	 Medium	 containing	0.5%	horse	serum	(1:200),	100	μM	dbcAMP	(1:500)	and	10	ng/ml	NRG1	(1:500).	The	cells	were	used	 for	 further	experiments	once	the	dish	had	become	confluent	(~7-10	days	following	purification),	but	were	placed	in	DM	without	any	mitogenic	factors	for	12	hours	until	experimental	reagents	were	added.	
2.3.5	Adenovirus	constructs	and	preparation	The	adenovirus	expressing	Cre	recombinase,	and	its	control	expressing	GFP	were	obtained	 as	 gifts	 from	 Dr	 Axel	 Behrens,	 made	 in	 the	 laboratory	 of	 Dr	 A	 Berns	(Akagi	 et	 al.	 1997).	 The	 HindIII	 fragment	 of	 PBS185,	 containing	 the	 Cre	recombinase	 open	 reading	 frame	 under	 the	 control	 of	 human	 CMV	 immediate	early	promoter		and	the	metallothionein	polyadenylation	signal	was	inserted	into	the	HindIII	site	of	pdE1spIA.	This	was	co-transfected	with	pJM17	into	293	cells	and	adenovirus	was	obtained	by	plaque	purification	(Akagi	et	al.	1997).	Adenoviral	 supernatants	 were	 prepared	 and	 titred	 as	 described	 previously	(Parkinson	et	al.	2001).	HEK	293	cells	were	infected	with	the	adenovirus,	and	once	the	cells	had	started	to	round	and	detach	from	the	culture	dish	(~3	days),	the	cells	were	scraped	and	transferred	to	a	50-ml	Falcon	tube	and	centrifuged	at	1,500	rpm	for	5	min	at	4˚C.	The	supernatant	was	discarded	and	the	pellet	resuspended	in	1.5	
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ml	of	PBS.	Three	cycles	of	 freeze-thawing	using	the	-80˚C	freezer	and	37˚C	water	bath	were	completed,	and	the	cell	 suspension	was	centrifuged	at	3,000rpm	for	5	min.	The	supernatant	was	passed	through	a	0.2	µm	filter	and	the	virus-containing	solution	was	aliquoted	and	stored	at	-80˚C.	The	 viruses	 were	 then	 titred	 by	 infecting	 Ara-C	 purified	 Schwann	 cells	 with	different	 volumes	 of	 the	 virus.	 The	 volume	 that	 resulted	 in	 >95%	 infection	 (as	determined	by	immunolabelling	Cre,	or	expression	of	GFP)	and	no	cell	death	was	chosen.	Viral	 titration	was	carried	out	each	time	when	preparing	new	adenoviral	stocks.	
2.3.6	Adenoviral	infection	The	adenoviruses	were	used	to	infect	the	expanded	primary	mouse	Schwann	cell	cultured.	 Briefly,	 the	 medium	 of	 confluent	 35-mm	 dishes	 was	 changed	 from	expansion	medium	 to	DM	containing	0.5%	horse	 serum	and	2	µM	Forskolin	and	Insulin	(10-6	M).	A	volume	of	adenovirus	was	added	(determined	by	titration)	and	after	24	hours,	the	medium	was	exchanged	with	DM	containing	0.5%	horse	serum	and	left	for	2	days	before	being	used	in	experiments.	
2.4	Migration	Assays	
2.4.1	Transwell	migration	assay	Primary	 mouse	 Schwann	 cells	 were	 used	 in	 all	 Transwell	 migration	 assays,	purified	 as	 described	 in	 section	 2.3.4.	 Cells	 were	 detached	 from	 35-mm	 culture	dishes	 following	 adenoviral	 infection	 (omitted	 in	 the	 case	 of	wildtype	 cells)	 and	pre-incubation	 with	 mitomycin-C	 (2	 hours)	 and	 then	 counted	 using	 a	hemocytometer.	 Approximately	 5,000	 cells	 in	 a	 volume	 of	 100	 µl	 of	 DM	 were	
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pipetted	into	the	top	compartment	of	a	Transwell	(pores	size	of	8	µm,	placed	in	a	24-well	 plate).	 The	 contents	 of	 the	 lower	 compartments	 were	 varied	 across	different	experimental	conditions.	Cells	were	allowed	to	migrate	 for	12	hours.	At	the	end	of	the	experiment,	the	Transwell	membrane	was	fixed	with	4%	PFA	for	10	min,	washed	three	times	with	PBS	and	the	upper	side	of	the	membrane	was	gently	scrapped	 with	 a	 cotton	 bud	 to	 remove	 non-migrated	 cells.	 The	 membrane	 was	stained	with	dapi,	cut	out	of	the	Transwell	supports	and	mounted	onto	slides.	The	total	 number	 of	 nuclei	 (representing	 migrated	 cells)	 were	 counted	 across	 the	entire	membrane	using	a	fluorescent	microscope.	
2.4.2	Wound	assay	Schwann	 cells	 were	 detached	 from	 35-mm	 culture	 dishes	 following	 adenoviral	infection	 (omitted	 in	 the	 case	 of	 wildtype	 cells)	 and	 counted	 using	 a	hemocytometer.	 Approximately	 200,000	 cells	were	 plated	 onto	 a	 laminin-coated	coverslip	 and	 cells	 were	 allowed	 to	 adhere,	 in	 the	 presence	 of	 mitomycin-C	 to	prevent	 cell	 proliferation.	A	 scratch	was	made	 across	 the	 center	 of	 the	 coverslip	using	a	yellow	pipette	tip	(Fig.	2.1).	The	scratch	was	practiced	beforehand	in	order	to	 generate	 a	 consistent	diameter,	 and	 this	was	determined	 to	be	 approximately	220	µm	wide.	The	 coverslips	were	placed	 inside	 the	wells	of	24-well	plates,	 and	covered	with	 400	µl	 of	medium	prior	 to	 the	wound	 being	made.	 The	 assay	was	terminated	at	several	time	points	(0,	6,	12	and	24	hours)	in	order	to	examine	the	rate	 of	 cell	 migration.	 The	 coverslips	 were	 immunolabelled	 with	 β1-integrin	 to	visualise	 the	migrating	 cells,	 the	 distance	 of	 the	 wound	 gap	was	measured	 at	 8	equidistant	positions	and	the	average	diameter	of	the	wound	was	calculated.		
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Figure	2.1	Scratch	Assay (A)	 a	 confluent	 layer	 of	 Schwann	 cells	 is	maintained	 in	 culture	 on	 35-mm	 glass	coverslips.	 (B)	 a	 scratch	 is	 made	 across	 the	 diameter	 of	 the	 coverslip	 using	 a	yellow	200µl	pipette	tip.	(C)	The	denuded	area	is	 imaged	to	mark	the	area	of	the	wound	at	0	hours.	(D)	At	the	end	of	the	time	point,	the	gap	is	imaged	again,	and	the	average	distance	is	calculated.	Adapted	from	(Hulkower,	2011).	
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2.5	Sciatic	nerve	transection	injury	models	All	surgical	procedures	were	carried	out	under	UK	Home	Office	guidelines,	using	sterile	surgical	technique.	Mice	were	shaved	in	the	region	of	the	leg	and	lower	back	and	subsequently	anaesthetized	with	2%	isofluorane.	For	the	complete	transection	experiment,	 the	 sciatic	nerve	was	exposed	and	 transected	at	 the	mid-thigh	 level,	approximately	1	cm	above	the	point	at	which	the	nerve	trifurcates	into	the	tibial,	peroneal	 and	 sural	 branches..	 For	 the	 partial	 transection	 injury	 model,	 no.	 5	forceps	were	used	to	gently	part	the	tibial	and	peroneal	branches	to	create	a	gap	of	sufficient	 size	 to	 insert	 the	 blades	 of	 the	 surgical	 scissors	 and	 then	 transect	 the	peroneal	branch.	Care	was	taken	to	separate	the	two	branches	in	small	area	so	that	following	 transection,	 the	 proximal	 and	 distal	 stumps	 were	 still	 attached	 to	 the	tibial	nerve	and	kept	in	close	proximity	to	each	other.	The		skin	was	closed	using	veterinary	autoclips	and	animals	were	left	to	recovered	in	a	heated	box.		
2.6	Genotyping	HotShot	 DNA	 extraction:	 Ear	 clips	 were	 collected	 from	 mice	 at	 P8-P12	 and	digested	using	HotShot	 lysis	 reagent	 (25	mM	NaOH,	0.2	mM	disodium	EDTA,	pH	12)	 for	 1	 hour	 at	 95˚C.	 Samples	 were	 then	 vortexed	 and	 cooled	 to	 4˚C	 and	subsequently	neutralised	with	40	mM	Tris-HCl.	Samples	were	stored	at	-20˚C	until	use.		Semi-quantitative	PCR:	Polymerase	chain	reactions	(PCR)	were	performed	for	each	sample	 using	 100-400	 ng	 of	 DNA	 from	 the	 above	 extraction,	 in	 a	 total	 reaction	volume	of	25	μl.	PCR	was	performed	in	an	Eppendorf	Mastercycler	Gradient	PCR	thermalcycler.	Specific	conditions	were	used	for	each	primer	pair.	15	μl	of	the	PCR	
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reaction	 was	 used	 for	 electrophoresis	 in	 a	 2%	 agarose	 gel	 containing	 ethidium	bromide,	 immersed	 in	 1x	 Tris	 Acetate	 EDTA	 (TAE)	 buffer	 (Horizon	 58	 gel	apparatus,	BRL-	Life	Technologies,	Gaithersburg,	MD).	Samples	were	run	alongside	10μl	of	1kb	DNA	ladder	(Invitrogen).	
2.6.1	Primers	and	PCR	conditions	for	genotyping	c-Jun	flox	mice:	Forward	CCGCTAGCACTCACGTTGGTAGGC		Reverse	CTCATACCAGTTCGCACAGGCGGC	2min	at	94˚C	35	cycles:	40secs	at	94˚C,	40secs	at	57˚C,	1min	30secs	at	72˚C	7min	at	72˚C	Wildtype	band	at	300	bp;	floxed	band	at	330	bp		P0-Cre	mice:	Forward	GCTGGCCCAAATGTTGCTGG		Reverse	CCACCACCTCTCCATTGCAC	4min	at	94˚C	30	cycles:	30secs	at	94˚C,	1min	at	50˚C,	1min	at	72˚C	10min	at	72˚C	Band	at	500	bp		 	
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2.7	Western	blotting	
2.7.1	Protein	extraction	The	 distal	 stumps	 of	 transected	 nerves	were	 snap	 frozen	 in	 liquid	 nitrogen	 and	transferred	to	tubes	containing	10-12	10B	lysing	matrix	beads	and	100	μl	of	lysis	buffer	(25	mM	Tris-HCl	pH	7.4,	95	mM	NaCl,	10	mM	EDTA,	2%	SDS	and	proteinase	and	 phosphatase	 inhibitors).	 The	 nerve	 samples	 were	 placed	 in	 a	 Fast-prep	homogeniser	 for	 45	 sec	 at	 level	 6,	 chilled	 on	 ice	 and	 then	 subjected	 to	 repeat	homogenisation	at	the	same	setting.	The	resulting	lysates	were	then	centrifuged	at	4˚C	 at	 10,000	 rpm	 for	 2	 min.	 Supernatants	 were	 transferred	 to	 new	 tubes	 and	centrifuged	again	at	 the	same	settings.	The	new	supernatants	were	collected	and	stored	at	-80˚C.	
2.7.2	SDS	PAGE	Protein	 lysate	 samples	 were	 separated	 by	 electrophoresis	 on	 acrylamide	 gels.	Sample	buffer	was	added	to	a	final	dilution	of	1x,	prior	to	gel	loading:	Laemmli	sample	buffer	(5x):	60	mM	Tris	pH	6.8,	2%	SDS,	10%	glycerol,	5%	beta-mercaptoethanol	and	0.01%	bromophenol	blue.	The	 protein	 samples	 (5	 μg)	were	 loaded	 into	 a	 10%	 gel	 and	 run	 alongside	 pre-stained	standard	molecular	weight	markers	(SeeBlue	Plus	2,	Invitrogen)	to	enable	identification	 of	 band	 sizes.	 Gels	 were	 run	 using	 the	 mini	 Protean	 II	 gel	electrophoresis	 apparatus	 (Biorad,	 USA)	 and	 then	 proteins	 were	 transferred	 to	nitrocellulose	 membranes	 (Hybond	 ECL,	 Amersham)	 using	 the	 Biorad	 semi-dry	system	and	transfer	buffer	(25	mM	Tris,	192	mM	glycine,	10%	methanol).		
 
 
	 74	
2.7.3	Detection	Membranes	were	washed	briefly	in	PBS	after	transfer	and	subsequently	incubated	in	5%	 fat	 free	milk	powder	 (Sigma)	 in	PBS	 for	1	hour	 (RT)	 to	block	non-specific	binding	 sites.	 Membranes	 were	 incubated	 overnight	 at	 4˚C	 with	 primary	antibodies	 diluted	 in	 5%	 milk/PBS	 on	 a	 slow	 rotator	 (Gallenkamp,	 UK).	Membranes	 were	 subsequently	 washed	 every	 10	min	 in	 PBS	 for	 30	min	 before	addition	 of	 secondary	 antibodies	 conjugated	 to	 horseradish	 peroxidase	 (HRP)	diluted	 in	 5%	 milk/PBS.	 After	 secondary	 incubation,	 membranes	 were	 washed	every	10	min	for	40	min.	The	 secondary	 antibody	 signal	 was	 detected	 by	 incubating	membranes	 in	 a	 1:1	mixture	of	ECL	solutions	A	and	B	 for	3	min	 in	 the	dark.	Membranes	were	placed	into	autoradiography	cassettes	(Appligene,	USA)	and	developed	by	brief	exposure	(5	sec	to	5	min)	to	Thermo	Scientific	CL-XPosure	film.	Films	were	developed	using	an	X-graph	Compact	X2	automatic	developer	(UK).		ECL	solution	A:	0.1M	Tris,	pH	8.5,	2.5	mM	luminol	and	0.4	mM	coumaric	acid	ECL	solution	B:	0.1M	Tris,	pH	8.5	and	0.02%	hydrogen	peroxide		Both	ECL	solutions	were	stored	at	4˚C	in	dark	conditions	and	mixed	immediately	prior	to	use.			 	
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2.8	Reverse	transcription-quantitative	polymerase	chain	reaction	(RT-qPCR)	
2.8.1	RNA	extraction	and	reverse	transcription	RNA	 was	 extracted	 from	 primary	 mouse	 Schwann	 cell	 cultures	 that	 had	 been	subjected	 to	 infection	 with	 adeno-Cre	 (c-Jun	 KO)	 or	 adeno-GFP	 (control).	 One	confluent	35-mm	tissue	culture	dish	was	used	 for	each	RNA	extraction,	and	RNA	was	 extracted	 3	 times	 for	 each	 knockout	 and	 control	 (n=3).	 RNA	was	 extracted	using	 the	 RNeasy	 Micro	 kit	 (Qiagen,	 Venlo,	 Netherlands)	 according	 to	 the	manufacturer’s	 instructions.	 RNA	was	 treated	with	 DNAse	 to	 eliminate	 genomic	DNA	 from	 the	 samples	 using	 Turbo™	 DNase	 treatment	 (Life	 Technologies)	 in	accordance	with	the	manufacturer’s	instructions.		For	 reverse	 transcription,	 RNA	 samples	 were	 added	 to	 a	 nuclease-free	microcentrifuge	 tube	 as	 follows:	 1μl	 of	 oligo(dt)20	 primers	 (50	 μM;	 Life	Technologies),	1	μg	of	RNA	samples,	1μl	of	10	mM	dNTP	mix	and	13	μl	of	sterile	distilled	 H2O.	 This	 mixture	 was	 heated	 to	 65˚C	 for	 5	 min	 in	 a	 Biorad	 CFX	thermalcycler	and	 incubated	on	 ice	 for	1	min.	To	each	tube,	6	μl	of	 the	 following	master	mix	was	added:	4	μl	of	5	x	First	strand	buffer,	1	μl	of	0.1	M	DTT	and	1	μl	of	RNAse	 Out	 40	 U/μl	 (all	 from	 Life	 Technologies).	 To	 each	 sample,	 1	 μl	 of	SuperScript™	 II	 reverse	 transcriptase	 (Life	 Technologies)	 was	 added,	 heated	 to	42˚C	for	50	min	and	then	70˚C	for	15	min.	Each	20	μl	sample	was	divided	into	two	and	stored	at	-80˚C	until	required	for	RT-qPCR	reactions.		
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2.8.2	Primer	design	and	optimization	for	RT-qPCR	Primers	for	housekeeping	genes	and	test	genes	were	designed	using	Primer3Plus	software,	 unless	 otherwise	 indicated.	 Primers	were	 designed,	where	 possible,	 to	span	intron-exon	boundaries	as	an	additional	control	for	the	presence	of	genomic	DNA.	 Primers	 were	 optimised	 by	 testing	 the	 following	 concentrations	 of	forward/reverse	primers:	200	nmol/200	nmol,	300/300,	300/200	and	200/300.	Primers	were	tested	according	to	the	following	PCR	conditions:		1)	95	˚C	for	3:00	2)	95	˚C	for	0:15	3)	60	˚C	for	0:30	4)	72	˚C	for	0:30					+	Plate	Read	5)	Gg	to	step	2,	39	more	times	6)	Melt	Curve	65	to	95	˚C,	increment	1	˚C,					0:05	+	Plate	Read					END		The	PCR	reactions	contained	the	following	components:	10	μl	of	Kapa	SYBR	green	(Kapa	biosystems,	Wilminton,	MA,	USA)	0.4	μl		each	of	Forward	and	Reverse	Primers	(if	200/200	nmol)	4	μl		of	cDNA	(diluted	1:60	in	sterile,	distilled	H2O)	5.2	μl	of	sterile,	distilled	H2O	(to	make	a	reaction	total	volume	of	20	μl)		The	PCR	products	of	each	primer	pair	were	analysed	and	 the	primers	were	only	accepted	 if	 they	 contained	 one	melt	 curve	 peak	 and	 gave	 a	 Ct	 (cycle	 threshold)	
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value	 that	 was	 <30.	 PCR	 products	 were	 run	 on	 an	 agarose	 gel	 to	 check	 for	 the	presence	 one	 band.	 Standard	 curves	 were	 carried	 out	 on	 the	 primers	 for	 each	cDNA	sample,	and	primers	were	only	accepted	if	R2>0.98	and	there	was	a	gradient	of	-3.2	to	-3.5	(Efficiency,	>95%).	
2.8.3	RT-qPCR	analysis	The	data	from	the	RT-qPCR	were	normalized	to	GAPDH	and	YWHAZ	as	these	had	the	least	variability	of	all	housekeeping	genes	tested	between	the	control	and	c-Jun	knockout	samples.	This	was	done	using	the	Biorad	CFX	Manager	Software	(version	1.6).	 Fold	 change	 of	 expression	 of	 c-Jun	 knockout	 compared	 to	 control	 was	calculated	using	the	2-ΔΔCt	method	using	the	Biorad	CFX	software.	
2.9	Immunolabelling	
2.9.1	Antibodies	
Antibody	 Supplier	 Host	Species	 Application	
β1-Integrin	 Abcam	 Mouse	mono	 ICC	1:500	Vinculin	 Abcam	 Mouse	mono	 ICC	1:400	c-Src	 Santa	Cruz	 Mouse	mono	 WB	1:500,	ICC	1:500	c-Jun	 BD	 Mouse	mono	 ICC	1:500	Cre	recombinase	 Merck	Millipore	 Rabbit	poly	 ICC	1:1000	GAPDH	 Enzo	Life	Sci	 Mouse	mono	 WB	1:2000	S100	 Dako	 Rabbit	poly	 IHC	1:500	Neurofilament	 Abcam	 Chick	poly	 IHC	1:1000		
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2.9.2	Fixation	Cells	were	fixed	with	4%	paraformaldehyde	for	10	min	at	RT	in	all	experiments.	Coverslips	were	subsequently	dipped	3	times	in	5	tubes	containing	PBS	for	in	order	to	rinse	the	PFA	from	the	samples.	
2.9.3	Immunolabelling	Coverslips	 for	 immunolabelling	 were	 treated	 for	 10	 min	 in	 100%	methanol	 for	permeabilisation,	for	all	antibodies	used.	Subsequently,	slides	and	coverslips	were	incubated	in	antibody	diluting	solution	(ADS)	for	30	minutes	to	1hr.	ADS:	Donor	Calf	Serum	20	ml,	Lysine	3.65	g,	PBS	180	ml	Primary	antibodies	diluted	in	ADS	were	applied	overnight	at	4˚C.	Coverslips	were	washed	by	dipping	3x	in	5	tubes	containing	PBS,	slides	were	washed	in	coplin	jars	containing	 PBS	 on	 a	 low	 speed	 platform	 shaker,	 3x	 10	minutes	 for	 30	minutes.	Secondary	 antibodies	 diluted	 in	 ADS	 were	 applied	 for	 30	 minutes	 and	 samples	washed	again.	Coverslips	containing	cultured	cells	were	inverted	and	mounted	on	glass	slides	using	citiflour	mounting	medium.		
2.9.4	Microscopy	Immunofluorescent	cells	or	were	visualised	using	either	a	Nikon	Optiphot-2	or	a	Nikon	Eclipse	E800	fluorescent	microscope.	Images	were	captured	using	a	digital	camera	(model:	DXM1200,	Nikon)	and	ACT-1	acquisition	software	(Nikon).	
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	2.9.5	Nerve	wholemount	immunohistochemistry	The	 peroneal	 nerve	 was	 carefully	 cut	 away	 from	 the	 tibial	 nerve	 with	 small	dissecting	 scissors,	 immediately	 prior	 to	 fixation	 with	 4%	 paraformaldehyde	overnight	at	4˚C.	The	nerve	sample	was	then	rinsed	with	PTX	(1%	triton	X-100	in	PBS)	three	times	for	10	min	each	and	then	incubated	in	blocking	buffer	(10%	FBS	in	 PTX)	 overnight	 at	 4˚C	 in	 a	 2-ml	 eppendorf	 tube.	 The	 primary	 antibodies	(Neurofilament	and	S100)	were	diluted	 in	10%	FBS-PTX	and	 incubated	with	 the	sample	for	72	hours	at	4˚C	with	gentle	shaking.	The	sample	was	then	rinsed	three	times	for	15	min	each,	followed	by	washing	in	PTX	for	6	hours	at	4˚C.	The	PTX	was	changed	 each	 hour	 and	 the	 samples	 left	 to	 wash	 overnight	 in	 the	 final	 wash.	Secondary	antibodies	were	diluted	in	10%	FBS-PTX	and	incubated	for	48	hours	at	4˚C	with	gentle	shaking.	The	samples	were	then	rinsed	in	PTX	three	times	for	15	mins	each,	followed	by	washing	overnight	in	PTX.	The	nerve	was	then	cleared	with	25%,	 50%	 and	 75%	 glycerol	 in	 PBS	 until	 the	 tissue	 sinks.	 Samples	 were	 then	mounted	 onto	 a	 coverslip	 and	 slide	 using	 Citifluor	 mounting	 medium	 and	 nail	varnish.	 The	 samples	 were	 visualised	 using	 a	 microscope	 (Leica	 SP2	 confocal	microscope),	 and	 a	maximum	 projection	 of	 30	 stacks	was	 created.	 Images	were	imported	into	Adobe	Photoshop.		
2.10	Statistical	Analysis	All	 data	 are	 presented	 as	 arithmetic	 mean	 ±	 standard	 deviation	 (SD).	 Unless	otherwise	 stated,	 statistical	 significance	was	 estimated	 using	 the	 Student’s	 t-test	using	Prism	version	6	software	(Graphpad).	
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Chapter	3:	c-Jun	controls	Schwann	cell	morphology	and	migration	
	
3.1	Introduction	Schwann	 cell	morphology	 and	migration	 are	 important	 features	 of	 the	 Schwann	cell	response	to	nerve	injury.	Schwann	cell	morphology	is	altered	following	injury	and	axonal	loss	in	the	distal	nerve	stump,	leading	to	the	formation	of	the	Bands	of	Büngner	-	Schwann	cell	tubes	that	guide	the	regrowth	of	regenerating	axons.	The	precise	 form	of	 these	cells	 is	 currently	under	 investigation,	however,	 it	 is	known	they	 differ	 greatly	 from	mature	myelinating	 and	 non-myelinating	 Schwann	 cells.	The	most	significant	difference	is	that	the	axon-Schwann	cell	interface	is	absent	in	Bungner	 Schwann	 cells	 (the	myelin	 ring	 and	 adaxonal	membrane	of	myelinating	Schwann	cells,	and	the	 invaginated	plasma	membrane	of	Remak	Schwann	cells	 is	lost	during	transdifferentiation).	Electron	micrographs	of	Bungner	cells	show	cells	with	multiple	processes	 inside	 the	basal	 lamina	 tube,	and	 loss	of	c-Jun	 leads	 to	a	reduction	 in	 the	 number	 of	 Schwann	 cell	 processes	 (Arthur-Farraj	 et	 al.	 2012).	Furthermore,	Schwann	cells	migration	from	the	endoneurial	tubes	is	necessary	to	bridge	the	gap	between	proximal	and	distal	nerve	stumps	following	a	transection	injury,	this	occurs	in	concert	with	the	extension	of	perineurial	cells,	blood	vessels	and	the	influx	of	macrophages,	as	discussed	in	more	detail	in	Chapter	1.	Considering	 that	 Schwann	 cell	 morphology	 and	 migration	 are	 influential	during	 peripheral	 nerve	 regeneration,	 I	 decided	 to	 investigate	 how	 these	 are	affected	 when	 c-Jun,	 a	 master	 regulator	 of	 Schwann	 cell	 transdifferentiation,	 is	deleted	 in	 Schwann	 cells.	 Studies	 in	 other	 cell	 types,	 such	 as	 fibroblasts	 have	shown	 that	 c-Jun	 exerts	 control	 over	 cell	morphology	 and	migration	 via	 several	distinct	pathways	(Jiao	et	al.	2008;	Jiao	et	al.	2010;	Zenz	et	al.	2003).	
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3.2	Results	
3.2.1	Loss	of	c-Jun	induces	flattening	and	reduces	the	polarity	of	primary	
Schwann	cells	In	order	to	analyze	the	effect	of	c-Jun	on	Schwann	cells,	control	and	c-Jun	knockout	cells	were	 generated	 by	 infecting	 purified	mouse	 c-Junflox/flox	 Schwann	 cells	with	adeno-GFP	and	adeno-Cre	respectively	(as	described	in	Chapter	2).	These	primary	mouse	 Schwann	 cells	were	 immunostained	with	 an	 anti	β1-integrin	 antibody	 in	order	 to	 visualize	 the	 plasma	 membrane	 (Figure	 3.1A).	 Additionally,	 c-Jun	knockout	cells	were	also	generated	using	the	P0-Cre	recombinase	mouse.	Schwann	cells	were	purified	from	P0-Cre+;c-Junflox/flox	and	P0-Cre-;c-Junflox/flox	P5	littermates	to	obtain	c-Jun	knockouts	and	controls.	I	used	two	methods	of	generating	the	c-Jun	knockout	 cells,	 firstly	 to	 demonstrate	 the	 robustness	 of	 the	 cell	 morphology	phenotype,	and	secondly	because	c-Jun	knockout	Schwann	cells	proliferate	slowly,	making	 them	hard	 to	 expand	 for	 use	 in	 experiments	 requiring	 large	 numbers	 of	primary	 Schwann	 cells,	 such	 as	migration	 assays.	 For	 this	 reason,	 I	 purified	 and	expanded	c-Junflox/flox	 cells	 for	all	of	my	subsequent	cell	 culture	experiments,	and	infected	 these	 with	 adeno-Cre	 or	 adeno-GFP	 to	 generate	 knockout	 and	 control	cells.	 The	 results	 of	 this	 experiment	 demonstrate	 that	 the	 c-Jun	 knockout	Schwann	cells	have	an	appearance	significantly	different	 to	 the	control	cells.	The	characteristic	bi-polar	and	tri-polar	morphology	of	cultured	mouse	Schwann	cells	is	replaced	with	a	flattened	and	rounded	profile	in	both	the	adeno-Cre	and	P0-Cre	Schwann	 cells.	 Furthermore,	 the	 expression	 of	 β1-integrin	 in	 control	 and	 c-Jun	knockout	cells	 is	distributed	across	the	entire	plasma	membrane	and	thus	serves	
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as	a	useful	way	 to	delineate	 the	 cell	 shape	 (Fig.	3.1A).	Quantification	of	 cell	 area	reveals	a	significant	difference	in	the	size	of	the	c-Jun	knockout	cells	compared	to	the	 control	 (Fig.	3.1B).	 There	 is	 a	 small	 difference	 in	 cell	 size	 between	 the	 two	types	 of	 c-Jun	 knockout	 Schwann	 cells	 (P0-Cre	 and	 adeno-Cre	 expressing	 cells).	Cell	shape	was	analysed	by	measuring	circularity	with	ImageJ,	as	described	in	the	methods,	using	the	formula:		Circularity	=	4π	x	(area	/	perimeter2).	Quantification	revealed	that	c-Jun	deleted	cells	are	significantly	more	circular	than	control	cells	(Fig.	3.1C).	
	
	
	
	
	
	
Figure	 3.1:	 Deletion	 of	 c-Jun	 in	 Schwann	 cells	 increases	 cell	 area	 and	
circularity.	(A)	 Immunocytochemistry	 of	 β1-integrin	 delineating	 the	 plasma	 membrane	 of	control	and	c-Jun	knockout	mouse	Schwann	cells.	c-Jun	was	deleted	from	primary	Schwann	cells	using	two	methods;	firstly	by	expression	of	Cre	recombinase	under	the	 P0	 promoter	 in	 c-Jun	 floxed	 mice	 (P0-cre;	 c-Jun	 flox/flox)	 and	 secondly	 by	infecting	 c-Jun	 floxed	 purified	 Schwann	 cells	 with	 an	 adenovirus	 containing	 the	gene	 for	 Cre-recombinase	 (adeno-Cre	 +	 c-Jun	 flox/flox).	 Controls	 were	mice/Schwann	cells	without	Cre-recombinase,	and	an	adenovirus	expressing	GFP	instead	 of	 Cre,	 respectively.	 Scale	 bar,	 20µm.	 	 (B)	 Cell	 area	 of	 control	 and	 c-Jun	knockout	 Schwann	 cells.	 (C)	 Circularity	 was	 measured	 for	 both	 control	 and	knockout	cells,	as	defined	by	4π	x	(area	/	perimeter2).	A	value	of	1	equals	a	circle,	while	a	value	of	0	represents	a	straight	line.	Data	are	means	±SD;	n=	a	total	of	180	cells	from	three	independent	experiments	(90	each);	***P<0.001.				
 
 
	 83	
Figure	3.1		 						
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3.2.2	c-Jun	deletion	impairs	Schwann	cell	migration	Changes	 in	 cell	 shape	 and	 the	 cytoskeletal	 rearrangement	 that	 accompanies	 this	are	 frequently	 associated	 with	 changes	 in	 cell	 migration.	 In	 particular,	 cell	flattening	and	a	loss	of	polarization	correlate	well	to	a	reduction	in	cell	migration.	In	order	to	determine	whether	the	morphological	phenotype	that	follows	the	loss	of	 c-Jun	 in	 Schwann	 cells	 also	 affects	 cell	 migration,	 I	 conducted	 transwell	migration	 assays.	 As	 discussed	 above,	 c-Jun	 knockout	 and	 control	 cells	 were	generated	 by	 infecting	 c-Junflox/flox	 purified	 Schwann	 cells	 with	 adeno-Cre	 and	adeno-GFP.	 Cell	 migration	 was	 induced	 by	 adding	 two	 concentrations	 of	 horse	serum	(0.5	and	3%)	to	the	lower	compartment	of	the	transwell.	Horse	serum	is	a	mitogen	 for	mouse	Schwann	cells,	 so	cells	were	pre-incubated	with	mitomycin-C	for	2	hours	before	the	assay	in	order	to	abolish	the	effects	of	proliferation	on	the	results.	 Figure	 3.2A	 shows	 that	 deletion	 of	 c-Jun	 in	 Schwann	 cells	 causes	 a	reduction	in	cell	migration	through	the	transwell	membrane	(47%	fewer	knockout	cells	than	wildtype,	P>0.001).	This	difference	is	maintained	in	both	concentrations	of	 serum,	 but	 no	 significant	 difference	 was	 observed	 in	 the	 absence	 of	 any	chemoattractant	(defined	medium	only),	where	very	few	cells	had	migrated	across	the	membrane	for	either	genotype.	NRG1	 is	 an	 important	 chemoattractant	 for	 Schwann	 cells,	 both	 during	development	and	regeneration.	In	order	to	investigate	its	affect	of	the	migration	of	c-Jun	knockout	Schwann	cells,	I	repeated	the	assay	with	NRG1	(20	ng/ml)	present	in	the	lower	compartment	of	the	transwell.	Again,	to	abolish	the	known	affects	of	NRG1	 on	 cellular	 proliferation,	 this	 was	 carried	 out	 with	 a	 pre-incubation	 of	mitomycin-C.	Figure	3.2B	shows	a	very	similar	reduction	in	cell	migration	for	c-Jun	knockout	 Schwann	 cells	 to	 that	 seem	 in	 response	 to	horse	 serum.	 In	 addition	 to	examining	 the	 effect	 of	 NRG1	 on	 cell	 migration,	 I	 also	 wanted	 to	 see	 if	 re-
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introducing	c-Jun	into	the	knockout	cells	would	restore	normal	cellular	migration.	This	was	achieved	by	infecting	the	knockout	cells	with	an	adenovirus	expressing	c-Jun	 and	 examining	 their	migration	 in	 response	 to	NRG1.	 Figure	 3.3B	 shows	 that	restoring	 c-Jun	 in	 knockout	 cells	 does	 indeed	 restore	 cell	 migration	 to	 a	 level	similar	to	that	of	the	control	(no	significant	difference),	and	elevating	c-Jun	levels	in	wildtype	Schwann	cells	leads	to	a	slight	increase	in	cell	migration	(P<0.01).	In	order	to	confirm	the	deficient	migration	of	c-Jun	knockout	Schwann	cells,	an	 additional	 assay	 measuring	 migration	 in	 response	 to	 NRG1	 was	 carried	 out	using	 the	wound	assay	 [described	 in	Chapter	2	and	(Meintanis	et	al.	2001)].	The	results	from	this	experiment	confirmed	that	deletion	of	c-Jun	leads	to	a	reduction	in	Schwann	cell	migration	(Fig.	3.2C).					
Figure	3.2:	Schwann	cell	c-Jun	is	required	for	cell	migration.	(A)	Cell	migration	was	measured	using	a	Transwell	migration	assay.	Migrated	cells	were	counted	after	being	incubated	with	defined	medium,	or	0.5%	and	3%	horse	serum	-	a	known	chemoattractant	for	Schwann	cells.	Data	are	means	±SD	of	three	independent	experiments;	 ****P<0.0001.	(B)	A	Transwell	migration	assay	showing	that	 enforced	 expression	 of	 c-Jun	 in	 c-Jun	KO	 cells	 using	 an	 adenovirus	 restores	normal	 cell	 migration	 in	 response	 to	 NRG-1	 (20	 ng/ml)	 compared	 to	 control	Schwann	 cells	 infected	 with	 adenoviral	 GFP.	 Control	 cells	 infected	 with	 c-Jun	adenovirus	 show	 a	 slight	 increase	 in	 cell	 migration.	 (C)	 Wound	 assay	 showing	Schwann	cell	migration	over	a	period	of	6,	12	and	24	hours	in	response	to	NRG-1	(20	ng/ml)	for	c-Jun	knockout	and	control	cells.	
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Figure	3.2	
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3.2.3	c-Jun	deletion	reduces	cell	migration	on	collagen	and	laminin	Collagen	and	 laminin	are	both	present	 in	 the	peripheral	nerve	and	are	known	to	promote	the	migration	of	Schwann	cells.	In	order	to	investigate	the	effect	of	these	molecules	on	the	c-Jun	knockout	cells,	I	performed	transwell	migration	assays	with	collagen	 I-(from	 rat	 tail)	 and	 laminin	 2-coated	 transwell	membranes.	 Figure	 3.3	shows	significantly	 fewer	Schwann	cells	migrate	on	both	 laminin	and	collagen	 in	the	 c-Jun	 knockout	 compared	 to	 the	 control	 (P<0.0001).	 Control	 Schwann	 cells	have	 significantly	 increased	migration	 on	 laminin	 over	 collagen	 (P<0.0001),	 but	this	difference	is	not	present	when	c-Jun	is	deleted	from	the	cells.					 	
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Figure	3.3																																
Figure	 3.3:	 Schwann	 cell	 c-Jun	 is	 required	 for	 migration	 on	 collagen	 and	
laminin	substrates.		Cell	migration	was	measured	using	transwells	coated	with	laminin	or	collagen	for	both	 control	 and	 c-Jun	 knockout	 Schwann	 cells.	 Data	 are	means	 ±SD	 from	 three	independent	experiments;	****P<0.0001;	ns=	no	significant	difference.					 	
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3.2.4	c-Jun	loss	disrupts	the	Schwann	cell	actin	cytoskeleton	The	 previous	 experiments	 show	 that	 c-Jun	 deletion	 causes	 significant	morphological	 changes	 to	 Schwann	 cells,	 affecting	 their	 ability	 to	 migrate.	 This	phenotype	has	a	significant	affect	on	the	sensitivity	of	these	cells	to	pro-migratory	signals,	 such	as	 serum,	NRG1,	 laminin	and	collagen.	For	 this	 reason,	 I	decided	 to	look	 at	 the	 arrangement	 of	 the	 actin	 cytoskeleton	 in	 these	 cells.	 Actin	polymerization	 and	 formation	 of	 actin	 filaments	 is	 strongly	 associated	 with	changes	in	cell	shape,	most	notably	the	formation	of	stress	fibers	and	lamellipodia.	Figure	3.4	shows	Schwann	cells	labeled	with	fluorescein-phalloidin,	which	binds	to	actin	inside	the	cell.	Control	Schwann	cells	show	staining	throughout	the	cell.	The	Schwann	 cell	 processes	 are	 so	 narrow	 that	 no	 detailed	 structure	 to	 the	 actin	positive	 staining	 can	 be	 seen.	 In	 comparison,	 in	 c-Jun	 knockout	 cells,	 thick	 actin	stress	fibers	are	visible	at	the	periphery	of	the	cell,	often	completely	encircling	to	form	an	actin	wreath.							
Figure	 3.4:	 Deletion	 of	 Schwann	 cell	 c-Jun	 induces	 actin	 cytoskeleton	
rearrangement.	The	actin	cytoskeleton	of	control	and	c-Jun	null	cultured	Schwann	cells	was	labeled	with	 fluorescein-phalloidin	 fluorescent	 stain	 (maginification,	 x40;	 scale	 bar,	50μm).	Nuclei	were	labeled	with	the	nuclear	stain,	dapi.			 	
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Figure	3.4	
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3.2.5	c-Jun	deletion	induces	the	formation	of	focal	contacts	The	 presence	 of	 large	 focal	 contacts	 is	 often	 associated	 with	 reduced	 cellular	migration.	 In	 order	 to	 visualize	 the	 presence	 or	 absence	 of	 focal	 contacts	 in	Schwann	 cells,	 I	 performed	 immunocytochemistry	of	 control	 and	 c-Jun	knockout	cells	using	an	anti-vinculin	antibody	(described	 in	Chapter	2).	Figure	3.5A	shows	negligible	cytoplasmic	staining	of	vinculin	in	control	Schwann	cells,	and	it	was	very	rare	to	see	any	aggregates	of	vinculin	that	would	 indicate	the	presence	of	a	 focal	contact	 in	 the	 cell.	 Those	 that	 were	 present	 were	 seen	 at	 the	 very	 end	 of	 the	Schwann	 cell	 process.	 The	 c-Jun	 knockout	 cell	 displays	 many	 more	 large	 focal	contacts	in	the	cell,	typically	located	at	the	ends	of	actin	stress	fibers	(mean	of	15	contacts	per	cell,	P>0.001).		
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Figure	3.5	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	3.5:	Deletion	of	Schwann	cell	c-Jun	induces	focal	adhesions.	(A)	 Focal	 adhesions	 were	 labeled	 with	 an	 antibody	 against	 the	 focal	 adhesion	protein	 vinculin.	 Actin	 was	 labeled	 with	 fluroscein-α-bungarotoxin.	 Focal	adhesions	are	visible	 in	 the	c-Jun	KO	at	 the	end	of	 large	actin	stress	 fibers.	Scale	bar,	20	µm	.(B)	Quantification	of	focal	adhesion	number	per	Schwann	cell.	c-Jun	KO	Schwann	cells	had	a	mean	number	of	14.97	±	0.502	focal	adhesions	compared	to	0.3667	 ±	 0.1123	 for	 control	 cells.	 Data	 are	 means	 ±SD	 from	 three	 independent	experiments,	with	a	total	of	150	cells.	****P<0.0001.	
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3.3	Discussion	Schwann	 cell	 c-Jun	 in	 important	 for	 the	 Schwann	 cell	 response	 to	 nerve	 injury,	including	 the	 transdifferentiation	 of	 myelinating	 and	 Remak	 Schwann	 cells	 to	Bungner	repair	cells	(Arthur-Farraj	et	al.	2012;	Fontana	et	al.	2012).	The	change	in	Schwann	cell	morphology	demonstrated	in	Figure	3.1	may	be	a	determinant	of	the	poor	regenerative	ability	of	the	P0-Cre+;	c-Jun	flox/flox	mouse	following	nerve	crush	injury.	 The	 results	 of	 the	 present	 study	 demonstrate	 that	 c-Jun	 is	 required	 for	Schwann	 cells	 to	 migrate	 normally	 in	 vitro.	 	 The	 Schwann	 cell	 morphological	change	has	been	published		(Arthur-Farraj	et	al,	2012)	and	forms	my	contribution	to	the	study	(Figure	3D	and	E).	This	paper	is	included	at	the	end	of	this	thesis.	Notably,	the	overexpression	of	c-Jun	in	wildtype	Schwann	cells	leads	to	a	slight	but	significant	 increase	 in	migration.	 This	 finding	 is	 significant,	 as	 it	 is	 of	 interest	 to	identify	factors	that	might	improve	Schwann	cell	migration	in	a	clinical	setting,	for	example	in	enabling	cells	to	colonize	grafts	of	tissue	or	conduit	more	rapidly.	Both	horse	 serum	 and	 NRG1,	 potent	 Schwann	 cell	 chemoattractants,	 failed	 to	compensate	for	the	loss	of	c-Jun	in	the	transwell	assays.	This	suggests	it	is	unlikely	the	 cells	 have	 lost	 sensitivity	 to	 a	 specific	 molecule,	 such	 as	 NRG1,	 but	 instead	show	 a	 fundamental	 inability	 to	 engage	 in	 persisted	 and	 directional	 movement.	This	 could	 be	 due	 to	 the	 adeno-Cre	 failing	 to	 infect	 all	 the	 Schwann	 cells	 in	 the	culture	 dish,	 but	 may	 also	 be	 due	 to	 genetic	 differences,	 since	 the	 c-Junflox/flox	Schwann	cells	are	derived	from	mice	of	a	pure	C57Bl/6	background,	whereas	the	P0-Cre	 derived	 Schwann	 cells	 have	 a	 partial	 FVB	 background	 (as	 described	 in	Chapter	 2.)	 To	 eliminate	 any	 potential	 phenotypic	 differences,	 c-Jun	 knockout	Schwann	cells	were	generated	from	c-Junflox/flox	mice	 infected	with	adeno-Cre,	 for	all	future	in	vitro	experiments	in	this	study.		
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The	 results	 from	 Figure	 3.3	 reveal	 that	 neither	 collagen	 or	 laminin	 substrates	enhanced	the	migration	of	c-Jun	knockout	Schwann	cells.	This	provides	a	 further	indication	that	putting	the	c-Jun	knockout	Schwann	cells	into	an	environment	that	favors	 cell	migration	has	no	 effect	 on	 their	 ability	 to	migrate.	The	 results	 of	 this	assay	also	agree	with	previous	findings	that	laminin	enhances	control	Schwann	cell	migration	more	than	collagen.	The	 cytoskeletal	 phenotype	 of	 the	 c-Jun	 knockout	 Schwann	 cells,	specifically,	the	induction	of	actin	stress	fibers	and	focal	contacts	is	similar	to	that	seen	when	 c-Jun	 is	 ablated	 from	mouse	 embryonic	 fibroblasts	 (Jiao	 et	 al,	 2008).	For	 this	 reason,	 I	 decided	 to	 investigate	 in	 later	 experiments	whether	 the	 same	molecular	pathway	downstream	of	c-Jun	in	these	cells	was	also	regulated	by	c-Jun	in	mouse	Schwann	cells.		In	 summary,	 the	 results	 of	 this	 chapter	 demonstrate	 that	 c-Jun	 regulates	Schwann	 cell	 morphology	 and	 migration	 in	 vitro.	 This	 is	 accompanied	 by	rearrangement	 of	 the	 actin	 cytoskeleton	 and	 the	 induction	of	 focal	 contacts,	 and	agrees	with	results	in	other	cell	types.		
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Chapter	4.	c-Jun	regulation	of	Schwann	cell	migration:		
Molecular	mechanisms	
4.1	Introduction	The	 results	 of	 Chapter	 3	 revealed	 the	 significant	 abnormalities	 in	 both	 Schwann	cell	morphology	and	migration	when	c-Jun	is	deleted	from	the	c-Junflox/flox	primary	Schwann	cell	cultures	using	adenoviral	Cre	recombinase.	As	a	proto-oncogene,	c-Jun	has	 attracted	 attention	 for	 its	 role	 in	 the	 development	 of	 tumor	malignancy,	and	studies	have	shown	that	its	expression	promotes	cell	migration	in	a	number	of	cell	types,	including	mouse	embryonic	fibroblasts	and	mammary	tumor	cells	(Jiao	et	al.	2010;	Jiao	et	al.	2008;	Katiyar	et	al.	2007;	Janowski	et	al.	2011).		There	 have	 been	 additional,	 earlier	 studies	 that	 show	 a	 role	 for	 c-Jun	 in	inducing	 cell	 migration	 and	 tissue	 morphogenesis	 during	 development.	 The	Drosophila	homologue	of	c-Jun,	DJun,	has	been	demonstrated	to	play	a	crucial	role	in	 dorsal	 closure,	 a	 morphogenetic	 process	 that	 involves	 the	 movement	 of	 two	lateral	 epithelial	 sheets	 towards	 the	 midline	 of	 the	 embryo.	 The	 Djun	 mutant	displays	a	dorsal-open	phenotype	and	 therefore	 lacks	a	dorsal	 epidermis.	 In	 this	example,	 DJun	 lies	 downstream	 of	 DRac	 and	 DJNK	 and	 exerts	 its	 control	 of	 cell	migration	 via	 the	 transcriptional	 regulation	 of	 Decapentaplegic,	 a	 homologue	 of	the	 vertebrate	 bone	 morphogenic	 proteins	 (BMPs)	 (Hou	 et	 al.	 1997;	 Riesgo-Escovar	&	Hafen	1997a;	Riesgo-Escovar	&	Hafen	1997b;	Glise	&	Noselli	1997).	An	additional	 developmental	 process	 involving	 c-Jun	 mediated	 cell	 migration	 is	murine	eyelid	closure.	Deletion	of	c-Jun	in	keratinocytes	leads	to	the	eyes	open	at	birth	 (EOB)	 phenotype,	 and	 in	 this	 case,	 c-Jun	 regulates	 the	 expression	 of	 EGF	receptor	to	control	cell	movement	and	eyelid	closure	(Zenz	et	al.	2003).	The	 transcription	 factor	 c-Jun	 therefore	 regulates	 cell	 movement	 and	morphology	 through	a	number	of	distinct	pathways,	and	 these	 take	place	during	
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development	 and	 pathogenesis.	 To	 date,	 there	 have	 been	 no	 examples	 of	 c-Jun	regulating	cell	migration	during	tissue	regeneration.	In	the	present	study,	I	aim	to	uncover	the	mechanisms	by	which	c-Jun	controls	Schwann	cell	shape	and	motility	using	a	combination	of	gene	and	protein	expression	analysis.	
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4.2	Results	
4.2.1	Deletion	of	Schwann	cell	c-Jun	does	not	alter	the	expression	of	NRG	and	
its	receptors	There	 exists	 a	 wealth	 of	 literature	 showing	 the	 important	 functions	 of	 NRG	signaling	in	Schwann	cell	biology.	Those	relating	to	Schwann	cell	proliferation	and	motility	have	been	discussed	in	detail	in	Chapter	1,	and	the	reduction	in	migration	observed	when	c-Jun	is	deleted	in	Schwann	cells	has	been	described	in	Chapter	3.	To	see	if	c-Jun	deletion	has	an	effect	on	the	expression	of	NRG	and	its	downstream	receptors	 and	 effectors,	 and	 to	 assess	 whether	 this	 contributes	 to	 the	 deficit	 in	migration	 and	 perturbed	 morphology,	 I	 performed	 RT-qPCR	 on	 c-Jun	 null	 and	control	 Schwann	 cells	 in	 three	 independent	 experiments.	 These	 Schwann	 cells	were	 purified	 from	 the	 neonatal	 nerves	 of	 c-Jun	 floxed	 mice	 and	 infected	 with	adeno-Cre	and	adeno-GFP	viruses	to	generate	purified	control	and	c-Jun	knockout	Schwann	cell	cultures.	Figure	4.1	shows	the	fold	upregulation	and	downregulation	of	the	mutant	mRNA	compared	to	that	of	the	control	cells	of	the	NRG	type	I,	II	and	III	isoforms,	their	receptors	ErbB2	and	ErbB3	and	Shp2,	a	downstream	activator	of	the	MAPK	pathway	in	many	cell	types	(see	Dance	et	al.,	2008	for	review).	There	are	no	 significant	 differences	 in	 the	 CT	 values	 of	 the	 c-Jun	 knockout	 and	 control	Schwann	cells	 for	any	of	 these	genes	when	normalised	to	the	housekeeping	gene	expression,	 indicating	 that	 similar	 levels	of	mRNA	are	present	 in	both	genotypes	and	 that	 c-Jun	does	not	affect	 the	expression	of	key	genes	 in	 the	NRG1	signaling	pathway.			 	
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Figure	4.1	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 4.1:	 In	 vitro	 deletion	 of	 Schwann	 cell	 c-Jun	 does	 not	 alter	 the	
expression	of	NRG1	isoforms	and	their	receptors	RT-qPCR	was	used	 to	examine	 relative	expression	of	NRG	Types	 I,	 II	 and	 III,	 the	NRG	 receptors	 ErbB2	 and	 ErbB3,	 and	 Shp2,	 which	 is	 downstream	 of	 ErbB2/3.	cDNA	 was	 prepared	 from	 RNA	 isolated	 from	 cultured	 control	 and	 c-Jun	 KO	Schwann	cells	 as	described	 in	Chapter	2.	 (A)	Fold	upregulation	of	 genes	 in	 c-Jun	knockout	 cells	 compared	 to	 wildtype	 control	 cells.	 (B)	 Fold	 downregulation	 of	genes	 in	 c-Jun	 knockout	 cells	 compared	 to	 wildtype	 cells.	 All	 data	 show	 no	significant	difference	in	fold	change	between	knockout	and	wildtype.	All	data	are	normalised	 to	 the	 reference	 genes	 GAPDH	 and	 YWHAZ.	 Reverse	 Transcriptase	minus	 (RT-)	 and	No	Template	 Controls	 (NTCs)	 negative	 controls	were	 used	 and	showed	 that	RNA	was	 adequately	 treated	with	DNase	 and	 that	 no	PCR	products	were	 formed	 from	 the	 primers	 in	 the	 absence	 of	 cDNA.	 All	 data	 are	means	 ±SD	from	three	independent	experiments.	
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4.2.2	Deletion	of	c-Jun	does	not	regulate	Schwann	cell	expression	of	c-Src	To	determine	directly	whether	 the	 removal	 of	 c-Jun	 in	 Schwann	 cells	 affects	 the	expression	 of	 c-Src,	 I	 performed	 immunolabelling	 of	 control	 and	 c-Jun	 knockout	cells	with	antibodies	against	c-Src.	Figure	4.2A	shows	the	distribution	of	c-Src	and	actin	in	the	control	and	c-Jun	knockout	Schwann	cells.	The	immunolabelling	in	the	image	 shows	a	 fairly	 even	distribution	of	 c-Src	 in	 the	 cytoplasm	of	 the	knockout	cell,	and	it	appears	to	be	absent	from	the	cell	cortex.	The	control	wildtype	Schwann	cell	 also	 shows	 expression	 of	 c-Src	 in	 the	 cytoplasm.	 In	 this	 case	 it	 is	 hard	 to	describe	a	specific	subcellular	location	of	this	protein	as	the	cell	processes	are	very	narrow	 but	 the	 overall	 brightness	 of	 the	 c-Src	 labeling	 in	 the	 control	 and	 c-Jun	knockout	 cells	 is	 similar.	 I	 also	 wished	 to	 investigate	 whether	 this	 observation	would	be	replicated	after	nerve	 injury.	To	determine	 the	protein	 level	of	c-Src	 in	
vivo,	 a	western	 blot	was	 carried	 out	 on	 cell	 lysates	 from	 the	 sciatic	 nerve	 distal	stumps	 of	 control	 and	P0-Cre;	 c-Jun	 flox/flox	mice,	 taken	 7	 days	 following	 nerve	transection.	c-Jun	is	not	present	in	the	Schwann	cells	in	the	P0-Cre;	c-Jun	flox/flox	mice	 (Arthur-Farraj	 et	 al.,	 2012)	 (see	 material	 and	 methods	 also).	 As	 expected,	levels	 of	 c-Src	 increased	 in	 the	 distal	 stumps	 of	 control	 nerves	 following	 nerve	transection,	 but	 no	 significant	 difference	 was	 observed	 between	 c-Src	 protein	levels	in	control	and	knockout	nerves	(Fig.	4.2B).	These	experiments	suggest	that	direct	 regulation	 of	 c-Src	 protein	 levels	 is	 unlikely	 to	 contribute	 the	 failure	 of	migration	seen	in	the	c-Jun	knockout	cells.			 	
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Figure	4.2	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 4.2:	 Deletion	 of	 c-Jun	 does	 not	 enhance	 Schwann	 cell	 expression	 of	
c-Src.		(A)	 Immunocytochemistry	 showing	 the	 distribution	 of	 actin	 and	 c-Src	 in	 c-Jun	knockout	 and	 control	 Schwann	 cells	 in	 culture.	 Control	 and	 knockout	 cells	were	purified	 from	 neonatal	 nerves	 and	 infected	 with	 adeno-GFP	 and	 adeno-Cre	respectively.	Cells	are	co-labelled	with	Hoechst	nuclear	dye.	Scale	bar,	50	µm.	(B)	Western	 blot	 showing	 expression	 of	 c-Src	 in	 uncut	 nerves	 of	 control	 and	 c-Jun	conditional	knockout	mice	and	in	the	distal	stump	of	control	and	knockout	mice,	7	days	 following	nerve	 transection.	Molecular	weight	markers	were	 located	on	 the	PVDF	membrane	and	not	visualised	on	the	film,	and	are	therefore	not	shown.	
A	
B	
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4.2.3	Modulation	of	c-Src	and	ROCKII	activity	affects	Schwann	cell	migration		Fibroblast	 and	 epithelial	 cell	 expression	 of	 the	 non-receptor	 protein	 tyrosine	kinase	 c-Src	 is	 reduced	 in	 the	 absence	 of	 c-Jun,	 and	 this	 leads	 to	 the	hyperactivation	of	ROCKII,	a	protein	kinase	that	affects	the	cytoskeleton	in	several	ways,	 including	 the	 induction	 cell	 flattening	 and	 reduction	 of	 cellular	migration.	This	pathway	is	thought	to	contribute	to	the	invasiveness	of	cancer	cells	that	over	express	c-Jun	and	therefore	lose	this	brake	on	cell	motility	(Jiao	et	al.	2008;	Jiao	et	al.	 2010).	 The	 cells	 lacking	 c-Jun	 described	 in	 these	 papers	 have	 a	 very	 similar	migratory	and	morphological	phenotype	 to	 that	 seen	 in	Schwann	cells	 lacking	 c-Jun,	 including	 the	 induction	 of	 actin	 stress	 fibers	 and	 focal	 adhesions	 (see	Chapter	3).	I	therefore	decided	to	investigate	whether	inhibiting	the	activity	of	either	of	these	molecules	would	 replicate	 the	migratory	 phenotype	 seen	 in	 the	 c-Jun	 null	Schwann	cells.	As	a	first	step,	I	set	out	to	see	if	these	proteins	had	an	effect	on	the	migration	 of	 wildtype	 Schwann	 cells	 in	 culture.	 Inhibition	 of	 ROCKII	 using	 the	inhibitor	 Y27632	 showed	 a	 slight	 but	 significant	 increase	 in	 Schwann	 cell	migration	using	the	transwell	assay.	Inhibition	of	c-Src	with	the	inhibitor	SU6656	produced	 a	 more	 significant	 change,	 with	 a	 large	 reduction	 in	 Schwann	 cell	transwell	migration	(Figure	4.3).				 	
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Figure	4.3	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	Figure	4.3:	Schwann	cell	transwell	migration	in	response	to	c-Src	and	ROCKII	
inhibitors.	Transwell	migration	assays	were	performed	using	wildtype	mouse	Schwann	cells	cultured	in	the	presence	of	inhibitors	for	c-Src	(SU6656,	2	µM)	and	ROCKII	(Y27632,	10µM).	Data	are	means	±SD	from	three	independent	experiments	and	***P	<0.001.		
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4.2.4	Inhibition	of	ROCKII	rescues	the	c-Jun	knockout	migration	phenotype	ROCKII	activity	has	several	effects	on	the	cytoskeleton	and	this	is	cell-type	specific.	In	 fibroblasts,	 increased	 ROCKII	 activity	 is	 linked	 to	 cell	 spreading	 and	 reduced	motility.	For	this	reason,	I	set	out	to	see	if	inhibiting	ROCKII	might	restore	the	cell	migration	of	c-Jun	knockout	Schwann	cells.	Figure	4.4	shows	the	migration	of	c-Jun	knockout	 Schwann	 cells	 using	 the	 wound	 assay,	 in	 response	 to	 the	 ROCKII	inhibitor	Y27632	 in	pro-migratory	 conditions	 (NRG1	20	ng/ml).	The	data	 shows	that	the	knockout	cells	were	able	to	migrate	across	the	wound	far	more	easily	 in	the	 presence	 of	 the	 inhibitor	 compared	 to	 those	 incubated	 with	 vehicle	 alone.	These	cells	were	able	to	almost	completely	close	the	wound	within	24	hours,	at	a	rate	 similar	 to	 wildtype	 Schwann	 cells	 (Figure	 4.5).	 These	 experiments	 suggest	that	 lack	 of	 c-Jun	 in	 Schwann	 cells	 may	 induce	 activation	 of	 ROCKII,	 although	further	 experiments	would	 be	 required	 to	 prove	 this	 point	 definitively,	 and	 that	this	pathway	is	likely	to	be	important	in	the	reduction	of	migratory	behavior	seen	in	c-Jun	knockout	Schwann	cells.					 	
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Figure	4.4	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 4.4:	 Inhibition	 of	 ROCKII	 rescues	 the	 c-Jun	 knockout	 migration	
phenotype	
A wound assay was performed using c-Jun knockout Schwann cells seeded on laminin-
coated coverslips. Knockout cells were incubated with inhibitor for ROCKII (Y27632, 
10µM). Data are means ±SD from three independent experiments; ***P <0.001 
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4.2.5	Inhibition	of	c-Src	in	wildtype	Schwann	cells	mimics	the	c-Jun	
phenotype	As	shown	in	Figure	4.2,	c-Src	inhibition	slows	the	rate	of	Schwann	cell	migration.	In	order	to	further	assess	whether	inhibiting	c-Src	has	an	effect	on	the	migration	of	the	Schwann	cells,	I	performed	the	wound	assay	with	these	cells	in	the	presence	of	SU6656.	 Figure	 4.5	 shows	 that	 in	 the	 presence	 of	 the	 inhibitor,	 Schwann	 cell	migration	 is	significantly	slowed	by	24	hours	and	does	not	close	 the	wound.	The	rate	 of	 migration	 is	 similar	 to	 that	 of	 the	 c-Jun	 knockout	 Schwann	 cells	 in	Figure	4.4.							 	
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Figure	4.5	
	
	
	
	
	
	
Figure	 4.5:	 Inhibition	 of	 c-Src	 in	 wildtype	 Schwann	 cells	 mimics	 the	 c-Jun	
migration	phenotype	A	wound	 assay	 was	 performed	 using	 control	 Schwann	 cells	 seeded	 on	 laminin-coated	 coverslips.	 Control	 and	 c-Jun	 knockout	 cells	 were	 incubated	 with	 an	inhibitor	 for	 c-Src	 (SU6656,	2	µM).	Data	 are	means	±SD	 from	 three	 independent	experiments;	***P	<0.001	
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4.2.6	Deletion	of	Schwann	cell	c-Jun	does	not	alter	the	mRNA	levels	of	
candidate	genes	involved	in	cell	migration	and	remodeling	of	the	
cytoskeleton	In	 order	 to	 discover	 genes	 regulated	 by	 c-Jun	 that	 are	 responsible	 for	 the	significant	 change	 in	 cell	 shape	and	migration	when	 c-Jun	 is	deleted	 in	 Schwann	cells,	I	decided	to	conduct	a	gene	screen	by	selecting	candidates	that	fell	into	three	groups:	genes	 that	are	already	known	to	affect	 these	attributes	 in	Schwann	cells,	genes	 that	 are	 both	 regulated	 by	 c-Jun	 in	 other	 cell	 types	 and	 regulate	 the	cytoskeleton,	and	finally,	genes	that	are	major	regulators	of	 the	cytoskeleton,	but	have	not	been	studied	in	Schwann	cells	or	have	been	shown	to	be	regulated	by	c-Jun	 (discussed	 in	 Chapter	 1).	 I	 performed	 RT-qPCR	 on	 cDNA	 synthesized	 from	mRNA	isolated	from	control	and	c-Jun	knockout	cells	that	had	been	infected	with	adeno-GFP	 and	 adeno-Cre	 respectively.	 Despite	 the	 careful	 choice	 of	 genes,	 the	results	 of	 this	 candidate	 screen	 show	 that	 these	 genes	 are	 not	 significantly	regulated	 by	 c-Jun	 at	 the	mRNA	 level	 (Figure	 4.6).	 The	 expression	 of	 the	 above	genes	 was	 not	 found	 to	 be	 significantly	 altered	 following	 nerve	 transection	between	c-Jun	KO	and	wildtype	mice,	according	to	microarray	data	(Arthur-Farraj	et	al.,	2012).	
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Figure	4.6	
	
	
	
Figure	4.6	c-Jun	deletion	in	Schwann	cells	does	not	alter	the	mRNA	levels	of	
genes	 that	are	known	 to	 regulate	Schwann	cell	migration	and	cytoskeleton	
dynamics.		RT-qPCR	 was	 used	 to	 evaluate	 the	 relative	 mRNA	 expression	 of	 a	 number	 of	cytoskeleton	 regulators.	 (A)	Fold	downregulation	of	 c-Jun	knockout	 compared	 to	wildtype	control.	(B)	Fold	upregulation	of	c-Jun	knockout	compared	to	control.	All	data	show	no	significant	difference	in	fold	change	between	knockout	and	wildtype.	All	 data	 are	 normalised	 to	 the	 reference	 genes	 GAPDH	 and	 YWHAZ.	 Reverse	Transcriptase	 minus	 (RT-)	 and	 No	 Template	 Controls	 (NTCs)	 negative	 controls	were	used	and	showed	that	RNA	was	adequately	treated	with	DNase	and	that	no	PCR	 products	 were	 formed	 from	 the	 primers	 in	 the	 absence	 of	 cDNA.	 Data	 are	means	±SD	from	three	independent	experiments.	
A	
B	
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4.2.7	Deletion	of	Schwann	cell	c-Jun	regulates	the	expression	of	c-Jun,	olig1,	
MBP	and	GDNF	Following	a	similar	experimental	approach	as	in	Figure	4.6,	I	tested	the	expression	of	 genes	known	 to	be	 regulated	by	 c-Jun	 in	 the	 injured	nerve.	The	 results	 of	 the	RT-qPCR	 analysis	 show	 that	 c-Jun	 is	 significantly	 downregulated	 (as	 expected),	when	the	c-Jun	floxed	gene	is	excised	from	the	cell	by	adeno-Cre	(Fig.	4.7A).	In	this	experiment,	Olig1,	the	most	regulated	gene	found	in	the	microarray	data	(Arthur-Farraj	 et	 al.	 2012)	 is	 also	 significantly	 downregulated	 in	 c-Jun	 knockout	 cells.	GDNF	 is	 also	 downregulated,	 approximately	 4-fold	 in	 the	 c-Jun	 knockout	 cells.	Conversely,	 the	myelin	protein	MBP	and	Adam23	are	significantly	upregulated	in	these	 cells,	 thus,	 confirming	 that	 the	 mRNA	 isolated	 from	 c-Jun	 knockout	 cells	produces	similar	gene	expression	results	to	those	of	the	microarray.	
 
 
	
	
	
	
	
	
	
	
	
	
	
	
 
 
	 110	
Figure	4.7	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 4.7	 c-Jun	 deletion	 in	 Schwann	 cells	 does	 alter	 the	 mRNA	 levels	 of	
genes	that	are	previously	known	to	be	regulated	by	c-Jun		RT-qPCR	 was	 used	 to	 evaluate	 the	 relative	 mRNA	 expression	 of	 genes	 known	previously	 to	 be	 regulated	 by	 c-Jun.	 (A)	 Fold	 downregulation	 of	 c-Jun	 knockout	compared	to	wildtype	control.	(B)	Fold	upregulation	of	c-Jun	knockout	compared	to	control.	All	data	show	a	significant	difference	in	fold	change	between	knockout	and	wildtype.	All	data	are	normalised	to	the	reference	genes	GAPDH	and	YWHAZ.	Reverse	 Transcriptase	 minus	 (RT-)	 and	 No	 Template	 Controls	 (NTCs)	 negative	controls	were	used	and	showed	that	RNA	was	adequately	treated	with	DNase	and	that	no	PCR	products	were	formed	from	the	primers	in	the	absence	of	cDNA.	Data	are	means	±SD	from	three	independent	experiments.	***P<0.01.	
A	
B	
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4.3	Discussion	As	a	 first	step	to	uncovering	the	molecular	mechanisms	by	which	c-Jun	regulates	Schwann	 cell	migration	 and	morphology,	 I	 initially	 considered	whether	 the	 gene	expression	of	NRG1	signaling	components	was	affected	when	c-Jun	is	deleted	from	Schwann	 cells.	 NRG1	 is	 known	 to	 have	 a	 significant	 affect	 on	 Schwann	 cell	migration,	rearrangement	of	the	cytoskeleton	and	the	induction	of	focal	adhesions,	in	 addition	 to	 its	 crucial	 roles	 in	 myelination	 during	 PNS	 development	 and	regeneration	 and	 remyelination	 following	 nerve	 injury	 (Stassart	 et	 al.	 2013;	Fricker	et	al.	2011;	Jessen	&	Mirsky	2005).	The	results	of	gene	expression	analysis	made	by	RT-qPCR	reveal	there	to	be	no	significant	differences	in	the	expression	of	NRG1	isoforms	and	their	receptors	between	the	c-Jun	knockout	Schwann	cells	and	control	 cells	 (Fig.	 4.1)	 This	 finding	 supports	 the	 idea	 that	 the	 reduced	 cell	migration	 observed	 between	 c-Jun	 knockout	 cells	 and	 controls	 in	 response	 to	NRG1	in	both	wound	and	transwell	migration	assays	(Fig.	3.2	B	and	C)	was	not	due	to	a	lack	of	expression	of	these	components	of	NRG1	signaling	in	the	mutant	cells.	In	addition,	the	RT-qPCR	data	shown	here	agrees	with	gene	expression	analysis	of	the	distal	stump	of	 the	 injured	Sciatic	nerve,	where	microarray	analysis	revealed	no	 significant	 change	 in	 expression	 of	 these	 genes	 between	 c-Jun	 conditional	knockout	mice	and	controls	at	7	days	following	nerve	transection	(Arthur-Farraj	et	al.	 2012).	 The	 actin-severing	protein	 cofilin-1	 has	 recently	 been	 identified	 to	 act	downstream	of	NRG1	to	affect	many	of	these	cellular	changes.	In	the	present	study,	I	 observed	 a	 similar	 flattened	 morphology	 and	 induction	 of	 actin	 stress	 fibers	when	 c-Jun	 is	 deleted	 in	 mouse	 Schwann	 cells	 (Fig.	 3.1A)	 as	 compared	 to	 the	cofilin-1-deficient	 rat	 Schwann	 cells	 generated	 using	 short	 hairpin	 RNA	interference	(shRNAi)	(Sparrow	et	al.	2012).	Whilst	 these	data	suggest	that	c-Jun	expression	does	not	 regulate	 the	upstream	components	of	 the	NRG1	pathway	 to	
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control	Schwann	cell	morphology	and	migration,	it	is	possible	that	proteins	known	to	be	regulated	by	NRG1	signaling	and	expressed	by	Schwann	cells,	such	as	cofilin-1	may	 also	 be	 regulated	 by	 c-Jun,	 and	 for	 this	 reason	 I	 performed	 further	 gene	expression	analysis	in	the	later	part	of	this	Chapter.	I	 proceeded	 to	 investigate	 potential	 molecular	 pathways	 that	 might	 be	regulated	 by	 c-Jun	 in	 Schwann	 cells.	 A	 previous	 study	 has	 shown	 that	 in	mouse	embryonic	fibroblasts,	c-Jun	deletion	reduces	the	expression	of	c-Src	(see	above),	which	 allows	 for	 the	 hyperactivation	 of	 Rho	 kinase	 II	 (ROCKII),	immunocytochemistry	of	c-Src	(Fig.	4.2A)	shows	that	expression	of	the	protein	is	abundant	 in	 both	 c-Jun	 knockout	 and	 control	 Schwann	 cells.	 I	 attempted	 to	examine	 c-Src	 expression	 levels	 in	 the	 cultured	 mouse	 Schwann	 cells	 using	western	 blotting,	 however	 this	 experiment	 was	 unsuccessful	 due	 to	 the	 large	numbers	of	primary	cells	required	to	give	a	signal	for	this	protein.	I	was	unable	to	resolve	this	 in	this	time	constraints	of	the	study.	I	was,	however,	able	to	perform	western	 blotting	 to	 examine	 levels	 of	 c-Src	 in	 the	 7	 day-old	 distal	 stump	 of	transected	sciatic	nerves	of	the	c-Jun	conditional	knockout	mouse	and	its	control.	The	results	of	this	assay	showed	no	demonstrable	effect	of	deleting	c-Jun	on	c-Src	levels	 between	 the	 control	 and	 c-Jun	 conditional	 knockout	 nerves	 (Fig.	4.2	 B).	There	was,	 however,	 a	 significant	 induction	 in	 c-Src	 expression	 following	 injury,	and	this	agrees	with	observations	by	Zhao	et	al.	(2003),	who	identified	a	three-fold	increase	in	c-Src	expression	following	both	nerve	crush	and	transection	injuries	to	the	rat	sciatic	nerve.	Expression	of	c-Src	mRNA	was	measured	using	RT-qPCR	for	c-Jun	 knockout	 and	 control	 Schwann	 cells	 and	 again,	 there	 was	 no	 significant	difference	 between	 the	 two	 samples	 (Fig.	 4.6A).	 While	 the	 data	 in	 the	 present	study	does	not	suggest	a	role	for	c-Jun	in	regulating	the	expression	of	c-Src	protein	or	mRNA,	 the	possibility	exists	 that	c-Jun	might	control	 c-Src	activity	 through	an	
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intermediate	 that	 can	 activate/deactivate	 c-Src	 through	 phosphorylation	 or	protein-protein	interactions,	rather	than	by	the	direct	transcriptional	upregulation	as	demonstrated	by	Jiao	et	al.	(2008)	It	would	therefore	be	informative	to	conduct	a	c-Src	kinase	activity	assay	and	ROCKII	activity	assay	in	the	future	to	see	if	c-Jun	does	in	fact	modulate	the	c-Src-ROCKII	signaling	axis	in	Schwann	cells.	To	 further	 probe	 a	 possible	 involvement	 of	 c-Src	 and	 ROCKII	 in	 c-Jun-dependent	 Schwann	 cell	 migration,	 I	 first	 conducted	 a	 transwell	 assay	 with	wildtype	 primary	 mouse	 Schwann	 cells	 to	 see	 if	 inhibiting	 their	 activity	 would	have	 an	 affect	 on	 cell	 migration.	 The	 results	 of	 this	 experiment	 showed	 that	inhibition	 of	 c-Src	 leads	 to	 a	 significant	 reduction	 in	 Schwann	 cell	 migration	compared	to	the	vehicle	control.	Conversely,	inhibiting	ROCKII	caused	an	increase	in	cell	migration	when	compared	to	Schwann	cells	treated	with	vehicle	alone	(Fig	4.3).	These	results	must	be	treated	with	caution,	since	within	the	timeframe	of	this	study	I	was	not	able	to	measure	the	effects	of	 the	 inhibitors	on	c-Src	and	ROCKII	with	 an	 activity	 assay.	 The	 inhibitors	 for	 c-Src	 (SU6656)	 and	 ROCKII	 (Y27632)	were	 used	 at	 concentrations	 (2	 µM	 and	 10	 µM	 respectively)	 reported	 in	 the	literature	(Jiao	et	al.	2008)	to	inhibit	the	activity	of	these	proteins,	and	I	observed	no	 effect	 on	 the	 cell	 viability	 in	 this	 experiment	 (data	 not	 shown).	 However,	 it	seems	reasonable	to	conclude	from	these	results	that	c-Src	activity	promotes	and	ROCKII	 activity	 inhibits	 primary	 mouse	 Schwann	 cell	 migration.	 The	 ROCKII	finding	 is	 supported	 by	 data	 from	 rat	 Schwann	 cell	 transwell	 migration	 assays,	where	Y27632	increases	cell	migration	by	~20%	(Yamauchi	et	al.	2004).	In	 light	of	 the	 findings	 that	c-Src	and	ROCKII	activity	can	change	wildtype	Schwann	 cell	migratory	 behavior,	 I	 conducted	 additional	migration	 assays	 (Figs.	4.4	 and	 4.5)	 to	 address	whether	 the	 activity	 of	 these	 proteins	 can	 alter	 the	 cell	migration	of	the	c-Jun	knockout	Schwann	cells.	Application	of	ROCKII	inhibitor	to	
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the	c-Jun	knockout	cells	in	the	wound	assay	led	to	a	significant	increase	in	closure	of	the	wound	(Fig.	4.4),	and	significantly,	at	24	hours,	the	diameter	of	the	wound	for	 c-Jun	 knockout	 Schwann	 cells	 at	 24	 h	 (Fig.	 4.4)	 was	 comparable	 to	 that	 of	control	Schwann	cells	 at	 the	 same	 time	point	 (Fig.	5.5).	This	 finding	 implies	 that	inhibition	of	ROCKII	in	c-Jun	knockout	Schwann	cells	is	sufficient	to	rescue	the	rate	of	 migration	 to	 that	 of	 c-Jun-expressing	 Schwann	 cells.	 There	 are	 two	 possible	explanations	for	this;	firstly	the	activity	of	ROCKII	is	abnormally	high	in	these	cells,	and	 reducing	 this	 with	 an	 inhibitor	 can	 restore	 normal	 rates	 of	 migration,	 or	secondly	 that	 c-Jun	 deletion	 affects	 Schwann	 cell	 migration	 by	 a	 ROCKII-independent	 pathway,	 but	 inhibiting	 ROCKII	 activity	 can	 compensate	 for	 this	alternative	brake	on	Schwann	cell	migration	and	return	it	to	normal.	This	present	study	 does	 not	 resolve	 this,	 but	 determining	 the	 activity	 of	 ROCKII	 in	 c-Jun	knockout	Schwann	cells	would	shed	some	light	onto	this	in	the	future.	It	has	been	shown	previously	that	negative	regulation	of	Rho/ROCK	signaling	in	Schwann	cells	can	 promote	 the	 extension	 of	 radial	 lamellipodia	 via	 the	 activation	 of	 Profilin1.	Cultured	 primary	 mouse	 Schwann	 cells	 were	 treated	 with	 shRNA	 directed	 at	Profilin1,	and	switched	to	a	bi-polar	morphology	from	the	original	ROCK-induced	flattened	morphology	(Montani	et	al.	2014).	It	would	be	informative	to	treat	the	c-Jun	knockout	Schwann	cells	with	shRNA	against	Profilin1	in	future	experiments	to	determine	whether	 its	 activity	 has	 an	 affect	 on	 the	morphological	 phenotype	 of	these	cells.	Further	 to	 these	results,	 I	 also	conducted	a	wound	assay	 in	which	control	Schwann	cells	were	incubated	with	the	c-Src	inhibitor.	These	results	show	that	c-Src	inhibition	mimics	the	loss	of	c-Jun,	as	the	SU6656-treated	cells	have	a	similar	rate	 of	 wound-closure	 to	 the	 c-Jun	 knockout	 Schwann	 cells	 (Fig.	 4.5).	 Again,	determining	 the	phosphorylation	 state	of	 c-Src	 and	 its	 kinase	 activity	 of	 the	 two	
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cell	populations,	and	transfecting	c-Jun	knockout	cells	with	recombinant	c-Src	as	a	rescue	experiment	would	help	to	resolve	whether	a	c-Jun-c-Src-ROCKII	axis	exists	in	Schwann	cells	to	control	cell	morphology	and	migration.	Finally,	 I	 conducted	 a	 gene	 expression	 screen	 using	 RT-qPCR	 on	 selected	candidate	genes	 to	 identify	proteins	associated	with	 the	cytoskeleton	and/or	cell	migration	 that	 might	 in	 turn	 be	 regulated	 by	 c-Jun	 (Fig	 4.6).	 This	 analysis	 was	conducted	in	three	independent	experiments	and	failed	to	identify	any	significant	differences	 in	gene	expression	of	 the	candidates.	Differences	 in	 the	expression	of	proteins	 already	 known	 to	 be	 mis-expressed	 (c-Jun,	 olig1,	 GDNF	 and	 MBP)	 in	Schwann	cell-specific	c-Jun	knockout	distal	nerve	stumps	were	identified	and	these	agreed	with	the	microarray	data	of	Arthur-Farraj	et	al.(2012).	Since	these	certain	genes,	that	are	known	to	be	upregulated	or	downregulated	in	the	microarray	are	also	regulated	in	the	same	manner	in	my	RT-qPCR	analysis,	this	gives	confidence	that	none	of	these	candidate	genes	are	significantly	regulated	at	a	transcriptional	level	when	c-Jun	in	removed	from	mouse	primary	Schwann	cells.		While	 the	 strategy	 (see	 Table	 4.1)	 in	 the	 present	 study	 was	 to	 carefully	select	candidate	genes	that	have	a	basis	in	the	literature	for	being	transcriptionally	regulated	 by	 c-Jun	 to	 control	 cell	 migration,	 or	 regulate	 cytoskeleton	 dynamics,	and/or	 are	 known	 to	 regulate	 Schwann	 cell	 migration,	 this	 approach	 was	ultimately	unsuccessful	 in	 finding	a	 target	of	 c-Jun.	Future	 studies	might	 identify	proteins	downstream	of	c-Jun	by	using	microarray	analysis	of	the	c-Jun	knockout	Schwann	cells.	A	more	informative	method	might	be	to	conduct	proteomic	analysis	of	 the	 cytoskeletome	 to	 study	 	 post-translational	 modifications	 such	 as	phosphorylation,	 since	many	 of	 proteins	 involved	 in	 cytoskeletal	 rearrangement	can	have	their	activity	modified	by	the	addition	of	phosphates	or	the	exchange	of	nucleotides	 such	 as	 GTP/GDP.	 Attempts	 were	made	 to	 quantify	 the	 activities	 of	
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Rac1	 and	 Cdc42	 in	 this	 study.	 I	 isolated	 cellular	 protein	 from	 primary	 mouse	Schwann	 cells	 for	 use	 in	 an	 immunoprecipitation	 assay,	 but	 this	 failed	 due	 to	sensitivity	 of	 the	 assay	 and	 the	 lack	 of	 protein	 available	 from	 the	 primary	 cell	cultures,	despite	the	use	of	pooled	samples.	Furthermore,	attempts	were	made	to	use	rat	Schwann	cell	primary	cultures	transfected	with	siRNA	targeted	at	c-Jun	for	the	Rac1	and	Cdc42	pull	down	assays,	since	these	primary	cells	can	be	expanded	more	easily	than	mouse	Schwann	cells,	however	due	to	time	constraints	I	could	not	optimise	these	assays	to	generate	data	for	use	in	this	report.	In	 conclusion,	 it	 seems	unlikely	 that	NRG1	 signaling	 is	 regulated	 by	 c-Jun	and	therefore	the	response	of	c-Jun	knockout	Schwann	cells	to	NRG1	is	most	likely	not	due	 to	 the	 lack	of	 expression	or	 recognition	of	NRG1-ErbB1/2	 in	 these	 cells.	Additionally,	 the	downstream	 target	 of	NRG1	 signaling,	 Cofilin-1,	 that	modulates	the	Schwann	cell	cytoskeleton	is	not	seen	here	to	be	transcriptionally	regulated	by	c-Jun,	but	could	be	aberrant	from	control	Schwann	cell	cofilin-1	in	terms	of	protein	expression,	 phosphorylation	 or	 additional	 post-translational	 modifications.	 The	expression	of	c-Src	mRNA	and	protein	does	not	appear	altered,	but	this	may	also	have	a	different	phosphorylation	status	in	the	c-Jun	knockout	Schwann	cells.	While	modulating	the	activity	of	c-Src	and	ROCKII	has	affects	on	cell	migration	consistent	with	 the	presence	of	a	c-Jun-c-Src-ROCKII	signaling	axis,	 further	experiments	are	required	 to	 confirm	 this.	Gene	expression	analysis	using	RT-qPCR	was	unable	 to	detect	 regulation	 by	 c-Jun,	 and	 so	 additional	 experiments	 are	 required	 to	 find	 a	target	 of	 c-Jun,	 should	 the	 c-Jun-c-Src-ROCKII	 pathway	 prove	 not	 to	 be	 active	 in	controlling	Schwann	cell	morphology	and	migration.	
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Table	4.1	Candidate	genes	for	RT-qPCR	screen	
	
Involved	in	cell	
migration	and	known	to	
be	regulated	by	c-Jun	in	
other	cells.	
Involved	in	Schwann	cell	
migration,	but	not	known	
to	be	regulated	by	c-Jun	
Known	to	be	
regulated	by	c-Jun	in	
Schwann	cells	c-Src,	 ROCKII,	 Vinculin,	Paxillin,	TSC2,	REST	 MYLK,	 Gelsolin,	 SRF,	RhoA,	WASP,	Cdc42,	ROCKI,	Wasf1,	 Rac1,	 Talin,	 Cofilin,	LIMK,	Beta	catenin,	Profilin,	SSH1,	 FAK,	 NRG1	 isoforms,	ErbB1/2,	Shp2	
c-Jun,	 Olig1,	 GDNF,	MBP,	Adam23	
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Chapter	5:	A	novel	assay	for	measuring	axonal	and	Schwann	cell	outgrowth	
in	a	nerve	transection	injury	
5.1	Introduction	Nerve	injury	is	a	common	problem	encountered	by	physicians,	with	many	of	these	involving	the	complete	transection	of	a	peripheral	nerve.	A	robust	and	repeatable	model	 of	 these	 injuries	 is	 needed	 in	 order	 to	 understand	 the	 precise	 events	 of	nerve	 injury	 and	 regeneration	 and	 also	 to	 develop	 therapies	 that	 enhance	 the	normal	 regeneration	 programme	 in	 place	 in	 the	 peripheral	 nerve.	 To	 date,	 the	most	commonly	used	assay	 for	quantifying	axonal	regrowth	 following	peripheral	nerve	transection	involves	complete	transection	of	the	sciatic	nerve	at	the	level	of	the	 sciatic	 notch.	 This	 assay	 requires	 improvement	 in	 several	 ways.	 Firstly,	 it	effectively	involves	severing	the	tibial,	common	peroneal	and	sural	branches	of	the	sciatic	 nerve	 and	 therefore	 results	 in	 significant	 morbidity	 to	 the	 animal.	 For	experiments	that	do	not	require	results	of	sensory	or	motor	function	from	all	three	branches,	this	procedure	could	be	refined	to	cause	less	harm	to	the	animals	in	line	with	Home	Office	guidelines.	In	order	to	study	axonal	regrowth	from	the	proximal	nerve	stump	 into	 the	distal	stump,	 it	 is	 in	principle	sufficient	 to	 transect	a	single	branch	of	the	sciatic	nerve,	and	doing	so	would	reduce	pain	and	mobility	problems	for	the	animal.		 Secondly,	 complete	 sciatic	 nerve	 transection	 results	 in	 gaps	 between	 the	proximal	and	distal	nerve	stumps	that	differ	significantly	in	length	from	animal	to	animal,	and	generates	variable	alignment	between	 the	 two	stumps,	 therefore	 the	complete	transection	model	requires	improvement	to	generate	more	accurate	and	reliable	 results.	 This	 improvement	 would	 have	 the	 added	 benefit	 of	 requiring	fewer	animals	 to	produce	statistically	 significant	 results,	 and	 therefore	satisfying	the	‘reduce’	criteria	of	the	guiding	principles	of	animal	research	in	the	UK.	In	this	
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chapter	 I	 will	 show	 the	 lack	 of	 reducibility	 in	 the	 current	 model	 of	 nerve	transection	injury	in	the	mouse	and	provide	evidence	for	a	more	reliable	method	that	 I	 have	devised,	 involving	 the	 transection	of	 only	 the	peroneal	 branch	of	 the	sciatic	nerve.		 	
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5.2	Results	
5.2.1	Transection	of	the	sciatic	nerve	does	not	produce	a	consistent	nerve	
bridge	During	my	initial	experiments	in	studying	the	role	that	Schwann	cell	c-Jun	plays	in	nerve	 regeneration,	 I	 quickly	 realised	 the	 standard	 protocol	 that	 had	 been	established	 in	 the	 laboratory	 for	 studying	 the	 effects	 of	 transection	on	 the	distal	nerve	stump	would	not	yield	consistent	results	when	 looking	at	growth	of	axons	and	 Schwann	 cells	 across	 the	 nerve	 bridge.	 Experiments	 by	 others	 in	 the	laboratory	had	looked	at	the	events	following	nerve	transection	in	the	distal	stump	in	 isolation,	such	as	demyelination	and	changes	 in	protein	expression	and	mRNA	expression.	 This	 was	 possible	 by	 ensuring	 the	 proximal	 stump	 was	 sutured	 to	muscle	far	away	from	the	distal	stump,	so	that	reconnection	was	not	possible.	For	my	studies,	 I	required	an	assay	that	would	provide	a	consistent	gap	between	the	proximal	 and	 distal	 stumps	 from	 which	 the	 axons	 and	 Schwann	 cells	 could	outgrow.	 Figure	 5.1	 shows	 the	 average	 gap	 between	 proximal	 and	 distal	 nerve	stumps	measured	at	5	days	following	transection.	At	this	time	the	nerve	bridge	is	still	 translucent	 and	 is	 easy	 to	measure	 by	 light	microscopy.	 	 The	measurement	showed	that	the	gap	between	the	nerve	stumps	varied	from	1	to	6	mm	in	the	case	of	 control	 mice	 and	 2	 to	 6	 mm	 in	 the	 case	 of	 c-Jun	 cKO	 mice.	 The	 substantial	variation	 in	 bridge	 length	 resulted	 in	 large	 error	 bars	 for	 the	 averages	 in	 both	genotypes	 (SEM	 =	 0.87	 mm	 and	 0.78	 mm	 for	 control	 and	 c-Jun	 cKO	 samples	respectively).		 	
 
 
	 121	
	
Figure	5.1	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 5.1	 Complete	 Sciatic	 nerve	 transection	 produces	 a	 variable	 nerve	
bridge	size.	Quantification	of	nerve	bridge	distance	at	5	days	post	 transection.	There	was	no	significant	difference	between	the	two	mouse	genotypes.	Significantly	there	is	the	large	variation	in	bridge	size	for	the	given	number	of	mice,	as	shown	by	the	large	error	bars.	Results	shows	are	the	mean	±	SEM	of	three	independent	experiments	performed	in	triplicate.	A	total	of	9	mice	were	used	for	each	of	the	control	and	c-Jun	KO	samples.	
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5.2.2	Transection	of	solely	the	peroneal	branch,	leaving	the	tibial	branch	
intact	produces	a	consistent	nerve	bridge	size	Due	 to	 the	 lack	 of	 repeatability	 from	 the	 complete	 sciatic	 nerve	 transection,	 I	needed	to	develop	an	assay	that	would	generate	more	consistent	results	and	allow	me	to	test	whether	Schwann	cell	c-Jun	deletion	has	an	effect	on	axon	and	Schwann	cell	outgrowth	and	the	formation	of	the	nerve	bridge.	To	achieve	this,	I	decided	to	transect	only	the	common	peroneal	branch	of	the	sciatic	nerve,	as	this	would	leave	the	larger	tibial	branch	intact	and	in	position	to	provide	support	for	the	proximal	and	distal	nerve	stumps	with	 the	aim	of	creating	a	more	consistent	gap	between	them.	The	sural	branch	was	not	suitable	for	this	due	to	 its	smaller	size	making	it	harder	 to	 visualize	 during	 surgery.	 Figure	 5.2	 is	 an	 illustration	 of	 the	 ‘partial	transection’	model	of	sciatic	nerve	injury.	A	full	explanation	of	the	method	for	this	assay	is	described	in	Chapter	2.	As	 shown	 in	 Figure	 5.3	 there	was	 a	much	more	 consistent	 size	 of	 bridge	between	the	nerve	stumps	for	both	control	and	c-Jun	cKO	mice.	The	gap	between	the	proximal	and	distal	common	peroneal	nerve	stumps	ranged	between	1	and	1.5	mm	for	both	the	control	and	c-Jun	cKO	mice.	The	standard	error	of	 the	mean	for	these	samples	was	0.087	mm	and	0.083	mm	for	control	and	cKO	mice	respectively.	This	compares	to	0.87	mm	and	0.78	mm	for	the	complete	sciatic	nerve	transection	results	 shown	 in	Figure	5.1.	This	 shows	clearly	 that	using	 the	partial	 transection	model	generates	much	more	consistent	replicates	than	the	complete	sciatic	nerve	transection	model,	 and	 therefore	 requires	 fewer	 animals	 in	 each	 experiment.	 In	line	with	the	results	shown	from	Figure	5.1,	there	was	no	significant	difference	in	bridge	length	between	the	two	genotypes.	
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Figure	5.2	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	5.2	An	illustration	of	the	Sciatic	nerve	partial	transection	model	The	 peroneal	 branch	 of	 the	 Sciatic	 nerve	 is	 transected	 using	 surgical	 scissors	 to	create	 a	 clean	 cut	 of	 the	 tissue.	Minimal	 disturbance	 of	 the	 nerve	 is	 required	 in	order	for	the	nerve	stumps	to	remain	in	place	and	supported	by	the	tibial	branch.	After	7	days,	outgrowth	of	tissue	from	the	two	stumps	has	formed	a	stable	nerve	bridge	that	is	suitable	for	wholemount	immunostaining.	
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Figure	5.3	
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.3	Partial	transection	of	the	Sciatic	nerve	produces	a	more	consistent	
nerve	bridge	Quantification	of	nerve	bridge	size	at	5	days	post	transection.	Results	shows	are	the	mean	±SEM	of	three	independent	experiments	performed	in	triplicate.	A	total	of	9	mice	were	used	for	each	of	the	control	and	c-Jun	KO	samples.	There	is	no	significant	difference	between	the	two	mouse	genotypes. 
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5.2.3	c-Jun	null	Schwann	cells	are	able	to	cross	the	nerve	bridge	by	7	days	I	 used	 the	partial	 transection	model	 to	 compare	 control	 and	 c-Jun	 cKO	Schwann	cells	 in	 the	 nerve	 bridge.	 This	 was	 done	 by	 carrying	 out	 wholemount	immunostaining	 of	 the	 samples	 to	 show	 localization	 of	 the	 Schwann	 cell	marker	S100	at	7	days	post	transection.	The	images	in	Figure	5.4	show	that	S100	positive	cells	were	distributed	along	the	entire	length	of	the	nerve	bridge.	This	experiment	was	 repeated	 in	 3	 animals	 per	 genotype	 and	 the	 images	 in	 Figure	 5.4	 are	representative	 of	 these.	 Surprisingly,	 in	 view	 of	 the	 difference	 in	 morphology	between	control	and	c-Jun	KO	Schwann	cells	 in	vitro	(Chapter	3)	the	morphology	of	individual	cells	in	the	c-Jun	cKO	appeared	to	be	similar	to	the	control,	showing	a	long	slender	profile	with	similar	sized	nuclei	(see	inset	of	Figure	5.4).					
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Figure	5.4	
 
 
 
 
Figure	5.4	Immunohistochemistry	shows	Schwann	calls	in	control	and	c-Jun	
cKO	mice	can	traverse	the	nerve	bridge	by	7	days	Immunohistochemical	 labeling	 of	 sciatic	 nerve	 wholemounts	 using	 anti-S100	antibody	to	visualise	Schwann	cells	at	7	days	following	transection.	 	Images	were	taken	by	a	Leica	confocal	as	described	in	Chapter	2	at	x20	magnification.	Arrows	indicate	the	approximate	ends	of	the	proximal	and	distal	nerve	stumps.	This	figure	is	 a	 composite	 of	 8	 separate	 confocal	 images	 (per	 sample)	 stitched	 together	 to	reveal	the	whole	nerve	sample.	Z-stacks	were	taken	at	an	interval	of	1	µm,	with	a	total	of	40	slices	to	a	depth	of	40	µm.	
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5.2.4	Both	control	and	c-Jun	cKO	nerves	show	regrowth	of	axons	across	the	
bridge	at	seven	days	after	injury,	but	control	axons	penetrate	much	farther	
into	the	distal	stump	than	axons	from	c-Jun	cKO	nerves.	I	 compared	 axon	 outgrowth	 from	 control	 and	 c-Jun	 cKO	 mice	 using	 a	 similar	experimental	 approach.	 In	 this	 case,	 the	 same	 wholemount	 samples	 	 shown	 in	Figure	 5.4	 were	 double	 labeled	 with	 anti-neurofilament	 antibody	 to	 visualise	axons.	 Similar	 results	 were	 obtained	 in	 three	 separate	 experiments.	 The	 double	labeling	protocol	is	described	in	Chapter	2	and	was	optimised	for	this	experiment	by	 performing	 a	 no	 first	 layer	 control	 to	 check	 for	 non-specific	 staining.	 I	 also	carried	 out	 the	 necessary	 second-layer	 controls	 to	 check	 for	 cross-reactivity	between	the	chick	anti-neurofilament	antibody	and	anti-rabbit-Cy3	antibodies	and	the	rabbit	anti-S100	and	anti-Chick-488	antibodies.	Several	antibodies	 for	axonal	markers	 were	 tested,	 including	 mouse	 anti-neurofilament,	 rabbit	 anti-neurofilament,	 anti-galanin	 and	 anti-CGRP	 antibodies,	 but	 the	 anti-chick	neurofilament	 yielded	 the	 best	 staining	 for	 both	 wholemount	 and	 cryosection	sample	preparations.		Figure	5.5	shows	that	at	7	days	post	injury,	axons	in	the	control	nerve	had	grown	through	the	nerve	bridge	and	into	the	distal	stump.	In	the	c-Jun	cKO	nerve,	on	 the	other	hand	axons	had	barely	penetrated	 the	distal	 stump.	This	effect	was	quantified	by	measuring	the	 length	of	 the	 longest	axon	 in	the	distal	stump	in	the	two	mouse	genotypes	using	additional	7	day	partial	 transection	samples.	 Injured	nerves	 from	 three	 separate	 pairs	 of	 mice	 were	 embedded	 in	 OCT	 and	 serial	sections	were	made	at	 fixed	100	μm	 	 intervals	up	 to	 the	 sample	 length	of	5	mm	(Figure	5.6).	This	showed	that	axons	reached	a	maximum	distance	of	0.8	mm	after	7	days	in	the	c-Jun	cKO	mice,	compared	to	at	least	5	mm	in	the	control	mice.		 	
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Figure	5.5	
	
	
	
	
	
Figure	5.5	Axonal	regrowth	into	the	distal	stump	is	deficient	in	the	c-Jun	KO	
mouse	at	7	days.	Immunohistochemical	 labeling	 of	 nerve	 wholemounts	 using	 anti-neurofilament	antibody	to	visualise	axons	at	7	days	following	transection.	Images	were	taken	by	Leica	confocal	microscope	as	described	in	Chapter	2,	at	x20	magnification.	Arrows	indicate	the	approximate	ends	of	the	proximal	and	distal	nerve	stumps.	This	figure	is	 a	 composite	 of	 8	 separate	 confocal	 images	 (per	 sample)	 stitched	 together	 to	reveal	the	whole	nerve	sample.	Z-stacks	were	taken	at	an	interval	of	1	µm,	with	a	total	of	40	slices	to	a	depth	of	40	µm.	 	
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5.3	Discussion	My	 results	 show	 that	 it	 is	 possible	 to	 form	 a	 consistent	 size	 of	 nerve	 bridge	 by	using	the	partial	transection	injury	model	that	I	have	developed.	This	proves	to	be	more	useful	than	a	complete	transection	due	to	the	increased	repeatability	of	the	results	and	reduced	morbidity	for	the	animals.	This	method	could	also	be	adopted	for	similar	experiments	in	rats.	Whilst	there	is	a	higher	degree	of	skill	necessary	to	perform	 this	 surgery	 over	 the	 complete	 transection	 model,	 this	 is	 fairly	 easily	overcome	with	 appropriate	 surgical	 scissors,	 a	 higher	magnification	when	 using	the	dissecting	microscope	and	practicing	the	technique	on	cadavers.	It	is	important	to	 note	 that	 the	 partial	 transection	 of	 the	 sciatic	 nerve	was	 performed	 far	 away	from	 the	 sacral	 plexus,	 at	mid-thigh	 level.	 In	 this	 region,	 the	 peroneal	 and	 tibial	nerves	 are	 held	 together	 by	 loose	 tissue	 from	 their	 respective	 outermost	 layers	(epineurium)	 and	with	 a	 precise	 transection	of	 the	peroneal	 nerve,	 it	 is	 unlikely	that	significant	damage	would	be	inflicted	upon	the	tibial	nerve	fibers,	however	to	confirm	 this,	 immunohistochemistry	 could	 be	 done	 in	 the	 future	 to	 ensure	 the	tibial	nerve	 fibers	remain	 intact	and	there	 is	no	 interaction	of	Schwann	cells	and	axons	from	the	tibial	nerve	into	the	newly	formed	peroneal	nerve	bridge.	Although	I	found	no	difference	between	c-Jun	and	control	mice	in	the	length	of	 the	 bridge	 between	 the	 proximal	 and	 distal	 stumps	 using	 the	 conventional	transection	assay,	it	might	be	possible	to	find	a	statistically	significant	difference	if	enough	 animals	 were	 used.	 However	 this	 would	 be	 both	 impractical	 and	expensive.	But	for	both	mouse	lines,	the	sciatic	nerve	complete	transection	model	is	problematic	for	the	purpose	of	assaying	outgrowth	of	Schwann	cells	and	axons	from	 the	 nerve	 stumps	 due	 to	 the	 high	 variability	 of	 the	 nerve	 bridge	 that	 is	formed.	 There	 are	 a	 number	 of	 reasons	 that	 may	 contribute	 to	 the	 lack	 of	consistency	 in	 the	 complete	 transection	method.	 The	 behavior	 of	 the	 mice	 may	
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contribute	to	gap	size	as	neither	the	proximal	or	distal	stumps	are	anchored	inside	the	thigh	cavity	and	are	free	to	move.	Stretching	of	the	hind	limb	could	move	the	stumps	apart	and	impede	the	formation	of	the	nerve	bridge	or	create	a	larger	gap	for	the	bridge	to	cross.	While	the	mice	used	in	this	experiment	were	matched	for	age	 and	 sex,	 some	 physiological	 differences	 between	 the	 mice	 exist,	 and	 these	might	further	contribute	to	the	gap	size.	The	amount	of	stress	applied	to	the	intact	nerve	in	normal	conditions	is	unlikely	to	be	precisely	the	same	between	different	mice.	Therefore,	when	 the	nerve	 is	 severed,	 the	 force	 that	pulls	 the	nerves	apart	would	 also	 not	 be	 identical	 and	 would	 result	 in	 varying	 distances	 between	 the	nerve	stumps.		 In	 contrast,	 a	 comparison	 of	 my	 results	 using	 the	 improved	 method	 of	creating	 the	 bridge	 (Figure	 5.2)	 with	 those	 achieved	 using	 the	 conventional	method	(Figure	5.1)	shows	that	the	assay	I	devised	can	produce	highly	repeatable	results	for	the	nerve	bridge	size,	giving	confidence	to	the	results	shown	in	Figure	5.3,	indicating	that	there	is	no	difference	in	nerve	bridge	size	between	the	control	and	 c-Jun	 knockout	 nerves.	 In	 vitro,	 c-Jun	 knockout	 Schwann	 cells	 show	 a	much	reduced	rate	of	migration	 in	 the	wound	and	transwell	migration	assays	(Chapter	3)	and	this	might	affect	formation	of	the	nerve	bridge,	but	for	now	I	can	conclude	that	c-Jun	null	Schwann	cells	do	not	affect	the	formation	of	the	bridge,	in	terms	of	the	amount	of	tissue	between	the	nerve	stumps.	This	is	somewhat	expected	since	the	initial	 formation	of	the	bridge	is	carried	out	mostly	by	perineurial	 fibroblasts		and	 see	 discussion	 below.	 The	 outgrowing	 fibroblasts	 possess	 the	 same	 type	 of	collagen	 fibrils	 as	 perineurial	 and	 endoneurial	 fibroblasts,	 distinct	 from	 those	fibroblasts	of	the	epineurium	(Thomas	1966).		To	see	whether	 the	Schwann	cell	emigration	 from	the	proximal	and	distal	stumps	 that	 normally	 occurs	 after	 injury	 is	 affected	 by	 the	 loss	 of	 c-Jun,	 I	 next	
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performed	 immunohistochemistry	 on	 peroneal	 nerve	 wholemount	 preparations	using	 antibodies	 to	 S100,	 a	 Schwann	 cell	marker,	 to	 visualise	 the	 Schwann	 cells	(Figure	5.4).		These	experiments	showed	that	at	7	days	after	injury	in	both	control	and	 Schwann	 cell	 c-Jun	 KO	 nerves,	 Schwann	 cells	 have	 migrated	 to	 fill	 the	 gap	between	 the	 proximal	 and	 distal	 stumps.	 	 Interestingly,	 as	 shown	 in	 the	 higher	power	insert	to	Figure	5,	 the	elongated	bipolar	shape	of	the	Schwann	cells	 in	the	bridge	appears	similar	 in	both	control	and	c-Jun	KO	nerves.	As	mentioned	above	this	 is	 surprising,	 given	 the	 reduced	 rate	 of	 Schwann	 cell	 migration	 in	 culture	assays	and	the	marked	difference	in	cell	shape	between	freshly	isolated	Schwann	cells	 from	 c-Jun	 and	 control	mice	 (Chapter	 3).	 Possible	 reasons	 for	 the	 c-Jun	KO	Schwann	 cells	 in	 the	 nerve	 bridge	 exhibiting	 a	 normal	 shape	 and	migration	 at	 7	days	 after	 injury	 include	 the	 very	 different	 environment	 of	 the	 bridge	 which	consists	of	a	gel-like	extracellular	matrix,	fibroblasts,	macrophages,	newly	formed	blood	vessels	and	other	 immune	system	cells	 (Parrinello	2012,	Chen	et	al.	2007)	compared	with	the	more	defined	conditions	used	in	the	culture	assays.	In	addition,	there	are	interactions	between	the	regenerating	axons	and	the	c-Jun	KO	Schwann	cells	that	are	not	present	in	the	Schwann	cell	cultures.	It	would	be	informative	to	carry	 out	 future	 experiments	 in	 neuron-Schwann	 cell	 co-cultures	 to	 see	 if	 axons	can	rescue	the	aberrant	c-Jun	KO	cell	morphology	in	vitro.		To	establish	definitively	whether	the	migration	rate	into	the	bridge	is	affected,	experiments	at	shorter	time	points	after	nerve	transection	would	need	to	be	carried	out.		Several	attempts	were	made	to	do	this,	but	technical	problems	involving	the	fragility	of	the	bridge	tissue	at	 three	and	 five	days	after	 transection	when	performing	 immunohistochemistry	would	need	to	be	solved	in	the	future	before	a	definitive	answer	could	be	obtained.	Seven	days	after	transection	my	experiments	show	that	axonal	growth	into	the	distal	stump	is	severely	retarded,	although	axons	in	both	control	and	Schwann	
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cell	c-Jun	KO	nerves	have	crossed	the	bridge	from	the	proximal	to	the	distal	stump.		It	 is	 therefore	 possible	 that	 removing	 c-Jun	 from	 Schwann	 cells	 provides	 an	unfavourable	 environment	 for	 axons	 to	 grow	 through	 the	 distal	 stump	 that	 is	different	 from	 the	 environment	 present	 in	 the	 bridge.	 	 Before	 coming	 to	 this	conclusion	however	it	would	be	important	to	establish	whether	the	rate	of	 initial	outgrowth	 of	 axons	 from	 the	 proximal	 stump	 into	 the	 bridge	 and	 the	 rate	 of	growth	across	the	bridge	once	the	axons	start	to	grow	is	identical	in	the	wild	type	and	 Schwann	 cell	 c-Jun	 KO	 nerve,	 since	 a	 slower	 outgrowth	 of	 axons	 from	 the	proximal	stump	in	the	knockout	will	also	contribute	to	the	lower	overall	growth	of	axons	 at	 7	 days	 shown	 in	 Figures	 5.5	 and	5.6.	 	 As	mentioned	 above	 it	would	 be	necessary	to	repeat	the	axonal	experiments	at	shorter	time	points	when	technical	problems	have	been	solved.	This	would	enable	me	to	determine	firstly	whether	the	initial	 outgrowth	 of	 axons	 from	 the	 proximal	 stump	 is	 delayed	 in	 the	 c-Jun	 cKO,	and	 secondly	 whether	 the	 rate	 of	 elongation	 across	 the	 bridge	 is	 slower	 once	axonal	growth	is	initiated	compared	with	control	nerves.		It	would	also	allow	me	to	determine	whether	the	rate	of	growth	after	entry	into	the	distal	stump	is	the	same	as	 the	 rate	 of	 growth	 across	 the	 bridge	 both	 in	 c-Jun	 cKO	 and	 control	 nerve	transected	 nerves.	 Preliminary	 results	 in	 the	 laboratory	 have	 shown	 that	 some	regeneration	 associated	 genes	 (RAGs)	 in	 sensory	 neurons	 are	 activated	 more	slowly	 when	 c-Jun	 is	 removed	 from	 Schwann	 cells	 (Shaline	 Fazal,	 unpublished	data)	suggesting	that	c-Jun	controls	signals	from	Schwann	cells	that	contribute	to	the	activation	of	axonal	growth	after	injury.				Nevertheless	 it	 is	 also	possible	 that	 the	Schwann	cells	 in	 the	distal	 stump	also	provide	an	unfavourable	environment	for	axonal	growth	that	is	not	present	in	the	different	environment	of	the	bridge.	The	fact	that	the	axons	in	the	Schwann	cell	c-Jun	 KO	 nerves	 are	 still	 able	 to	 cross	 the	 nerve	 bridge	 could	 be	 related	 to	 the	
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different	molecular	and	cellular	composition	of	the	two	tissues.	The	nerve	bridge	architecture	 is	 less	 developed	 than	 that	 of	 the	 distal	 stump	 and	 lacks	 the	 basal	lamina	 endoneurial	 tubes	 of	 the	distal	 stump.	The	nerve	bridge	 also	 contains	 an	abundance	 of	 fibroblasts,	 inflammatory	 cells	 and	 growing	 blood	 vessels	 at	 this	early	 stage	 of	 regeneration.	 Nerve	 bridge	 formation	 and	 axonal	 regrowth	 occur	concurrently,	 and	 it	 is	 possible	 that	 events	 that	 take	 place	 in	 the	 nascent	 nerve	bridge	 but	 not	 in	 the	 distal	 stump,	 such	 as	 fibroblast-Schwann	 cell	 sorting	 and	guiding	 of	 axonal	 growth	 cones	 by	 Schwann	 cell	 processes	 are	 sufficient	 to	 aid	axon	 regrowth	 across	 the	 bridge,	 but	 that	 this	 regeneration	 stalls	 in	 the	 very	different	environment	of	the	distal	stump	(Zochodne	2010;	Parrinello	et	al.	2010).		Previous	experiments	 in	 the	 laboratory	using	Schwann	cell	 c-Jun	KO	mice	have	 shown	 that	 Schwann	 cells	 in	 the	 distal	 stumps	 of	 these	 mice	 fail	 to	 make	trophic	 factors	 for	 axons	 such	 as	 GDNF,	 BDNF	 and	 artemin	 at	 7	 days	 after	transection,	 that	 axonal	 regeneration	 after	 crush	 injury	 is	 slower	 and	 that	expression	of	cell	surface	molecules	such	as	N-Cadherin,	p75NTR	and	L1	is	down-regulated.	 The	 rate	 of	 myelin	 breakdown	 is	 also	 slower	 in	 the	 c-Jun	 cKO	 nerve	(Parkinson	 et	 al.	 2008;	 Arthur-Farraj	 et	 al.	 2012).	 A	myelin-rich	 environment	 is	generally	 considered	 inhibitory	 to	 axonal	 regrowth,	 and	 this	 may	 be	 a	 further	factor	 in	 the	 slow	 regrowth	 of	 the	 axons	 into	 the	 c-Jun	 cKO	 distal	 nerve	 stump	(Vargas	&	Barres	2007).		It	is	also	known	that	the	bands	of	Bungner	in	the	c-Jun	cKO	nerves	have	an	abnormal	morphology	at	4	weeks	after	nerve	transection	injury	(Arthur-Farraj	et	al.,	2012)	with	 flatter	Bungner	cells	and	fewer	cellular	profiles.	As	I	have	already	shown	 in	 Chapter	 2,	 Schwann	 cells	 freshly	 isolated	 from	 P9	 c-Jun	 cKO	 nerves	already	 display	 a	 similar	 phenotype	 to	 the	 Bungner	 cells.	 This	 morphological	phenotype	may	stop	axons	 from	growing	normally	 into	 the	endoneurial	 tubes	of	
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the	distal	 stump	and	help	 to	account	 for	 the	 retarded	axonal	 regrowth,	 although	this	seems	unlikely	since	there	is	no	sign	of	axon	build	up	at	the	junction	between	the	bridge	and	the	distal	stump	in	the	c-Jun	cKO	nerve	samples	similar	to	that	seen	when	regenerating	axons	become	trapped	by	the	over-expression	of	neurotrophic	factors	such	as	GDNF	in	nerve	grafts,	the	so-called	“candy	store	effect”	(Blits	et	al.	2004)	(Fig	5.5).	The	morphological	abnormalities	may,	however,	have	a	significant	effect	on	axonal	growth	once	the	axons	have	to	grow	through	the	environment	of	the	distal	stump.	In	 summary,	 in	 the	 future	 it	 will	 be	 important	 in	 conduct	 further	experiments	 to	distinguish	between	 the	 contributions	of	 each	of	 the	possibilities	mentioned	 above.	 A	 future	 experimental	 approach	 to	 confirm	 this	 includes	 the	grafting	of	a	wildtype	distal	stump	to	wildtype	and	c-Jun	cKO	proximal	stumps	to	assay	 for	 the	 regrowth	 of	 axons	 from	 neurons	 that	 have	 not	 been	 affected	 by	Schwann	cell	c-Jun	via	the	possible	induction	of	RAGs.		 	
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Chapter	6:	General	Discussion		The	 earliest	 studies	 carried	 out	 on	 peripheral	 nerves	 were	 quick	 to	 identify	Schwann	 cells	 as	 being	 highly	motile	 cells,	 both	 during	 development	 and	 in	 the	degenerating	 nerve.	 This	 migratory	 behavior	 has	 been	 studied	 since,	 however,	mostly	 in	 the	 context	 of	 uncovering	 the	mechanisms	 of	 Schwann	 cell	 precursor	migration	using	cultured,	neonatal	Schwann	cells.	These	cells	were	referred	to	 in	the	past	as	dedifferentiated	Schwann	cells,	however,	work	from	our	 lab	 indicates	that	 a	more	 appropriate	 term	would	 be	 ‘transdifferentiated’,	 since	 the	 Schwann	cell	 formed	following	nerve	injury	functions	as	a	specialized	repair	cell,	and	does	not	resemble	the	immature	Schwann	cell	progenitor,	aside	from	the	lack	of	myelin	and	 the	 expression	 of	 some	 cell	 markers.	 Cells	 undergoing	 an	 epithelial-to-mesenchymal	 transition	 lose	 their	 polarity	 and	 contacts	with	 neighbouring	 cells	and	 adopt	 a	migratory	behavior.	This	 is	 comparable	 to	 the	behavior	of	 Schwann	cells	 following	 nerve	 injury,	 where	 they	 lose	 contact	 with	 axons	 and	 where	possible,	can	migrate	from	nerve	stumps.		The	aim	of	this	thesis	was	to	investigate	whether	the	transcription	factor	c-Jun,	a	key	player	 in	 the	generation	of	 transdifferentiated	(Bungner)	Schwann	cells,	also	played	a	role	in	their	adoption	of	a	migratory	phenotype.	The	results	of	this	study	clearly	 show	 that	 c-Jun	 does	 regulate	 Schwann	 cell	 motility	 and	 morphology	 in	vitro.	Initial	results	in	this	thesis,	using	an	in	vivo	model	of	nerve	transection	injury	suggest	 that	 c-Jun	 is	not	 required	 for	Schwann	cells	 to	 cross	 the	bridge	between	the	proximal	and	distal	stumps.	This	is	surprising,	given	the	significant	migratory	deficit	 of	 c-Jun	 knockout	 cells	 in	 two	 migration	 assays,	 however	 the	 fact	 that	Schwann	 cells	 of	 the	 proximal	 stump	 are	 in	 contact	 with	 regrowing	 axons	 may	point	 to	 an	 explanation	 for	 this	 difference.	 It	 is	 possible	 that	 axonal	 contact	
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activates	signalling	pathways	inside	the	proximal	stump	Schwann	cells	that	allow	them	to	overcome	a	brake	on	migration	caused	by	the	absence	of	c-Jun.	Performing	migration	assays	from	DRG	explants	to	observe	the	affect	of	growing	axons	on	c-Jun	knockout	Schwann	cell	migration	might	resolve	this	question.	It	would	also	be	informative	 to	 perform	 the	 nerve	 bridge	 assay	 from	 Chapter	 5	 at	 earlier	 time	points	 to	 reveal	 whether	 the	 Schwann	 cells	 that	 are	 able	 to	 traverse	 the	 nerve	bridge	are	predominantly	from	the	proximal	stump.		It	is	clear	that	further	studies	are	 required	 to	 understand	 the	 molecular	 control	 of	 Schwann	 cell	 migration	 in	vivo,	and	the	precise	involvement	of	c-Jun	in	this.	The	finding	that	c-Jun	regulates	Schwann	cell	migration	in	vitro	may	be	important	in	the	development	of	therapies	for	nerve	injury,	 in	particular	for	nerve	conduit	experiments.	Chemical	or	genetic	modulation	 of	 c-Jun	 activity	 may	 allow	 for	 control	 over	 the	 colonization	 or	immobilization	of	Schwann	cells	in	this	environment.		The	work	presented	in	this	thesis	also	demonstrates	that	disruption	of	c-Jun	has	significant	affects	on	the	Schwann	cell	cytoskeleton,	with	the	formation	of	actin	stress	fibers	and	the	induction	of	focal	adhesions.	This	is	similar	to	the	effects	of	c-Jun	deletion	in	other	cell	types	(Jiao	et	al.	2008;	Katiyar	et	al.	2007),	however	in	the	present	case	it	is	not	apparent	that	c-Jun	directly	regulates	the	protein	expression	of	c-Src.	It	is	possible	that	c-Jun	regulates	the	phosphorylation	of	this	protein,	and	given	more	time,	further	experiments	would	be	carried	out	to	examine	the	activity	and	phosphorylation	of	c-Src,	ROCKII	and	downstream	effectors	such	as	LIMK	and	cofilin-1.	It	would	also	be	informative	to	examine	the	expression	and	activation	of	Lck	tyrosine	kinase,	as	the	expression	of	this	Src	family	member	is	associated	with	the	 formation	 of	 Schwann	 cell	 lamellipodia	 and	 the	 induction	 of	 focal	 adhesions	(Ness	et	al.	2012).	Analysis	of	gene	expression	of	a	number	of	candidates	known	to	be	 involved	 in	 cell	 cytoskeleton	 regulation	 and	 Schwann	 cell	 migration	 did	 not	
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demonstrate	 any	 significant	 differences	 between	 control	 and	 c-Jun	 knockout	Schwann	 cells.	 Further	 investigation	 using	 a	 microarray	 gene	 screen	 might	uncover	 some	 genes	 that	 are	 regulated	 by	 c-Jun,	 that	 directly	 regulate	 the	cytoskeleton,	however	 it	 is	also	possible	that	c-Jun	might	regulate	the	expression	of	 proteins	 with	 functions	 far	 removed	 from	 the	 cytoskeleton,	 that	 can	 interact	with	 cytoskeleton	proteins	 via	 signalling	 cascades.	 It	 is	 therefore	 probably	more	informative	 to	 carry	 out	 further	 analysis	 of	 protein	 activity	 and	 protein	modifications	 in	 order	 to	 determine	 the	 mechanism	 by	 which	 c-Jun	 controls	Schwann	cell	migration.	 I	 attempted	 to	measure	Rac1	and	 cdc42	activity	using	a	pull-down	 assay,	 but	 this	was	 unsuccessful	 due	 to	 technical	 difficulties	 and	 time	constraints.	The	 activity	 of	 these	Rho	GTPases	might	provide	 valuable	 clues	 into	the	regulation	of	Schwann	cell	morphology	and	migration	by	c-Jun.	Finally,	 the	 results	 herein	 demonstrate	 that	 the	 sciatic	 nerve	 partial	 transection	model	provides	a	 reproducible	and	reliable	method	 for	creating	a	nerve	gap	and	ensuing	bridge	between	proximal	 and	distal	 nerve	 stumps.	Whilst	 this	 assay	did	not	 reveal	 any	 differences	 in	 Schwann	 cell	 migration	 between	 genotypes,	wholemount	 immunostaining	 of	 the	 nerve	 stumps	 and	 bridge	 did	 allow	visualisation	of	axonal	regrowth,	and	showed	clearly	that	axonal	growth	into	the	c-Jun	knockout	distal	 stump	 is	defective.	This	nerve	 injury	model	may	be	useful	 in	future	experiments	that	consider	outgrowth	from	the	nerve	stumps,	 in	particular	to	 examine	 how	 the	 nerve	 bridge	 is	 formed	 from	migrating	 fibroblasts	 from	 the	perineurium.	In	 conclusion,	 through	 the	 investigations	 described	 in	 this	 thesis,	 I	 have	identified	c-Jun	as	a	regulator	of	Schwann	cell	migration	and	morphology	and	have	demonstrated	 a	 new	model	 of	 sciatic	 nerve	 transection	 that	 offers	 a	 significant	improvement	over	the	original	complete	transection	model.	
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Appendix	
 Primer		 Sequence	(5’	to	3’)	 Conc.,	nmol	rev/fw	 Source	GAPDH	fwd	 AGGTCGGTGTGAACGGATTTG	 200/300	 D.	Wilton,	Jessen	lab	GAPDH	rev	 TGTAGACCATGTAGTTGAGGTCA	YWHAZ	fwd	 TAAATGGTCTGTCACCGTCT		 200/300	 Sigma-Aldrich	OligoArchitect™	YWHAZ	rev	 GGAAATACTCGGTAGGGTGT		c-Jun	fwd	 AATGGGCACATCACCACTACAC		 200/200	 M.L-Hartmann	Jessen	lab	c-Jun	rev	 TGCTCGTCGGTCACGTTCT		Vinculin	fwd	 CTTCGATGAGGCTGAGGTTC	 200/300	 Primer	3	Plus	Vinculin	rev	 TGGTGAGTCAACTCCTGCTG	FAK	fwd	 CGTGAAGCCTTTTCAAGGAG	 200/200		 Primer	3	Plus	FAK	rev	 TCCATCCTCATCCGTTCTTC	Src	fwd	 TGTAGCCATGACAGGCTGAG	 300/200		 Primer	3	Plus	Src	rev	 CATGGTCCTGGCTGATAGGT	Profilin	fwd	 TGACCTCATCTGTCCCTTCC	 200/200	 Primer	3	Plus	Profilin	rev	 ACAGGAGGGGGTATGGGTAG	Cofilin1	fwd	 TGCTGCCAACTTCTAACC		 200/300	 Primer	3	Plus	Cofilin1	rev	 GTCATTTCCACATTTCATTTACAC		Paxillin	fwd	 CAACTTCGTATGGCTCAA		 200/300	 Primer	3	Plus	Paxillin	rev	 CAAGGACAGACCAGAGTA		MYLK	fwd	 GACGTGTTCACCCTGGTTCT	 150/200	 Sigma-Aldrich	OligoArchitect™	MYLK	rev	 GTCACCATCACCATGAGCAC	LIMK1	fwd	 TGCTCAAGTTCATCGGAGTG	 300/200	 Primer	3	Plus	LIMK1	rev	 TTCATCGAATGGAGGTAGGC	WASP	fwd	 CCTGGCCCAACTGATAAGAA	 200/200	 Sigma-Aldrich	OligoArchitect™	WASP	rev	 AGACCTCCCTGGTCCTCAAT	Actn1	fwd	 GGCAAGATGAGAGTGCACAA	 200/200	 Primer	3	Plus	Actn1	rev	 AGATGTCCTGGATGGCAAAG	SRF	fwd	 ATGCCCCATCCCTTAAAATC	 200/300	 Primer	3	Plus	SRF	rev	 CGCAGAAGTAGGCTTGTTCC	ROCK2	fwd	 CTGAATGAAATGCAGGCTCA	 300/200	 Sigma-Aldrich	OligoArchitect™	ROCK2	rev	 CACAGGCAATGACAACCATC	NRG1	I	fwd	 GGGAAGGGCAAGAAGAAGG	 200/300	 Stassart	et	al.,	2012	NRG1	I	rev	 TTTCACACCGAAGCACGAGC	NRGI	II	fwd	 CCTCGTTTCCTCCGCTG	 200/200	 Stassart	et	al.,	2012	NRGI	II	rev	 GACTCCTGGCTTTTCATCTCTT	NRGI	III	fwd	 ACTCAGCCACAAACAACAGAAAC	 200/200	 Stassart	et	al.,	2012	NRGI	III	rev	 GAAGCACTCGCCTCCATT	ErbB2	fw	 GAGACAGAGCTAAGGAAGCTGA	 300/200	 Primer	3	Plus	ErbB2	rew	 ACGGGGATTTTCACGTTCTCC	ErbB3	fw	 AAGTGACAGGCTATGTACTGGT	 200/200	 Primer	3	Plus	ErbB3	rev	 GCTGGAGTTGGTATTGTAGTTCA	Shp2	fw	 CATGGCAGCTTCCTCGTTC	 200/200	 Primer	3	Plus	Shp2	rev	 TCCCCTTTGTCGTCACCAGT	GDNF	fw	 GATTCGGGCCACTTGGAGTT	 200/200	 M.L-Hartmann	Jessen	lab	GDNF	rev	 GACAGCCACGACATCCCATA	Olig1	fw	 CCGCCCCAGATGTACTATGC	 200/300		 M.L-Hartmann	Jessen	lab	Olig1	rev	 AACCCACCAGCTCATACAGC	MBP	fw	 TCACAGCGATCCAAGTACCTG	 300/200	 Primer	Bank	MBP	rev	 CCCCTGTCACCGCTAAAGAA	MAL	fw	 TTTGTGAGTTTGTCTTTGGAGGC	 200/300	 PrimerBank	
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MAL	rev	 CCGCCATGAGTACCAATTATGT	SSH1	fw	 ACCTTCTGCGTTGCGAAGAC	 200/200	 PrimerBank	SSH1	rev	 AGGTGGATTTTCGTGTCGCTC	Gelsolin	fw	 TCACGGGTGATGCCTATGTCA	 200/300	 Primer	3	Plus	Gelsolin	rev	 AGCCAATAGTGGAGGTCATACTG	NF2	fw	 GCTCCCGAAAAGGGTGATAAA	 200/300	 Primer	3	Plus	NF2	rev	 GCATACCAAGCCGTAATTCTCTC	WASF1	fw	 ATGCCGTTGGTGAAAAGAAACA	 300/200	 Primer	3	Plus	WASF1	rev	 ACACTAACAGACAATCGGTCCA	ARP3	fw	 CGCTGACGGGTACAGTAATAGA	 200/300	 Primer	3	Plus	ARP3	rev	 TCCTGCGATTGGAATGTGTTTA	Krox20	fw	 GCCAAGGCCGTAGACAAAATC	 300/200	 M.L-Hartmann	Jessen	lab	Krox20	rev	 CCACTCCGTTCATCTGGTCA	Talin1	fw	 TACTACATGCTCCGAAATGGGG	 200/200	 Primer	3	Plus	Talin1	rev	 CACCGTTCCGTCTAACATCCG	Villin1	fw	 TCAAAGGCTCTCTCAACATCAC	 200/200	 Primer	3	Plus	Villin1	rev	 AGCAGTCACCATCGAAGAAGC	Beta-catenin	f	 ATGGAGCCGGACAGAAAAGC	 200/200	 Primer	3	Plus	Beta	catenin	r	 CTTGCCACTCAGGGAAGGA	Adam23	fw	 CTTTCGGCTCCAAGTTCATTCT	 300/200	 Primer	3	Plus	Adam23	rev	 TCCCGTCTTCATAGTGGATCTC	TSC2	fw	 TGCCGCAGCATCAGTGTATC	 200/300	 Sigma-Aldrich	OligoArchitect™	TSC2	rev	 TGCCAGGAGGAACTCTCCC	REST	fw	 GGCAGATGGCCGAATTGATG	 300/200	 Sigma-Aldrich	OligoArchitect™	REST	rev	 CTTTGAGGTCAGCCGACTCT	Cadherin1	fw	 CAGGTCTCCTCATGGCTTTGC	 200/200	 Primer	3	Plus	Cadherin1	rv	 CTTCCGAAAAGAAGGCTGTCC	RhoA	fw	 AGCTTGTGGTAAGACATGCTTG	 200/200	 PrimerBank	RhoA	rev	 GTGTCCCATAAAGCCAACTCTAC	Rac1	fw	 GAGACGGAGCTGTTGGTAAAA	 300/200	 Primer	3	Plus	Rac1	rev	 ATAGGCCCAGATTCACTGGTT	Cdc42	fw	 CCCATCGGAATATGTACCAACTG	 200/300	 Primer	3	Plus	Cdc42	rev	 CCAAGAGTGTATGGCTCTCCAC		 Gene	 C(t)	value	GAPDH	 26	YWHAZ	 24	c-JUN	 24	Vinculin	 23	FAK	 28	SRC	 26	Profilin	 27	Cofilin1	 27	Paxillin	 23	MYLK	 26	LIMK	 23	WASP	 21	Actn1	 24	SRF	 24	ROCK1	 20	ROCK2	 25	NRG1	I	 34	
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NRG1	II	 33	NRG1	III	 25	ErbB2	 29	ErbB3	 28	Shp2	 25	GDNF	 26	Olig1	 21	MBP	 23	MAL	 23	SSH1	 29	Gelsolin	 27	NF2	 29	WASF1	 29	ARP3	 25	Krox20	 24	Talin1	 23	Villin1	 27	Beta-catenin	 26	Adam23	 26	TSC2	 21	REST	 24	Cad1	 26	RhoA	 29	Rac1	 24	Cdc42	 23		
